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Development of Novel Scaffolds for Skeletal Muscle 
Tissue Engineering Applications 
ABSTRACT  
Tissue Engineering (TE) is emerging as an effective way of curing tissue oriented 
disorders through new tissue regeneration. Recently graphene oxide (GO composed of 
graphene oxide nanoplatelets, GOnPs) is widely being used for electronic and 
biomedical applications because of its favourable physicochemical properties. The 
present thesis work focuses on the fabrication of  electrospun GO-poly (ɛ-caprolactone, 
PCL) and GO-poly (lactic-co-glycolic acid, PLGA) composite scaffolds for myoblast 
proliferation and differentiation of human cord blood derived mesenchymal stem cells 
(hMSCs), which is novel and challenging. The GO surface possessing different 
hydrophilic groups allowed it to be well dispersed in the polymer matrices for making 
electrospun fibrous scaffold meshes. Addition of GO in these polymers enhanced 
mechanical property, hydrophilicity and electrical conductivity of the GO-polymer 
composites. Electrical conductivity of the GO-PCL and GO-PLGA scaffolds increased by 
about two orders of magnitudes (from ~5x10-9 to 2.3 x10-7 S/m2) with the addition of 
low GO concentration (within non-toxicity limit <20 µg/ml for human cells). Such 
enhancement of conductivity along with nanostructural surface morphology of GO 
improved the biocompatibility and cell viability of the developed scaffolds. GO-polymer 
composites showed percolation behavior at low GO concentrations (~0.79 and 
0.76wt%, respectively, for GO-PCL and GO-PLGA). High resolution TEM (HRTEM) and 
Raman G and D peak values indicated the presence of GO in the composite scaffold  
messes. In-vitro cell culture study confirmed excellent myoblast differentiation of 
hMSCs on these electrospun composite scaffolds. The GO-PCL composite scaffolds with 
suitable mechanical properties, little higher hydrophilicity as well as conductivity and 
dielectric constant (associated with GO surface charge) compared to those of GO-PLGA,  
exhibited better myoblast differentiation and promoted self-aligned myotubes 
formation, which were  evident by cell attachment (FESEM studies), viability and 
proliferation (WST-8 assay), Immunohistochemical analysis etc. Moreover, IGF-1 cell 
signalling pathway study done on GO-PCL scaffolds also indicated superiority of the GO-
PCL scaffolds for skeletal muscle tissue regeneration. It was  revealed, for the first time, 
vii 
 
that GO surface charge and significant enhancement of conductivity of the GO–polymer 
nanocomposite scaffolds, GO-PCL scaffold in particular, might be considered as 
potential candidates for the myoblast differentiation of hMSCs for the next generation 
human skeletal muscle tissue regeneration. 
Keywords: Tissue Engineering; Myoblast differentiation;  Graphene Oxide (GO); GO-
Polymer Composites;  Electrospun Scaffolds;  Umbilical Cord Blood; Mesenchymal 
Stem Cells; Skeletal Muscle Tissue. 
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1. General Introduction 
This chapter provides a general introduction and brief discussion on different basic 
aspects of tissue engineering (TE), skeletal muscle structure and functions, muscle repair 
mechanism, challenges of skeletal muscle TE, significance and important properties of TE 
scaffolds, material aspect of scaffolds, stem cells and their importance in TE, future 
prospect of TE, its limitations and problems. A brief outline of the organization of the 
thesis is presented at the end of the chapter. 
1.1. Background and Importance of the Study 
With the advent of modern science and technology, conventional clinical fields of 
research and development have reached to a peak of excellence; various complicated 
tissue related diseases are being treated via medication and through surgeries with the 
aid of available modern sophisticated instrumental facilities. But, in several acute cases, 
precise clinical services with adequate advanced technological approaches are 
occasionally needed; especially when replacement or regeneration of tissue is of vital 
importance and where application of advanced TE becomes inevitable. Scientists and 
biotechnologists with their innovative ideas are engaged working in this highly 
demanding field of “Tissue Engineering”, that regenerates, maintains and improves the 
functionality of the damaged or diseased tissues [1,2]. Currently, TE has  become  one of 
the rapidly emerging fields of clinical research contributing to the advancement of 
regenerative medicine to cure various diseases related to skeletal muscle [3,4], bone [5], 
cartilage [6,7], skin [8] and cardiac failure [9] to name a few. 
The skeletal muscle tissue (SMT) is one of the most important tissue types 
responsible for the movements of different parts of human body. The main purpose of 
SMT engineering is to restore movements of defective limbs [10] or organs. The SMT 
damage might occur due to various causes like injuries, burns and disease like muscle 
trauma [11]. In such cases, large muscle tissues are lost or damaged thereby become 
non-functional.  Moreover, there is also a chronic shortage of donor organs available for 
transplantation that highlights the urgency to develop novel strategies to address this 
problem.  In general, medical treatment is performed by grafting of muscle from another 
part of the body to compensate the damaged area (auto graft) or by healthy tissues, 
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harvested from another animal or human (allograft), are  used. Moreover, as mentioned 
above, there is also acute donor scarcity. In such cases, immunorejection and matching 
of identical physical structure are of major concerns [12]. Even if this procedure is 
carried out successfully, it may not provide natural orientation and functionality to the 
repaired or cured tissues [13]. Under such circumstances, patients might have to go 
through repeated surgeries that might sometimes be fatal [14]. To cope up with such 
adverse circumstances, TE has come forward with immense potential, not only to regain 
lost tissue, but also to maintain and provide tissue structure and strength without 
hampering its original functionality [15].  
The most important requirements of successful tissue engineering are 
biocompatible scaffolds and live cells. Scaffolds must provide favorable environment for 
the differentiation and proliferation of the despised tissues. Such scaffolds should 
facilitate necessary guiding cues for tissue regeneration within the required time frame. 
For making skeletal muscle TE scaffolds, various biocompatible polymers have so far 
been used depending upon specific tissue types. Most popular biocompatible and widely 
studied polymers are both synthetic such as PCL (polycaprolactone) [3,4], PLA (poly-
lactic acid) [16], PGA (poly-glycolic acid) [17], PLGA (poly-lactide-co-glycolide) [18] as 
well as natural polymers namely collagen, silk fibroin, chitosan [19,20]. But various 
problems related to biodegradability, mechanical stability, cell scaffold interaction, 
hydrophilicity, and conductivity of these scaffolds are needed to be tuned to develop a 
suitable scaffold for a particular tissue engineering application. A single polymer (natural 
or synthetic) scaffold has not been found, so far, to be suitable to provide all the desired 
properties (mechanical, biodegradability, conductivity etc.) to successfully regenerate a 
specific tissue type, for instance, skeletal muscle tissue. Therefore, continuous research 
and developments are still going on to find a suitable scaffold using novel materials that 
could effectively be employed to fulfil most of the required factors as mentioned above. 
Recently carbon based materials like carbon nanotubes (CNT) [3] or nanowire and 
nanocrystalline diamond have been widely tested for their potential toxicological risks 
and their possible uses in biomedical applications. The results of such studies involving 
carbon nanotubes (CNTs) are, however, not beyond contradiction, showing cytotoxic 
effects in some cases and improved cell growth in other case [21]. The toxicity of 
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nanotubes is apparently affected by their degree of dispersion, their level of 
functionalization and length [22-24]. Preparation of pure CNT is also difficult.  Another 
recently discovered very important carbon based material is graphene and its 
derivatives. These novel graphene and graphene derivative, viz. graphene oxide (GO) 
and reduced graphene oxide (rGO) have drawn attention world-wide  for applications in 
electronic devices, biosensors as well as in tissue engineering because of their favorable 
physicochemical properties as well as excellent biocompatibility that support skeletal 
muscle and other tissue growth and proliferation [24]. In graphene oxide, there are 
many hydrophilic groups on its surface (like carboxyl, hydroxyl and epoxy) so it can be 
dispersed in water and  many other organic liquids, which are ideal solvents of several 
polymers. More importantly, GO is antibacterial and nontoxic (within 50µg/mL for 
human cells), ease to make composites with a wide range of conventional biopolymers 
which facilitate GO for TE and other biomedical applications. Graphene oxide 
nanoplatelets (GOnPs) form composites with many bioactive polymers [25], for 
examples, PCL, PLGA and PVA (polyvinyl alcohol). As usual, bioactive scaffolds composed 
of GOnPs and polymer can be prepared by various techniques. Electrospinning [26] is 
one of the latest popular modern techniques that had widely been used for the last 
decade to fabricate fibrous scaffolds with define and controlled characteristics [27]. This 
technique can also be successfully applied for the fabrications of GO-polymers or other 
polymer based composites for making scaffold meshes, similar to many other polymer 
meshes, for TE applications.  To find a convenient and easily available source of stem 
cells for tissue regeneration is also of crucial importance [28-30]. 
1.2. Challenges in Skeletal Muscle Tissue Engineering 
Tissue engineering is an emerging multidisciplinary field of research and development. 
There are various challenges which researchers encounter for the successful applications 
of TE. TE applies biological, chemical, mechanical, physical and engineering principles 
[28-31] towards the repair, regeneration or restoration of living tissues using 
biomaterials, cells, and growth factors. The most important issues related to the success 
of TE are the procurement of stem cells and the development  of temporary holders 
providing favourable environment for cell growth and proliferation called ‘Scaffolds’. 
Cells are grown onto appropriate scaffolds with various optimized parameters to make 
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suitable constructs. Here, one of the major challenges is to design and fabricate the 
scaffolds using suitable biocompatible material that would provide necessary 
advantageous cues for the growth and proliferation of the desired muscle tissues. 
Moreover, one has to deal with various physicochemical parameters of the solid 
materials to find the best biocompatible scaffolds for the growth of specific cells on 
those scaffolds successfully [32-34] and also for the desired cells differentiation and 
proliferation before final implantation in the body. For tissue engineering, constant 
supply of living cells is also needed. In this connection, it is to be mentioned that among 
the various sources of human stem cells (viz. bone marrow, cord blood etc.), the use of 
human umbilical cord blood (UCB), considered as biological waste, would be highly 
significant if widely being used for TE purposes in a convenient way.  
1.3. Skeletal Muscle Structure and Function 
Skeletal muscles (SM) are responsible for locomotion of limbs and breathing and they 
also produce body heat called thermogenesis. Human body is comprised of 324 muscles 
and about 40-45% of human body mass consists of muscles. There are three types of 
muscles found in human body such as (a) skeletal muscle [3,4] (b) smooth muscle [35,36] 
located in the blood vessels, respiratory tract, iris of the eye, gastro-intestinal tract and 
(c) cardiac muscle [37] located in the heart that provides the contractile activity [38]. The 
SMT is composed of muscle fibers that are cylindrical-shaped having many nuclei per cell 
(multinucleated) which make up the entire skeletal muscle [30,38,39]. Muscle fibers or 
myotubes are made up of several muscle cells or myoblasts fused together. These fibers 
are again made up of number of myofilaments (~0.05-0.10mm of diameter and ~15cm in 
length). There is a layer of connective tissue called epimysium surrounding the entire 
skeletal muscle fiber [38]. But if this connective tissue is situated surrounding a bundle 
of muscle fibers, it is called perimysium while endomysium surrounds an individual 
muscle fiber. Each of the muscle fibers contains contractile machinery and cell 
organelles [38]. Skeletal muscle fibers contain blood vessels (capillaries) that enable flow 
supply of micronutrients and removal of waste. Through muscle contraction, skeletal 
muscle shortens and makes various parts of the skeleton moving. Muscle contraction is 
activated through specific signals carried out to the muscle via somatic nervous system 
[40]. 
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1.4. Muscle Repair Mechanism 
Natural muscle fibers cannot be repaired by their own. Muscle repairing cells, called 
satellite cells [41] are the main tools that involve in this complex mechanism of muscle 
tissue repair [42, 43]. Skeletal muscles repair themselves via fibrosis repair unlike skin or 
cardiac tissue repair [44]. Satellite cells are present in the outer layer of muscle fibers 
within the sarcolemmal basement membrane [45]. During muscle tissue repair, collagen- 
III is produced which plays an important role in muscle tissue regeneration. Researchers 
[46]  later reported matrix metalloproteinase one (MMP-1) which destroyed previously 
produced collagen III and involved in the development of extracellular matrix (ECM) to 
migrate to the site of wounded/ injured tissue by releasing of MMP-2 [47]. Site 
specificity of MMP-1 was also reported by Wang and co-workers [48]. MMPs are 
naturally involved in the formation of ECM. But they can also be used by satellite cells to 
degrade basement membrane in order to migrate. On the other hand, expression of 
various transcription factors clearly indicate the current status of the muscle tissue. For 
example, MyoD is expressed until cell fusion occurs in muscle tissues. Similarly, 
myogenin marker also involves in myoblasts differentiation. After fusion of those 
satellite cells, MHC (myosin heavy chain) is expressed. So, Satellite cells are important 
tools to regenerate skeletal muscle tissue and to track myoblasts fusion for the 
formation of muscle fibers [49]. 
 
Figure 1.1. Schematic representation of human Skeletal Muscle Tissue (SMT) showing 
progression from muscle body surrounded by the epimysium. Bundles of muscle fibers are 
encapsulated by the endomysium and collected into fascicles by the perimysium. 
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1.5. Scaffolds for Skeletal Muscle Tissue Regeneration 
On an average, skeletal muscle occupies 40-45% of total body mass. Skeletal muscle 
defects arising due to injury and/or diseases like muscle trauma are very much common 
and a major challenge to conventional therapeutic techniques. Various alternative 
techniques have been developed to cope up with the situation. Tissue regeneration is 
one of the most attractive and promising of them. However, for the success of TE, the 
design and development of suitable biocompatible scaffolds, as mentioned above, are of 
paramount importance. Skeletal muscle tissue engineering scaffolds have to be 
engineered in such a way so that cells can grow onto them and can form myotubes with 
natural orientation. In addition, scaffolds must facilitate muscle formation by stimulating 
cells adhesion, proliferation and differentiation. To prepare scaffolds, various 
biopolymers are used either in pure form or in the form of composite. As mentioned 
earlier, PCL [50] and PLGA [51] are among the most common synthetic biopolymers used 
for scaffolds preparation [52]. Various other polymers or solid materials are generally 
used as fillers to make these polymer composites suitable for TE applications. Recently 
graphene, a 2D monolayer of Sp2 bonded carbon atoms and its derivatives like graphene 
oxide (GO) were found to be applicable in diverse fields for their excellent 
physicochemical, electro-chemical and mechanical properties [3, 53]. Interestingly, GO 
addition in polymer enhances the conductivity along with mechanical property of the 
GO-polymer composites. Conductivity enhancement of the scaffolds is important to 
induce myoblast differentiation and formation of self-aligned myotubes, a desirable 
factor for skeletal muscle tissue regeneration [28]. GO being nanomaterial like carbon 
nanotubes, there are several advantages of using such nanomaterial in TE [3, 54]. 
Graphene based materials are also utilized for various biomedical applications such as 
drug delivery [55], cancer therapy [56], and bio-sensing devices [57] because of their 
unique chemical and physical properties. Graphene based materials have also got 
application as a suitable implantable platform for electro conducting tissue engineering 
applications [3,58,59]. For example, fibroblast, osteoblasts and human mesenchymal 
stem cells (hMSCs) adhered well onto graphene based substrates and developed good 
cellular interaction [58,59]. Pristine graphene induced the osteogenesis of hMSCs [60] 
and differentiation of human neural stem cells into neurons [59,61]. GO stimulated the 
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differentiation of hMSCs to adiposities and the differentiation of induced pluripotent 
stem cells (iPSCs) into endodermal lineages [62]. GOnPs (or GO) form interesting 
nanocomposites with bioactive polymers like PCL [3] or PLGA [63] which can be 
electrospun to produce fibrous meshes for tissue regeneration. The GO-polymer 
composites with improved mechanical and electrical conductivity provide suitable cues 
for electro-responsive muscle tissue regeneration [64-67]. Biocompatibility and 
myoblast differentiation onto such composite meshes might also be very important for 
skeletal muscle or other tissue engineering applications. Because of excellent 
physicochemical properties, it has been proposed [59,67] to use these GO-polymer 
composite scaffolds as one of the potential candidates for myoblast differentiation and 
proliferation and also for myotubes formation.  
In relation to scaffolds, cells-scaffold interaction also plays an important role in 
TE.  Bone marrow (BM) derived stem cells have generally been used for various tissue 
engineering applications. Cord blood derived human mesenchymal stem cells (hMSCs) 
have also been reported to possess remarkable properties to differentiate into different 
cell types under suitable condition [68-70]. The study of cell adhesion, proliferation, and 
differentiation of hMSCs to skeletal myoblast cells (SkMCs) might be interesting. 
However, so far, very little work has been done on the differentiation of human 
mesenchymal stem cells (hMSCs) on GO sheet and GO-polymer composites (like GO-PCL, 
GO-PLGA or other polymers). Such investigation would establish the potential of GO and 
GO-polymer composites for myoblast differentiation and proliferation using cost 
effective hMSCs for tissue regeneration [71-74]. In this context, it might be argued that 
the availability of copious amount of stem cells from umbilical cord blood (UCB) would 
also increase the importance and feasibility of the TE research and applications in the 
field of regenerative medicine.  
1.6. Important Properties of Skeletal Muscle Tissue (SMT) 
Engineering Scaffolds 
The scaffolds used for TE applications must have certain well recognized basic properties 
as follows- 
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(a) Biocompatibility 
It is to be noted that biocompatibility is associated with the characteristics of the 
biomaterials in different ways. It is actually the ability of biomaterial to response 
adequately (providing suitable environmental cues) with the host cells attached to it. 
Every scaffold material intended to apply in human or other animal body should be 
biocompatible to prevent blood clot leading to thrombosis or immunogenicity. All 
materials used for tissue engineering or drug delivery purposes should be excellent 
biocompatible. Scaffolds materials have to be free from toxins and non-immunogenic. 
Scaffolds (in-vivo) must be accepted by the body without any infection or immune 
response [75,76] . In this regard GOnPs appears to be an ideal biocompatible material. 
(b) Biodegradability 
It is actually a chemical dissolution of the biomaterial by biological means. Scaffold 
materials must have appropriate degradability inside the body (in-vivo). In most 
desirable case, the rate of degradation must match with new tissue formation. In 
addition, the rate of biodegradation must not be faster than cellular growth [77]. 
(c) Hydrophilicity 
Hydrophilicity is the behavior of molecule that has tendency to attach or dissolve in 
water or other polar substances.  Scaffolds must be hydrophilic (as much as possible) to 
accelerate cell adhesion and proliferation. Cells naturally prefer hydrophilic environment 
[78,79]. 
(d) Mechanical properties 
Depending on the applications, scaffolds must have certain amount of mechanical 
strength. It is important mainly for the bone tissue regeneration. Hard tissues like bones 
require more mechanical strength compare to soft tissues like muscle tissues. But some 
researchers have reported mechanical stimulation improves skeletal muscle tissue 
regeneration [80]. For Go based GO-PCL composite  films, Young’s modulus  varied from 
13-19 +± 0.15 (MPs) and for graphene oxide it is around 10 MPs [64]. The addition of 
filler like graphene oxide in polymer composites enhances their mechanical properties 
along with conductivity which might also be varied depending on GOnPs contents in the 
composites [64-67]. Physical properties of the composite scaffolds depend on the 
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properties (nanostructure, size etc.) of the filler and the filler-polymer interaction [65-
67]. 
(e) Conductivity () 
Conductivity (electronic or ionic) is a measure of the ability of scaffold material to 
conduct electric current, associated with movement of electron or ionic charge.  
Conductivity of scaffolds is an important physical property that contributes to the 
enhancement of biocompatibility and also influences specific cellular growth and their 
orientation. For skeletal muscle tissue regeneration, conducting scaffold materials 
accelerate cells adhesion and cell-cell interaction [81-83]. Biocompatibility of graphene 
oxide based insulating polymer composites is associated with unusual physicochemical 
properties of GO, namely, surface charge and dielectric permittivity similarly to many 
other scaffold materials [56,85,86].  Conductivity of PAV , PCL , PLGA, and MPPA are very 
small (5-10x10-9S/m2). In case of conducting polyaniline added PCL conductivity 
increases more than 5 times along with the increase of biocompatibility [84]. Similar 
increase of mechanical property,  conductivity and dielectric constant of GO-PVA was 
also reported [65]. So an interdisciplinary approach of studying various physical 
properties (conductivity and dielectric constant associated with scaffold surface charge ) 
of the scaffold materials is being currently made to explore the origin of biocompatibility 
of novel materials for the development of better scaffold materials for tissue 
engineering and other applications. 
(f) Dielectric permittivity (ε) 
Permittivity is a material property that affects the Coulomb force between two point 
charges in the material like graphene,  polymers etc. Relative permittivity is the factor by 
which the electric field between the charges is decreased relative to vacuum. This 
property is associated with dipoles and surface charge  present in the scaffold materials. 
In general, dielectric permittivity which is frequency and temperature dependent is very 
small (~5-10 at room temperature) for most of the biopolymers (PVA, PLGA, PCL, PVDF 
etc.). Addition of GO possessing surface charge to these polymers enhances both 
conductivity and permittivity along with biocompatibility of the composites [26,87] 
thereby showing percolating threshold behavior. 
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(g) Percolation behaviour of composites 
Percolation is a random probabilistic process which exhibits a phase transition. Different 
percolation systems may contain clusters of different sizes and shapes. Studying the 
statistics of the clusters helps to understand the critical value of density when formation 
of finite or long range conductivity in random system first occurs. This is called the 
percolation threshold [87]. Figure 1.2 shows schematically the non-percolating and 
percolating network formation of equal size filler particles within a matrix (say, polymer)  
which indicates that as the concentration of the filler increases, clusters of individual 
particles are formed when the filler concentration approaches the percolation threshold, 
such clusters get self- connected and extend throughout the system. This theory has got 
great appreciation in material research as a powerful tool to account for the physical 
properties of heterogeneous material [87,88]. 
 
Figure 1.2. Representative diagram of the formation of non-percolating and percolating network 
composed of similar size fillers. 
 Percolation is a general phenomenon applicable in almost every area of science 
and technology as the simplest model for spatial disorder. Percolation has got wide 
applications in mathematics, physics, biology, geography, chemistry, hydrology, 
petroleum ecology and material sciences. Implication of percolation should be made to 
dielectric permittivity and electrical conductivity in polymer –graphene oxide composite 
scaffold. Percolation in polymer composites is highly important due to the potential to 
create electrically conducting material with an optimised dielectric permittivity with 
lowest possible filler (graphene oxide in the present investigation).  Since one cannot use 
as much as possible GO in the composite because of the toxicity limit, the knowledge of 
percolation threshold would be important to find the lowest filler concentration with 
higher conductivity. A Lower percolation threshold is important for making 
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biocompatible substrates of desired mechanical strength. Higher concentration of the 
filler destroys mechanical property of the scaffold. 
1.7. Scaffold Characterization 
(a) Morphological studies 
Morphological studies of the scaffolds and scaffold materials are very important for 
characterization of the material. Morphological studies are carried out by scanning 
electron microscopy (SEM), field emission scanning electron microscopy (FESEM), 
tunnelling electron microscopy (TEM), atomic force microscopy (AFM) and X-ray 
diffraction (XRD) studies [33].  
(b) Porosity 
Scaffolds must contain optimum porosity to facilitate nutrient diffusion to rejuvenate 
cells. Porosity of scaffolds depends on the type of cells they will carry and the type of 
tissues to be regenerated.  Porosity and pore size may vary depending of application of 
that scaffolds and cell types. Porosity can also regulate mechanical behavior of a scaffold 
[33,89]. 
(c) Phase analysis and structural studies 
Phase analysis of the prepared GO-polymer composite scaffolds is carried out by X-ray 
diffractometer (Model PA Analytical Philips, USA) using CuKα radiation (λ=0.1542A
o) at 
room temperature [4,26,87,89]. 
(d) Contact angle            
For the study of surface property (homogeneity, surface resistance, interaction of the 
scaffold surface) contact angle (CA) measurement is important [90]. There are several 
instruments  available for the direct measurement of CA (both wetting and dewetting). 
(e)  Spectroscopic studies 
Fourier transform infrared (FTIR) spectroscopy measurement  is  performed to estimate 
various structural properties and functional groups of the fabricated scaffolds. The 
machine is operated in transmitted mode in the frequency range within 500 -4000cm-1 
[4,26,33]. 
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1.8. Polymer Biomaterials for Skeletal Muscle Tissue Engineering 
Applications 
Bioactive polymers are the major and most suitable components for the preparation and 
development of tissue engineering scaffolds [30]. There are mainly two types of 
biocompatible polymer materials viz. synthetic and natural along with their composites 
used to fabricate TE scaffolds that provide favorable cues for cells growth and 
proliferation [88]. Polymer being its own or in the form of polymer derivatives, blends, 
or copolymers are the building blocks of tissue engineering scaffolds.  
(a) Natural polymer 
These are abundantly available and resemble the components present in extracellular 
matrices (ECM) of cells. Natural polymers are obtained from natural living source such as 
animal shell, skin, plants etc. They are used for better cellular growth and proliferation. 
Recently, silk fibroin, chitosan, collagen, fibrin and gelatin are among the vastly useable 
natural polymers. These polymers are hydrophobic and non-immunogenic. But due to 
lack of strength and high swelling rate, they are not always desirable for every 
application. The higher cost of natural polymers is another disadvantage for rapid usages 
[91,92] of such polymers. 
(b) Synthetic polymer 
Synthetic polymers are easily available, versatile and comparatively cheaper synthetic 
polymers (PCL, PVA, PLA, PLGA, PMMA etc.) with predictable physicochemical 
properties, which are now widely being used in pure or mostly in the form of 
composites. These are highly stable for long term study and more non-immunogenic 
than natural ones [4,30].    
(c) Composites 
The composite materials can be defined as a composition of more than one distinct 
phase that is separated by interfaces. To take the advantage of more than one materials, 
many researchers are using composites instead of pure one [93-96]. For example, PCL is 
a suitable biopolymer for tissue engineering applications because of its biocompatibility, 
biodegradability, elasticity and mechanical properties [97]. But, lesser hydrophilicity, 
biodegradability and insulating (non-conducting) behavior limit its use in various 
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biomedical fields. During the last decade, researchers have made several attempts to 
make it more hydrophilic and electro conductive by preparing PCL-PANi (polyaniline) 
composites or by various surface coatings (via plasma treatment) to increase cellular 
activities [91]. There are also limitations for the use of organic polymeric scaffolds 
originating due to the release of acidic by-products that cause inflammation inside the 
human body and the lack of adhesion with the bone cells due to differences in their 
compositional properties [92]. The addition of a bioactive material to the polymeric 
system gives an added advantage of cell adhesion with the organic phase. Different 
biomaterials like hydroxyapatite, bioactive glasses, and glass-ceramics having bonelike 
mineral compositions are generally added to the polymers so as to make the tissue 
regeneration process faster by improving bone bonding in vivo [93-95]. Another 
advantage of using a filler is that the alkaline degradation products of the mineral help in 
neutralizing acidic by-products of the biopolymers thereby reducing inflammation. Thus 
polymeric scaffolds prepared from composites based on PLA, PCL and PLGA are expected 
to provide improved mechanical as well as physiological activity by way of initially 
reinforcing the polymer blend matrix and later as a bio-initiator. However, for the 
desired results, appropriate fillers supporting biocompatibility, biodegradability, cells-
scaffold interactions, rate of cells proliferation etc. are to be chosen carefully. 
Biomaterial composites should create a favorable environment for cells to grow and 
develop tissues [93-95]. To prepare best possible scaffold for skeletal muscle tissue 
engineering, the material properties should provide favourable cues to grow muscle 
tissue. Although various biodegradable polymers are being used for skeletal muscle 
tissue engineering purpose, still there is urgent need for the development of novel and 
suitable electro-conductive biocompatible materials/composites providing necessary 
cues for the adequate growth and proliferation of skeletal muscle tissues. Experiments 
have been done with conductive matrix to understand their properties and usefulness as 
biomaterials. For better biocompatibility and specific tissue (like skeletal muscle) 
regeneration, as mentioned above, conductivity appears to be one of the important 
parameters to be acquired by the scaffolds [26, 93-95]. To improve conductivity of 
insulating biopolymers like PCL, researchers have used conducting polymers like 
polyaniline (PANi) which enhanced biocompatibility of the scaffolds [84].  So, different 
studies are being carried out for the discovery of new scaffolds with conducting 
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materials. In this context, graphene based polymer composite materials appear to be 
promising for the development of new scaffolds for future TE applications [26,97-101]. 
Interestingly, graphene oxide nanoplatelets (GOnPs) added polymer composite systems, 
hereafter also abbreviated as GO-polymer composites, are important for the 
enhancement of both mechanical stability and biocompatibility of the GO-polymer 
composites. GO-polymer composite electrospun meshes are also free from bead 
formation, a problem generally appears in polymer scaffolds [102-104]. The material 
properties of these composites can be optimized to enhance tissue regeneration. 
Composites composed of such novel GOnPs with suitable polymers are highly promising 
for skeletal muscle TE application discussed in the present thesis. 
(d) GO-polymer composites and percolation behavior 
With the addition of many solid fillers (GOnPs, for instance) in the polymers, mechanical 
electrical and dielectric properties are improved. But such enhancements showed 
limitation above a certain concentration of the filler (called percolation threshold 
concentration, fc). Beyond that concentration, mechanical or electrical properties 
decline and such properties show anomalies at that concentration and mechanical and 
other properties of the polymer drastically change. The percolation concentration of the 
filler (GOnPs) depends on the physical properties (structure of the nanoparticles etc.) of 
the fillers as well as polymer character. It is desirable that the filler should be 
biocompatible and percolation threshold should be low without compromising the 
mechanical property (flexibility) of the scaffold materials. For nanomaterials like GOnPs 
the fc is quite low [65]. Therefore, study of percolation behavior of composites is 
important to make composites with suitable mechanical stability as well as electrical 
conductivity. 
1.9. Techniques Used for Scaffold Fabrication 
There are several conventional techniques available to fabricate scaffolds. Such as 
Electrospinning, rapid prototyping, phase separation etc. which are briefly mentioned 
and discussed below. 
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(a) Electrospinning 
This is the conventional and widely used method of producing nanofibers. Here electric 
field (with high voltage ~30-40kV) is applied to facilitate the fiber (nano or micro) 
formation.  At the point when critical voltage is applied, surface tension of the polymeric 
solution is overcome by the charge imbalance that forces the solution towards target 
(collector) in the form of fiber. Here working distance, applied voltage, nozzle diameter 
are some of the important parameters [102-103] to be controlled. Various companies 
are making this machine such as Elmarco Nanospider, Czech Republic (Model: NS Lab 
200 nano-spider), PICO Electrospinning machine, India (Model: ESPIN NANO). 
Electrospinning is the mostly used technique for making fibrous polymer or composite 
scaffold meshes. 
(b) Rapid prototyping 
Rapid prototyping or solid free fabrication (SFF) is the most technologically advanced 
method of producing 3D scaffolds with desired shape and structure. Computer aided 
design (CAD) is used to determine the structure of the scaffold using software and then 
RP machine generates the main structure. Layer by layer methodology is made to 
construct a 3D structure. Stereo-lithography, fused deposition modelling and laser 
sintering are among the most popular rapid prototyping methods. Scaffolds with 
complex geometry can be produced via this technique [98]. 
(c) Salt leaching 
This is a simple method of preparing porous scaffolds. In this process, soluble salt 
particles are added in polymer solution as porogen and then casted into suitable moulds. 
After the solvent evaporates, the salt particles are removed by leaching and porous 
scaffolds are formed [105]. When salt particles are removed, the vacant areas appear in 
the form of pores. The major shortcomings of this method are difficulties in controlling 
pore size with porosity, low mechanical strength, pore interconnectivity, use of toxic 
solvents. To overcome the limitations of this process, more advanced methods were 
developed [99]. By controlling the pore size of the salt particle, it is possible to monitor 
the properties of the porous structure of scaffold material [106]. 
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(d) Freeze drying 
In this process, thermally induced phase separation (between two components) method 
is used. The pore size of the prepared scaffolds is established during this process. 
Freezing temperature can be varied from −5oC to −80oC. The heating steps can be 
introduced to find the effects on the pore sizes. Annealing in the freeze drying process is 
associated with the rise of temperature of the frozen suspension as well as to boost the 
growth of ice crystals. The results indicated [105] that the pore size of the scaffolds  are 
reduced along with the reduction of freezing temperature. It is also noticed that the 
introduction of annealing steps during freezing increased pore size (~30-40%). Phase 
separated mixture (water and the scaffold materials in most cases) is kept in low 
temperature and high vacuum atmosphere to sublime the solvent. Pores are generated 
by the removal of ice crystals. Here, by optimizing freezing temperature as well as 
concentration of the polymer solution, the solvent crystal (porogen) size can be 
controlled. The major drawback in this process is lower interconnectivity, production of 
toxins (residual solvent) and lower mechanical strength of the produced scaffolds [105]. 
Freeze drying works on the principle of thermally induced phase separation [107].  
(e) Freeze gelation  
This is a very common technique to produce porous 3D scaffolds and depends on the 
principle of thermally induced phase separation. This simple and effective method is 
vastly used to control pore size. Scaffold material solution is gelled and then dried to 
retain proper pore size thereby symmetry of scaffold remains intact. While the gel is 
warmed to melt the ice crystals, it makes the scaffold porous with comparatively 
continuous porosity with similar pore size and shape. On the other hand, this process is 
simple, cost effective and produces crack free scaffolds made up of various natural as 
well as synthetic polymers [101]. This is a simple effective technique where frozen 
polymer solution is  immersed in a gelation environment at temperature lower than the 
freezing temperature of the polymer [86]. As the polymer matrix becomes gel before the 
drying stage, the porous structure can be retained without freeze drying. After freezing, 
the gel is warmed to melt the ice crystal and then dried [108]. This method overcomes 
many limitations of freeze drying like surface skin formation. It allows preparing low cost 
and crack-free 3D scaffolds in a convenient way [109].  
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1.10. Stem Cells for Tissue Engineering 
Stem Cells have the unique property to differentiate into various cell types in the body 
[110]. Stem Cells are found in internal repair systems where they can divide unlimitedly 
to either repair or replace damaged cells throughout the body. Stem cells have the 
capability of forming a new cell which either has the potential of a stem cell or becomes 
a more dedicated type of cells having specific functionality. Stem Cells can be regarded 
as undifferentiated cells having high proliferative capability, ability of self-renewal and 
can form in multinuclear organisms. Stem cells have two unique properties compared to 
other cells namely, they are undifferentiated cells and capable of self-renewing for a 
longer period of time. Moreover, stem cells can be differentiated into different lineages 
with specific functionality. There are two types of stem cells: (a) Embryonic stem cells 
(ESCs) and (b) Adult or Somatic Stem Cells. ESCs can give rise to the whole body. On the 
other hand, an adult stem cell is undifferentiated cell found in different tissue or organ 
[111,112]. Adult Stem Cells maintain and repair the tissue in which they are found. Adult 
stem cells are immunocompatible, immunomodulators and immunosuppressant  [110-
114]. 
1.10.1. Mesenchymal stem cells  
Mesenchymal stem cells have the ability to proliferate in-vitro and also differentiate into 
a number of mesoderm type lineages which include osteoblasts, chondrocytes, 
myocytes, adiposities cells [115-120]. hMSCs are potential source of TE because they are 
easily available in large quantity [118]. These cells also have high proliferation rate [116], 
immunocompatible and immunosuppresent. These are useful in allologous and 
autologous stem cells transplantation. hMSCs do not form teratoma or tumor as in the 
case of ESCs [121,122]. hMSCs were first identified in 1968 [123] from rat marrow. 
hMSCs in culture have fibroblastic morphology and can adhere on tissue culture plate 
(TCP) [124]. The important sources of hMSCs are bone marrow (BM), Umbilical Cord 
Blood (UCB), Placental Tissue (PT), Adipose Tissue (AT), Amniotic Fluid (AF) and others. It 
is to be noted that hMSCs derived from different sources might differ in proliferation 
and differentiation capabilities [125,126]. However, the most advantage of using UCB 
derived hMSCs are ease of their availability in large quantity and cost effectiveness 
(usually discarded as waste). Moreover, their ability to proliferate and maintain self-
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renewal capability for long period of time in culture make these cells more useable for 
research and development [111]. One important characteristic of human mesenchymal 
stem cells (hMSCs) is their adherence to plastic surface (>90% expression of CD105, 
CD73, CD90) and differentiation to chondrocytes, adiposities, osteoblasts, myoblasts 
[127]. 
1.10.2. Site specificity of  hMSCs 
Site specificity is another important factor of tissue growth. Regeneration of new tissue 
has to be highly précised and should also be at the required injured site where 
replacement of old tissue with the new one is only needed.  It has also been observed 
that under proper conditions, hMSCs can differentiate to specific tissues that had 
already been injured and urgently needed to be regenerated to support normal muscle 
function. Most importantly, the site specificity and efficiency are highly desirable to 
regenerate the damaged part without disturbing the rest where no further regeneration 
is required. Recently, it has been demonstrated [128-132] that hMSCs might 
differentiate selectively into tissue types that have only been injured. These tissues have 
systemically administered the growth of hMSCs to clone into immune deficient mice 
after subsequent carbon tetrachloride hepatic injury. Further to add, differentiation of 
hMSCs only into albumin expressing hepatocyte-like cells was also observed in those 
mice. All these are strong evidences that hMSCs possess some unique properties that 
are specific to the site of injury. 
1.11. Future Prospects of Tissue Engineering (TE) 
  
As mentioned earlier, TE is a parallel branch of medical technology that tries to 
overcome various difficulties of conventional therapeutic methods. In USA alone, 55% of 
all sports injuries are related to muscle damage caused by contusion, strain, or 
laceration [133]. Tissue engineering has the potential to cure organs with its original 
structure and functionalities. Till today, researchers have reported its tremendous 
benefit and prospects towards clinical science. Several tissue engineered and 
regenerative medicine products have been successfully developed prior to clinical trials 
in the United States alone [134] to overcome various difficulties regarding quality 
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control, ethical complications and in-vitro transplantation. Besides the therapeutic 
values of tissue engineering, in 2010, Journal of the Royal Society Interface [135]  
reported tremendous industrial impacts of this field due to an urgent need to overcome 
certain limitations of the conventional medical practices. They have also highlighted an 
emergency need for tissue engineering industries. USA alone has spent ~$2.5 billion in 
2007 to develop this field that includes over 167 companies along with ~6000 
employees.  But this is not enough to serve the entire population of the world.  
Moreover, there are various ethical and approval (FDA) issues that still limit researchers 
as well as business personnel working in this areas [136].  But, the urgent need for an 
alternative therapy is taking this new field forward both in research and industrial level. 
Thus, it is highly expected that in the near future TE would make a parallel way beside 
conventional therapies [137]. Use of cord blood derived mesenchymal stem cells instead 
of bone marrow (BM) derived stem cells would further make this field of TE more 
attractive. A comparative study had already been done [138,139] which demonstrated 
the increasing growth rate of tissue engineering and number of employees involved in 
these industries. So, it is quite clear that TE industries are at constant growth. Another 
study also reported overall TE and stem cell sectors that spent ~$3.6 billion and 
employing almost ~14,000 employees during mid-2011 [139,140]. 
1.12. Tissue Engineering Limitations 
The first scientific meeting on TE held in 1988 at Lake Tahoe, California [137,138], 
established the concept and importance of tissue engineering. Though TE is immerging 
as the next generation clinical practices capable of curing various diseases, this new field 
has several limitations and various challenges yet to overcome. First of all, there is 
immense gap between in-vitro and in-vivo experiments to know the actual efficiency of 
biomaterials due to lack of laboratory setup, research funds and expertise working in 
this area. Even after vigorous testing in sophisticated laboratories, FDA approval to 
functionalize a new product is another difficult procedure which various industries 
encounter. Furthermore, there are ethical issues involved that sometimes make barriers 
to the researchers. Beside developed laboratory facilities in USA and Europe, many Asian 
developing countries are nowadays conducing various research on this emerging area 
with limited research funds. Cost effective chemicals and lack of sophisticated 
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laboratories for in-vivo testing often make such kind of studies quite  difficult. However, 
still there is increasing interest in research as well as in building industries.  It has been 
noticed that most of the investors are from private sector or small scale organizations 
with limited financial capabilities [141-143]. The major industrial difficulties such as: (1) 
excessively high manufacturing and maintaining costs, (2) insufficient attention to 
reimbursement, (3) poorly structured agreements with marketing partners or 
Government, (4) unrealistic assessments of the cost-to-benefit ratio of the early 
products, (in developmental stage), (5) unrealistic sales forecasts leading to excessive 
fixed costs of sales, (6) financial exhaustion after protracted regulatory approval (FDA) 
processes, (7) less significant products with higher costs compare to conventional 
proven medication, (8) competition with existing well established companies (J&J, Pfizer, 
GSK, P&G etc.) who make pharmaceutical drugs and successfully treating diseases with 
conventional therapeutic products over centuries. In such a  case, acceptance of tissue 
engineering products would be in doubt for majority of patients as well as doctors [140, 
144-146]. However, researchers are now in contact with various related industries to 
enhance the growth of tissue engineering facilities both in research as well as in 
industrial scale production to bring the benefits of this novel field of biotechnology 
serving the mass.  
1.13. Thesis Outline 
Present study was intended  to  establish excellent cellular interaction and myoblast 
differentiation of cord blood derived human mesenchymal stem cells (hMSCs)  on GO 
sheet composed of graphene oxide nanoplatelets (GOnPs), electrospun GO-PCL and GO-
PLGA composite scaffold meshes which might be considered as  potential candidates for 
skeletal muscle regenerations. The organization of the thesis is briefly described below: 
The thesis consists of nine chapters(General introduction and literature review–Chapters 
1 and 2, Experimental part –Chapter 3, Results and Discussion–Chapters 4-8 and 
Summary and Conclusion– Chapter 9). 
Chapter 1  considers  the fundamental concepts of TE and describes skeletal muscle 
structure and function, skeletal muscle repair mechanism and various types of scaffolds 
used in TE applications. Different types of biomaterials including the novelty of graphene 
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oxide (GO) based biocompatible composites, human stem cells used for TE applications 
are also briefly discussed in this chapter.  
Chapter 2  consists of the summary of previous work done mainly on skeletal muscle 
tissue engineering scaffolds and mesenchymal stem cells used in TE for the regeneration 
of skeletal muscle tissue. Biocompatible composite biopolymer scaffolds used for 
skeletal muscle regeneration, importance of graphene oxide based polymers composite 
scaffold for TE applications have been briefly elucidated. The scope and objective of the 
thesis have been discussed at the end of this chapter.  
Chapter 3  deals with the experimental part of the thesis. Synthesis of graphene  oxide 
nanoplatelets (GOnPs), preparations of GO sheets, electrospun GO-polymer composite 
meshes (GO-PCL and GO-PLGA scaffolds), different characterization techniques have 
been discussed. Apparatus used for cells characterization and immunostaining analysis 
have been briefly mentioned in this chapter. Isolation of cord blood derived 
mesenchymal stem cells (hMSCs) from umbilical cord blood (UCB), used for myoblast 
differentiation on GO-based polymer composite meshes, has also been discussed. 
Chapter 4 represents morphological characterizations of GOnPs (abbreviated simply as 
GO) sheet and GO-PCL composite scaffolds. Structural, vibration spectroscopic, 
mechanical and other characterizations (XRD, SEM, FESEM, HRTEM, Raman, FTIR, UV-VIS 
spectroscopic studies) of the prepared GO sheet and GO-PCL composite  meshes have 
been discussed. 
Chapter 5 deals with the in-vitro cell culture study on the fabricated scaffolds (GO sheets 
and electrospun GO-PCL scaffold meshes). Myoblast differentiation of cord blood 
derived stem cells, hMSCs and myotubes formation on thin GO sheet and GO-PCL 
scaffolds.  In this part an attempt has been made to demonstrate myogenic proteins and 
gene expression on GO sheet and GO-PCL scaffolds along with IGF-1 cell signaling 
pathway analysis on these substrates. Importance of IGF-1 pathway on skeletal muscle 
differentiation and maturation has been explained.  
Chapter 6 describes characterization of graphene oxide-PLGA composite scaffolds. 
Morphological and different other physical characterizations of the fabricated composite  
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(GO-PLGA) meshes (using, XRD, SEM. FESEM, HRTEM, Raman, FTIR, UV-VIS spectroscopic 
studies) have been presented. 
Chapter 7 represents in-vitro myoblast differentiation and proliferation of cord blood 
derived stem cells, hMSCs, and myotubes formation on GO-PLGA scaffolds  similar to 
that done on GO-PCL meshes. Myoblast differential potential of GO-PLGA composite 
scaffold has also been examined along with immunophenotypic characterizations, cell 
viability assay and flow cytometric analysis.  
Chapter 8 highlighted the origin of excellent biocompatibility of the GO-polymer 
composites. From the study of GO surface charge, capacitance–voltage and current–
voltage characteristics, an attempt has been made to elucidate the importance of 
conductivity and GO surface charge for the enhancement of conductivity and its 
contribution towards biocompatibility of GO added polymer composites . 
Chapter 9  briefly  summarizes  the results obtained from the experimental work. 
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2. Literature Review 
This chapter deals  with the current scenario of skeletal muscle (SM) tissue regeneration, 
some conventional polymer scaffolds used for skeletal muscle tissue engineering (SMTE), 
growth factors, novel aspects of new generation graphene in tissue engineering 
applications, graphene oxide nanoplatelets (GOnPs)-polymer composite scaffolds for 
tissue engineering and other applications. The scope and objectives of the thesis have 
been highlighted at the end of this chapter.  
2.1. Skeletal Muscle Tissue Regeneration 
The statement of purpose defined for tissue engineering (fabrication of artificial tissue 
and organs) is very promising with numerous scientific and technological challenges. 
Cells and biomaterial (which stimulate mammalian extranuclear matrix) are important 
components of artificial organs fabricated using tissue engineering strategies. Though 
the conventional medical therapeutic methods used in skeletal muscle repair and 
regeneration have now reached at an optimum state of remediation, still  it is necessary 
to find an alternative method of tissue regeneration as there is large demand of skeletal 
muscle tissue repair and regeneration. Tissue damage generally occurs by various ways  
viz. injury, high degree burns etc. [3-5,147,148]. Though current therapeutics  might cure 
such muscle disorders, but to acquire natural orientation maintaining functionality of 
the cured muscles, have not been discovered by the clinical practitioners yet. There is 
need of engineering living tissues which can be directly implanted inside the body [6, 
54,72,148-150]. The main issue of tissue engineering is to precisely and safely 
regenerate or reconstruct injured tissues of skeletal muscle, bone, teeth, neural, cardiac, 
cartilage etc. [5,149,150]. One of the primary requirements for the development of 
tissue engineering is a constant source of supplementary stem cells which have the 
ability to be differentiated into various tissue types such as chondrocyte, osteoblast or 
myoblast cells. In modern tissue engineering, mesenchymal stem cells (derived from 
bone marrow or other sources) play the most important part [151] for in-vitro growth or 
regeneration of the required tissues. Researchers have already made various ingenious 
attempts focusing on the beneficial issues of mesenchymal stem cells [152] for the 
skeletal muscle regeneration and repair tissues with suitable scaffold materials that 
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would provide favourable environment including structural orientation [153] for muscle 
tissue regeneration.  
Though the detailed process how dystrophic muscles are replaced or 
regenerated by fibrotic tissues inside the living organs is still not very clearly understood, 
skeletal muscle tissue engineering has been proved as one of the  most important fields 
of regenerative medicine, a parallel potential therapeutic approach [154-156] to the 
conventional clinical practices, for the benefit of next generation human society. 
Myoblast cells or satellite cells are myogenic stem cells. These cells can multiply, align 
themselves and fuse to form multinucleated myotubes and then to myofibrils [38]. In 
vitro myoblast cells are stimulated to fuse and form myotubes by reducing the mitogen 
content in the growth medium [38].  The reaction of satellite cells to injury is similar to 
that of myoblast differentiation with regards to transcription factor. Several 
transcription factors that are part of the MRF (myogenic regulatory factor family) stand 
out from the plethora of molecular mechanisms involved in MyoD, and myf5 expressions 
which are involved in satellite cell/myoblast activation resulting in terminal 
differentiation of myoblast cells [157]. The transcription factors are often used as 
markers for proliferative or differentiated myoblasts. Modulating or maintaining the 
level of these transcription factors rely on cell-cell communication and also factors 
available in the ECM environment. Differentiation is negatively regulated by a host of 
mitogens and growth factors like Hepatocyte growth factor (HGF), fibroblast growth 
factor (FGF), transforming growth factor -β (TGF-β) and various cytokines, to name a 
few, which have enormous effects on the expression of transcription factors. HGF was 
shown to be associated with the maintenance of the proliferative state of myoblasts and 
also to stimulate satellite cells to enter the cell cycle. This was shown when injected in to 
the injured muscle. HGF blocked regeneration but increased the myoblast population 
[158]. FGF has been shown to interact with MyoD transcription factor. Yablonka-Reuveni 
and Rivera  studied [159] primary cell lines and cultured immortal cell lines from the  
lineage and they found that with primary cell lines FGF had no difference on MyoD 
expression, but the cells maintained proliferation [159]. In immortalised cell lines, FGF 
only effects cells [160] not expressing MyoD to maintain the proliferative state. 
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2.1.1. Skeletal muscle tissue regeneration on electrospun scaffolds 
For the development of tissue engineering and regenerative medicine, the importance 
of biocompatible polymer scaffolds (for instance, cell adhesion, differentiation, protein 
adsorption etc.) is unimaginable [33,161,162]. In stem cell therapy, scaffold material and 
appropriate scaffold design contribute in a most significant way to determine the 
desired shape and structure of the neo tissue [163]. Recently computer aided scaffold 
designing is becoming more popular [164,165]. Scientists working with suitable 
biomaterials are giving efforts to control over pore geometry and architecture of the 
scaffolds that would be favourable for the cell growth [164-166]. Bioengineered 
scaffolds made up of porous polyvinyl alcohol (PVA), silk, polycaprolactone (PCL), 
chitosan, polyhydroxylbutyrate, collagen, heparin, gelatin etc. had  been used  efficiently 
for scaffold preparations [167-170]. Earlier non-toxic polyvinyl alcohol (PVA) was used 
[164] as it tended to dissolve quickly after implantation. There are several convenient 
techniques which are in use for scaffold preparation viz. solvent casting [171,172], 
polymerization [173], melt quenching and moulding [174], phase separation [175] and 
freeze drying [176]. Regeneration of new muscle and degradation of scaffold should take 
place simultaneously. Ultimately the scaffold should be degraded within appropriate 
time frame and that space would gradually be occupied by the neo muscles [177,178]. 
This phenomenon might be compared with the phagocytosis of artificial (scaffold) 
basement membrane by neo muscles. It has recently been reported that surface charge, 
conductivity etc. also play important role in cellular interactions which may be beneficial 
for skeletal muscle tissue engineering application [26,179].  New generation scaffolds 
with new materials are being developed taking all these factors under consideration. 
2.1.2. Some conventional polymers and composites for skeletal muscle 
tissue regeneration 
Researchers are in constant search of an ideal material for specific tissue regeneration 
and their clinical applications. Vandenberg and his group [180] first used collagen gel as 
the substrate for skeletal muscle tissue engineering applications. Later, their work was 
modified by Huang [181] through the use of biocompatible silk fibrin gel as the matrix 
for muscle cells growth. The fibrin was degraded in three to four weeks as cells grew 
onto them maintaining their own ECM. The same research group [182,183] also 
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prepared 3D silk fibrin gel with better cellular activities and force transduction 
properties. Force measured at around ~40 kN/m2  was similar to soleus muscle (~44 
kN/m2)  in 1 day old  wistar  rats. This study also suggested how much force muscle 
produces in relation to specific occupied muscle area. However, some drawbacks were 
found that inhibited researchers from using such scaffolds for the application to skeletal 
muscle tissue engineering. The major drawback of using fibrin gels as a scaffold for 
skeletal muscle tissue regeneration is that they convey no template for muscle 
alignment and orientation.  
Lam and his co-workers [183] had successfully used PDMS (polydimethylsiloxane) 
aligned scaffold and coated with 2μg/ml of laminin to accelerate myoblast attachment 
and gave rise to proper alignment on them. At the time when ~80%  myotubes formed, a 
thin silk fibroin layer was applied onto them to create a natural extra cellular matrix. But 
the results did not show desirable alignments. Later, Dennis and co-workers [184,185] 
fabricated electrospun aligned PDMS scaffolds using a rotating drum collector aiming to 
give rise proper alignment of myotubes. Here electrospun scaffolds were used for the 
initial stage on which cells grew and a thin gel applied for better 3D myotube expansion 
on them. But, the main drawback of fibrin was immunogenic that caused infection 
leading to cells death. Another study [186,187] described that flexibility of the scaffold 
had an impact on myoblasts differentiation as well as myotubes orientation. Engler and 
co-workers [185,186] reported that myoblasts differentiated into myotubes were better 
and they also resembled natural muscle more closely on elastic scaffolds. They 
compared glass slides with collagen coated poly-acrylamide gels and collagen gels 
maintaining similar stiffness to natural muscle (~12kPa). Myoblasts differentiation was 
accelerated on elastic substrates. Levy-Mishali and his group [188] also did some 
research on this topic. This study was on polyelectrolyte multilayer films made from 
poly(l-lysine)/hyaluronan  with various  cross linkers to modify/regulate  the stiffness of 
the scaffolds. They found myoblasts were detached earlier from soft gels because of 
formation of fewer focal adhesions on those flexible substrates. Levy-Mishali and co-
workers [188] used PLGA foams with various PLA:GA ratios and concluded that scaffolds 
with Young’s modulus of greater than 200kPa along with a higher lactic acid content  
showed better results for myoblasts differentiation in comparison to scaffolds with a 
greater glycolic acid content. That was an important finding to be considered for future 
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researchers for the fabrication of scaffolds for skeletal muscle tissue engineering 
[27,189]. Random and aligned fibers possess tensile strength of ~4 and ~5MPa, 
respectively.  This finding demonstrates that random fibers are more elastic than aligned 
one suggesting the random one could be better for skeletal muscle tissue engineering if 
elasticity is considered.  
Producing and maintaining the myotubes morphology both in-vivo and in-vitro 
are challenging problems of TE [190-191]. Cell growth and proliferation were done by 
using a scaffold [192,193]. Electrospun  PLGA scaffold provided guidance for alignment 
of myoblasts [194,195] and an elastic substrate for myotube differentiation. A 
comprehensive review of the electrospinning process was carried out by Subbiah and co-
worker [196]. High-speed rotating mandrel was used to create aligned fibers  [53,195-
198]. To date PCL, PLA, PGA, and their co-polymer PLGA have been used in the form of 
foams, films, and electrospun fibers for tissue engineering applications [199-201]. They 
used a sponge of PLLA and PLGA to form a highly porous three-dimensional (3D) scaffold 
for skeletal muscle development. Choi and co-workers [27] used electrospun PCL with 
collagen fibrous scaffold to induce myotube formation. Previous reports showed that 
flat, inflexible scaffolds were not suitable for myoblasts differentiation [202]. PLGA might 
overcome this problem making scaffolds suitable for  myoblast  cells growth. An 
elastomeric polymer like PLGA might show elastic deformation. Scaffold must withstand 
the stresses and strains of a monolayer of differentiating myoblasts into myotubes 
[185,203]. Graphene oxide –PLGA or PCL produced suitable electrospun scaffolds for 
myoblast differentiation and myotube formations [67].  
2.1.3. New generation graphene in TE: Novel opportunities for skeletal 
muscle tissue engineering (SMTE) applications 
Graphene has planer nanoflakes that consist of rings of carbon atoms with a hexagonal 
lattice structure [204]. It is the basic building block for other graphitic materials such as 
few layer graphene, graphene oxide (GO), and reduced graphene oxide (rGO). Few layer 
graphene is a flake-like stack of 2-10 graphene layers. When graphene undergoes 
oxidation, it becomes a chemically modified graphene; GO. Graphene oxide can be 
further reduced to produce reduced graphene oxide, rGO. Over the last several years 
graphene has emerged as a promising nano-platform with enormous potential for 
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biomedical applications and translational research because of its chemical, physical and 
mechanical properties, which make graphene and its derivatives ideal candidates for 
many biomedical applications including tissue engineering [51,58,62] and drug delivery 
[205]. Graphene  is a newly added material for the use in Biomedicine and TE [206], its 
discovery won 2010 Nobel prize. Graphene and its derivatives have  found  their ways 
towards the interests of researchers working in different fields across the world. 
Interesting electrical, mechanical, optical, and chemical properties of graphene have 
further widen the application in a various interdisciplinary fields like electronic devices, 
biosensors, drug delivery, cancer therapy as well as in tissue engineering. 
2.2. Characteristics of Graphene  
Graphene possesses distinct properties different from any other carbon molecule, such 
as benzene and other allotropies. With such properties, graphene has provided 
advantages in TE and in much other applications. Its noble properties, such as electrical 
conductivity, elasticity, dielectric constant, surface charge, and adsorption of protein and 
low molecular weight substances, may favour the stem cells differentiation and neural 
or myoblast  cells proliferation [206-208]. 
2.2.1. Electroconductivity of graphene 
Electrical conductivity of graphene is due to sp2 hybridized carbon atoms. Three of the 
outer carbon atoms form sigma bonds with neighbouring three electrons. The remaining 
one electron forms a π bond. In accordance with the Pauli Exclusion Principle, the 
outermost shells of the C-atoms are filled.  ơ -bond forms a solid and stable bond. In the 
π bond only half of the each C-atom p- orbital is filled. The electrical conductivity of 
graphene arises due to such bond formation. 
2.2.2. Adsorption of proteins and low molecular weight substances 
Graphene has the unique property that can be utilized for tissue engineering which is its 
ability to adsorb protein and low molecular weight chemicals. In order to either grow or 
communicate with neighbouring cells, cells secret various substances. Such substances 
are adsorbed onto the graphene surfaces and affect cell proliferation and differentiation 
[206-209]. 
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2.2.3. Graphene promotes mesenchymal stem cells proliferation and 
differentiation 
Marie Kalbacova and co-workers [58] showed that graphene based substrates  promote 
the growth of  hMSCs. Their study was based on hMSCs adhesion and proliferation. They 
found that hMSCs proliferated much better when cultured on graphene films compare 
to other substrates [58]. Though graphene is usually hydrophobic in nature, but other 
parameters such as surface chemistry, roughness and texture in combination create a 
favourable platform for the hMSCs to grow better. Cellular attachment involves 
physicochemical linkages between the cells (hMSCs) and the graphene surface through 
ionic forces or adsorption of any conditioning molecules such as proteins.  Furthermore, 
differentiation of mouse skeletal myoblasts cells [67] have been done on graphene 
based substrates and these cells have grown better on GO because of their important 
physicochemical properties. 
2.2.4. Exfoliation of  isocyanate-treated GO nanoplatelets (GOnPs) 
Researchers also have exfoliated functionalized GO nanoplatelets [204] that formed very 
stable dispersion in polar aprotic solvents. Treatment of GO with organic isocyanates 
forms new class of GO possessing reduced hydrophilic properties that are  able to 
exfoliate in polar aprotic solvents thereby yields derivative of graphene oxide 
nanoplatelets. That was the first findings of complete exfoliation of chemically derived 
GO importantly in organic solvents. Use of cyano, keto, azidosulfonyl also modified the 
surface properties and chemistry of GO that can be further utilized for better cellular 
attachment and proliferation.  
2.3. Graphene Oxide Based Skeletal Muscle Tissue Engineering  
2.3.1. Graphene oxide and polymer composites for tissue engineering 
This is a tedious work to find a novel material for specific applications. However, 
intensive and continued researches carried out all over the world thereby discovered 
different carbon based bioactive materials like carbon nanotubes, graphene and 
diamond. For skeletal muscle tissue engineering applications, the biomaterials have to 
be biocompatible, non-immunogenic and electro-conducting and also flexible with 
suitable mechanical strength. Recently, graphene and its derivatives are found to be very 
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suitable for tissue engineering applications. GO itself is non-toxic within the limit 
(~50µg/mL for human cells) which is suitable for use as an additive for the preparation of 
electro-responsive tissue engineering polymer composite scaffolds and other clinical 
applications [210]. GO can also form homogeneous composites with various 
biocompatible polymers suitable for producing composite meshes [51].  
Yang and his co-workers [211] prepared GO-PVA composite films and 
characterized them using SEM, XRD, FTIR and thermogravemetric analysis. Films were 
prepared by reducing graphene oxide in polymer matrix using simple solution 
processing. Their interesting findings from structural and study of physical properties 
indicated the dispersion of graphene on molecular scale and aligned in PVA matrix which 
exhibited strong interfacial interactions among graphene and PVA via strong hydrogen 
bonding.  Interestingly, this phenomenon was responsible for changing the structure and 
properties of the composite such as increasing glass transition temperature (Tg) and 
decrease in the level of crystallization. Though no study was done on cellular interaction 
or biocompatibility, this is well reported findings that helped future researchers. 
Recently, intensive study indicated enhancement of conductivity of polymer composites 
enhanced biocompatibility of the composite that are important for skeletal muscle 
tissue regeneration [4,212].  
2.3.2. Graphene oxide nanoplatelets (GOnPs)–polymer composites 
enhanced mechanical, electrical and dielectric properties 
Recently, intensive study of the GOnPs-PVA composite films have been done [56,66] 
showing enhancement of conductivity and dielectric constant in the composite. GOnPs 
form homogeneous composites with many bioactive polymers [213] are suitable for 
tissue engineering application because of their enhanced mechanical, electrical and 
dielectric properties [213]. Bhadra and co-workers [214] studied  GO-PVA polymer 
composites and their percolating behaviour. Their results demonstrated that compared 
to pure PVA polymer, the GO-PVA composite significantly increased electrical 
conductivity and dielectric properties even at very low GO concentration. Low 
percolation threshold value was also estimated from the concentration dependent 
transport and dielectric data. Nearly 300 time increase in dielectric permittivity 
(compare to pure PVA) was observed which could be very much suitable for the growth 
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of cells, which are electro conducting such as skeletal myoblast cells and neural cells. 
The percolation threshold values of PLGA and PCL-GO composites were also found to be 
very small (~0.78 and ~0.81wt%, respectively for the PLGA and PCL composites. The 
enhancement of conductivity is very interesting indeed and could be very useful for 
enhancing biocompatibility of the composite scaffold (as in the case of conducting 
polyaniline added PCL composite scaffolds [172]) and hence such scaffold would be 
suitable for TE applications.  
A few detailed studies on the relationship between human stem cell and 
graphene have drawn a tremendous impetus in the field of different TE applications 
[54]. These investigations were carried out mainly with bone marrow derived 
mesenchymal stem cells, induced pluripotent stem cells and neural cells. Although 
mouse myoblast proliferation on reduced graphene oxide deposited modified glass 
substrate was reported [67], no study was focused on the proliferation and 
differentiation of human mesenchymal stem cells to skeletal myoblast cells on GO sheet 
or GO-polymer fibrous scaffold. These studies are important for exploring the possibility 
of fabricating different GO-polymer based biocompatible conducting electrospun 
scaffolds for the repair and regeneration of skeletal muscle and other tissues using 
human stem cells.  
2.3.3. Graphene oxide nanoplatelets (GOnPs)-polymer composites for 
tissue engineering 
Graphite, a single atomic layer of sp2-hybridized carbon covalently bonded in a 
hexagonal lattice is a naturally abundant material composed of stacked graphene layers 
(figure 2.1). Recently, GO based materials are being given high importance for their 
ability to differentiate and proliferate mesenchymal stem cells to different tissue types. 
Therefore, GO and GO based polymer composites are being used as potential 
biomaterial candidates for TE applications. 
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Figure 2.1.Schematic representation of graphene and carbon based materials. The hexagonal 
honeycomb structure with chemically active edges, graphene is a single layer of carbon atoms. 
The folded single carbon layer for carbon forms nanotubes. Graphene oxide is the oxidized  form 
of graphene, increasing stiffness with number of layers. 
 Graphene has zero band gap with very high carrier concentration and mobility 
that results in remarkable electrical property that is suitable for various biomedical 
applications as well.  Materials for such scaffolds should have suitable mechanical 
properties, chemical and biological compatibility and degrade in an appropriate time 
window [215-217]. During the last couple of decades many electrospun nano fibrous 
scaffolds [3,25,64,97,218-220] and carbon based nanomaterials (e.g. carbon nanotubes 
(CNTs) [221-223],  graphene and its derivatives [58,224]) have widely been investigated 
for different clinical and TE applications. The CNT and GO incorporated scaffolds have 
good mechanical property and are useful for stimulating cell growth [221]. However, the 
metal catalysts used in the fabrication of CNTs are generally trapped inside the 
nanotubes [222] which have negative effects on their cytotoxicity [223]. Currently,  
graphene and its derivatives have drawn special attention as novel nanomaterials with 
great potential in applications and utilizations such as photonics and optoelectronics 
[225], sensors [55,86], biomedical as well as TE [56,87,226-228] because of their 
extraordinary physicochemical properties and favourable bioactivity. These properties 
further extended their intensive applications for the differentiation of human neural 
stem cells [56], osteogenic differentiation of human stem cells, drug delivery [227,228]. 
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An injectable graphene/hydrogel-based gene delivery system has been developed for 
vasculogenesis and cardiac tissue repair [229]. The antibacterial property [230,231], anti-
inflammatory effects [232] and biocompatibility [233]  of graphene and graphene GOnPs 
were also tested with mammalian cells [95,101,117] by different research groups. 
Induced pluripotent stem cells (iPSCs) cultured on GO surface were found to adhere and 
proliferate even at a faster rate than graphene [60]. Graphene showed controlled and 
accelerated osteogenic differentiation of human mesenchymal stem cells [60,62]. All 
these favourable results revealed superior biocompatibility of graphene based materials 
for tissue culture and other biomedical applications compared to many bioactive 
polymer scaffolds [234]. Moreover, in contrast to carbon nanotubes and nano-diamond, 
GOnPs can be more easily prepared in pure form [235]. GO forms homogeneous 
composites with many bioactive polymers which are biocompatible and suitable for 
tissue engineering applications. A schematic representation of GO-polymer composite is 
shown in figure 2.2. Some important aspects of GO favouring TE application are 
mentioned in Table-2.1. 
 
2.3.4. Importance of PCL and PLGA polymers for making biocompatible 
composites  
It has already been mentioned that PCL and PLGA have been vastly used in TE and in 
other biomedical applications [236-242] because of their biocompatibility and solubility 
in different solutions for making fibrous scaffolds (Table 2.2).  It is also important to note 
that the biocompatibility of graphene and graphene derivatives appear to be  related to 
their different physical properties namely electrical conductivity (σ), surface charge (Q) 
which favours cells growth and proliferation [51,81,97,179]. Myoblast differentiation is 
also stimulated by electrically conductive scaffold fibers. In case of TE, the cells growth is 
improved in presence of electro-responsive materials [38]. Insulating PCL blended with 
conducting nanofibers formed excellent conducting biocompatible composites which 
enhanced cells proliferation [219]. Tables (2.1) and (2.2) describe some other important 
features of PCL, PLGA and GO for their favourable properties, suitability for making 
composite scaffolds for TE and other biomedical applications. Similar characteristic 
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behaviour is also exhibited by PLGA  [51]. Over the last decade, PLGA composites have 
also been used extensively as artificial scaffold materials [243-246].  So, study of 
composites of PLGA and PCL with any new filler (like GO) for skeletal muscle TE 
application would be important. However, the filler used must be biocompatible and 
should have low percolation threshold for conductivity/dielectric permittivity. GO is 
biocompatible and GO-polymer composites have also shown low percolating threshold 
[214], higher conductivity and dielectric with low GO content. Therefore, graphene oxide 
nanoplatelets are promising fillers for the fabrication of biocompatible PCL and PLGA 
nano-composite scaffolds [247,248]. 
 
Figure 2.2. Schematic representation of graphene oxide (GO) and polymer interacting to form 
composites (edges are chemically active). It shows honeycomb structure with hydrophobic π 
bond. The polymer interacts with OH and carbon bonds. Uncharged polar groups (OH, -O) are 
seen on the basal surface. 
 
 It is reported  that all the carboxyl groups cannot interact with the polymer chain. 
Only unbounded or free carboxyl groups interact. Unhindered -COOH groups bond 
covalently with the ester functional groups of the polymer [27,51,81,82,88,179]. 
Discussion on the interaction of graphene oxide and polymer has been made by Kim and 
his group [25] where strong interaction of GO and polymer has been shown. Both 
covalent and non-covalent functionalization of GO platelets has been reported to 
generate stable dispersions of chemically modified graphene platelets in organic 
solvents and also to enhance their compatibility with various polymer matrices. Among 
others, reactions using amines and isocyanates [27,51] have also been reported for small 
molecule functionalization of GO platelets because of the facility of the reactions and 
the ability to react in multiple ways (e.g., amidations, nucleophilic epoxide ring-
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openings, carbamate formation, etc.). However, covalent functionalization of GO 
platelets could adversely affect the electrical conductivity of the platelets as these 
functionalizations disrupt (or retain the disruption already present in) the sp2 hybridized 
network required for good electron conduction [27]. Non-covalent functionalization of 
GO nanoplatelets via, for example, pep stacking could minimize disruption of the 
conductive and conjugated structure [61,81]. 
Enzymatic degradation of graphene/PCL for tissue engineering was studied by 
Murry and co-workers [71] exploring the effects of graphene addition on the 
degradation rates of the correspondent nanocomposite scaffolds. In addition to 
electrical and topographical cues, piezoelectric (related to dielectric constant ε) 
responses of scaffold materials might also control the addition and differentiation of 
specific cell types [27]. Hydrophobicity is the only major drawback of pure PCL that 
prevents cell attachment which can, however, be overcome with surface coating of PCL 
or blending of PCL with other suitable materials such as gelatin, collagen, PANi, chitosan  
etc. Till now, researchers and scientists have given tremendous efforts to successfully 
regenerate skeletal muscle tissue construct. There is immense scope of research and 
development in this field of tissue engineering in terms of finding Novel materials like 
graphene and its derivatives that provide suitable physicochemical and biological 
properties required for skeletal muscle tissue regeneration.  A few detailed studies on 
the relationship between human stem cell and graphene have drawn a tremendous 
impetus in the field of different TE applications [4,230,234]. These investigations were 
carried out mainly with bone marrow derived mesenchymal stem cells, induced 
pluripotent stem cells and neural cells. Although mouse myoblast proliferation on 
reduced graphene oxide deposited modified glass substrate was reported [67], no study 
has focused on the proliferation and differentiation of human mesenchymal stem cells 
to skeletal myoblast cells on such novel GO based composite scaffold. These studies are 
important for exploring the possibility of fabricating different GO-polymer based 
biocompatible conducting electrospun scaffolds for the repair and regeneration of 
electro-responsive skeletal muscle and other tissues using human stem cells.  
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 Polymer blends and composites are the main composition for the preparation of 
various scaffolds. Recently, considerable interest has been paid on the skeletal muscle 
regeneration by tissue engineering to overcome various limitations of conventional 
medical approaches [4]. It has been demonstrated that conducting graphene oxide (GO) 
accelerates myoblast differentiation showing the potentiality of GO in the field of 
skeletal muscle tissue engineering. Graphene-based nanomaterials have obtained much 
interest in the field of biomedical and drug/gene delivery, cancers remedy, image 
resolution, as well as cells engineering. Beside dose dependent biocompatibility, GO is 
nontoxic and implantable within its nontoxic limit. But, their own influence on myogenic 
differentiation has almost never been learnt earlier other than the culture of neural cells 
and stem cells [207]. Many researchers explained graphene-based nanomaterials, 
particularly GO  as well as reduced graphene oxide (rGO) as the emerging bioactive 
materials. Some important aspects of GO favouring TE applications are shown in Table 
2.1. Recent reviews discussed many important biomedical and related applications of 
graphene and graphene based materials such as superior anticancer activity of graphene 
nanoplatelets [249,250]. 
2.3.5. Biocompatibility and toxicity of graphene and graphene based 
materials 
Biocompatibility of GO and graphene–polymer composites have already been 
mentioned. Though graphene and its derivatives are in use for quite some time, 
biocompatibility and toxicity of graphene in case of human cells have recently been 
discovered. Wang and co-workers in 2011 [210] examined on this topic and put some 
valuable findings for further research and development. Graphene oxide was prepared 
from modified Hummers method and biocompatibility was measured on them using 
human fibroblast cells. Previously cells were cultured on various graphene substrates 
with different graphene concentration (low, middle to higher dose).  In addition, they 
have also injected various amounts (dose) of graphene oxide to animal model (mice) to 
observe the biocompatibility of graphene oxide. Finally, they concluded that graphene 
oxide with dose less than 20µg/ml did not cause any adverse effect on human fibroblast 
cells. But, same way, it shows toxicity if dose is increased to more than 50µg/ml.  
Similarly, graphene oxide (0.1 to 0.25mg) injected in mice did not show any toxicity to 
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their body. But, if 0.4mg was injected onto them, there was some amount of adverse 
effects reported. Higher concentration of graphene oxide caused mice death due to lung 
granuloma formation in liver, kidney, spleen [210].  Another study with fibroblast cells 
showed that higher dose of graphene oxide caused cell apoptosis and disruption of cells 
causing cell death [210]. In conclusion, it is very much clear that careful selection of the 
amount of graphene oxide addition is very much important to enhance the 
biocompatibility.  
2.4. Growth Factors for Skeletal Muscle Tissue Engineering 
Growth factors play important role in skeletal muscle tissue engineering. Skeletal or 
other muscle regeneration needs collective action of cells, scaffolds, signalling molecules 
and growth factors [250]. Growth factors are soluble-secreted signalling polypeptides 
which instruct specific cellular responses in a biological environment. Under various 
circumstances, for instance, to regenerate affected tissues, cells secreted growth factors 
(GFs) protein perform various cellular actions viz. control over migration, differentiation 
or proliferation of a specific subset of cells and cell survival. Localized delivery of GFs is 
believed to be therapeutically effective for replication of cellular components directly 
involved in tissue regeneration and healing process [250-253]. Though all growth factors 
are important, some have more specific importance over the others for skeletal muscle 
regeneration. One important GF is Transforming growth factor (TGF)-beta1 which is very 
effective for fibroblast tissue regeneration. Immunohistochemical results predict TFG-
beta as local stimulators for the tissue repairing process [253]. It has been shown that 
TFG-beta1 is one of the best fibrogenic mediators and it is over expressed in human 
dystrophic muscle [250-253]. Some important GFs are Angiopoietin-related growth 
factor (AGF), bFGF (basic fibroblast growth factor), Hepatocyte growth factor (HGF), 
Trand growth factor   (TGF), Insulin-like growth factor (IGF), Platelet-derive growth factor 
(PDGF), Colony stimulating growth factor  (CSF), Leukaemia inhibitory growth factor (LF) 
etc. It has been shown that TFG-beta1 is one of the best fibrogenic mediators and it is 
over expressed in human dystrophic muscle [250-253]. With increased TFG-beta1, mRNA 
levels are directly associated with initial stage [27] of tissue fibrosis which could be a 
positive indicator that the starting point of muscular tissue regeneration occurs through 
the TFG-beta1. It has also been shown that plasma TGF-beta1 level is elevated in 
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patients with DMD and congenital muscular dystrophy [254-256]. TFG-beta also shows 
positive effect on reorganization of extracellular matrix and basement membrane 
surrounding the damaged myofibers. By stimulating the synthesis of collagens, 
fibronectin and novel matrix proteins, TFG-beta directly induces angiogenesis to 
regenerate new blood vessels [257]. For example, it has been examined that TFG-beta is 
expressed by regenerating skeletal muscle within a few days after trauma. So, TFG-beta 
is undoubtedly one of the major multifunctional growth factors that can motivate the 
entire skeletal muscle regeneration process. Moreover, TFG-beta also stimulates the 
production of Platelet Derived Growth Factor (PDGF) that is well known to cause cell 
migration to the injured tissues thereby accelerate regeneration [258]. PDGF also acts as 
a potent stimulator of cell division in fibroblast-like cells. So PDGF is likely to accelerate 
fracture repair in early stages. Similarly, after tissue disruption, Fibroblast Growth Factor 
(FGF) released during inflammation which induces the satellite cells to further 
proliferate and hence accelerate the regeneration process [259]. Like TFG-beta, it has 
also been found that FGFs are angiogenic in nature. So, they can also be involved in the 
growth process of new blood vessel from pre-existing vessels, which gives another new 
aspect that TFG-beta not only regenerates new tissues but also helps in the formation of 
new blood vessels [68,204]. So it is quite evident that Transforming growth factor TGF-
beta1 has some potentiality to directly influence  the fibrotic process of human muscular 
dystrophy. Leukaemia inhibitory factor (LIF) has also been well examined and found to 
have some most important role in the regeneration of injured muscle [78]. LIF is also 
addressed as multifunctional cytokine that directly stimulates the growth of skeletal 
muscle after damage. Finally, growth factors have a great influence in proper growth 
and development of skeletal muscle regeneration. 
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Table 2.1. Some important aspects of graphene oxide (GO) for TE 
applications 
Sl 
no. 
Properties Advantages of GO 
1 Structural stability Structurally high stable, doesn’t breakdown during processing, can 
withstand high pressure & temperature [4,214]. 
2 Biocompatible Suitable for in-vitro & in-vivo applications, non-immunogenic 
 [4,67,260,261]. 
3 Electroconductivity Excellent myoblast attachment and supports proliferation towards 
formation of myotubes. Declared as one of the BEST materials for SMTE.   
[ 4,67, 214,261]. 
4 Nontoxic (dose 
dependent) 
Dose dependent toxicity has been observed [4,67, 72,84]. 
5 Self-Antibacterial Additional benefit to prevent contaminations & infections [67,72]. 
6 Anti-cancer activity Researchers have done some work on GO that indicates its anti-cancer 
activity which will be beneficial to support normal cells growth [13,67]  
72]. 
7 Supports myoblast 
differentiation 
GO supports myoblast differentiation and fusion to obtain multinucleated 
myotubes  [53, 194,243]. 
8 Induces formation of 
multinucleated 
myotubes 
GO supports myoblast differentiation and fusion to obtain multinucleated 
myotubes  [13,53,194,243] 
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Table  2.2. Some important aspects of  PCL and PLGA  for TE applications 
Sl 
No 
Some Important aspects of PCL for TE Applications 
 Properties Advantages 
1 Highly 
biocompatible  
One of the most suitable scaffold materials that is highly biocompatible and non-
immunogenic therefore suitable for in-vivo applications. This remarkable property 
enables PCL to be used intensively for the fabrication of various tissue engineering 
scaffolds in the form of films or electrospun meshes [5,197].   
2  
 Blendability  
PCL can be blended with several natural and synthetic polymers. Moreover, PCL can 
be solubilized by various solvents like DMSO, chloroform etc. that makes it easier to 
blend with various other polymers for the preparation of scaffolds. It has also been 
observed that PCL makes uniform blend with other polymers which is useful to 
fabricate scaffolds with uniform distribution of polymers [4,260-264] 
3 Structurally 
stable 
Suitable for long term culture without breaking down the structure.  This property 
enables PCL to sustain scaffolds properties while being used as composites [4,64].   
4 Electrical 
conductivity of 
PCL composite 
scaffolds 
Though pure PCL is less favourable towards cellular attachment, increased electrical 
conductivity with addition of Polyaniline (PANi) with PCL increased muscle cells 
growth of this composite. Electrical conductivity is an interesting feature that 
qualifies those materials for electro-responsive muscle tissue engineering 
[26,82,179,219]. 
5 Easy  to 
fabricate 
PCL by its own as well as in the form of composites can be easily fabricated by 
electrospinning for the preparation of fibrous meshes or for the preparation of 
films. This ease the scaffold fabrication process [64,261-264]. 
6 Used as 
composites 
PCL as one of the popular scaffold materials used in the form of composites in 
tissue engineering and other biomedical applications. PCL can be blended 
homogeneously with silk-fibroin, PLGA, Chitosan, PLLA, collagen, gelatin etc. that 
increases its potential to be used as a scaffold material [5,260-264]. 
7 Non-acidic 
degradation 
PCL does not produce any harmful by-products along with its degradation. This 
property does not put strain on growing cells and hence improves cellular 
interaction of the PCL-composite [5,260-264].  
8 Economical 
 
PCL is one of the cheapest biocompatible polymers being used Today for the 
preparation of tissue engineering scaffolds or in other biomedical applications. Use 
of PCL is thus beneficial especially for research purpose in developing countries 
[4,260-266]. 
Some important aspects of PLGA for TE applications: 
 
Both PCL and PLGA are similarly important for TE and other biomedical applications [67,260-265]. Amongst 
most of the biopolymer, PLGA has shown immense potential as a drug delivery carrier and as scaffold 
material for tissue engineering.  Conductivity, biodegradability, and mechanical stability of PLGA can be 
improved by making composites with GO similar to that of PCL. PLGA is often described in terms of the 
relative percentage of two monomers (PLA and PGA); PLA and PGA  ratio  of 50:50, used in the present 
work, refers to 50%lactic acid and 50% glycolic acid [266]. One of the main advantages of PLGA is the non-
toxicity of its degradation products. Both of which are easily metabolized by the body [266]. The ability to 
control the degradation kinetics of PLGA has made it a suitable biomaterial for control release strategies. 
PLGA has also been widely used as porous scaffolds for various TE applications [266].  
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2.5. Scope and Objectives of the Work 
From the literature survey, it appears that graphene and its derivatives (graphene oxide) 
are emerging as important biocompatible materials for tissue engineering applications.  
Graphene oxide has many oxygen-containing functional moieties, such as hydroxyl, 
carboxyl and epoxy groups. GO based composites are more conducting than the pure 
polymer scaffolds. The addition of GO enhances conductivity and mechanical stability of 
the polymer substrates as well as improve their cellular behavior. GO has antibacterial 
property and it is also non-toxic within certain limit (within 50 µg/mL) for human cells 
and provides necessary environment for TE applications. Therefore, GO is potential for 
use as a bio-building block for the fabrication of scaffolds for skeletal muscle 
regeneration. Because of the unique physicochemical characteristics such as electrical 
conductivity, high elasticity and good molecule adsorption of graphene oxides (GO and 
reduced graphene oxide, rGO) have drawn interest worldwide for their applications in 
tissue engineering and biomedical science. Graphene derivatives have been 
demonstrated as biocompatible substrates for the promotion of growth and 
spontaneous differentiation of various stem cells such as hMSCs, iPSCs, and neural cells. 
These investigations were carried out mainly with bone marrow derived mesenchymal 
stem cells, induced pluripotent stem cells and neural cells. Mouse myoblast proliferation 
on reduced graphene oxide (rGO) deposited on modified glass substrate was also 
investigated showing potential for myoblast differentiation. Elaborate investigation 
focused on the proliferation and differentiation of human mesenchymal stem cells 
(hMSCs) to myoblast cells on such novel GO based polymer composite fibrous scaffolds 
are highly important. Previous studies stimulated to explore the possibility of fabricating 
different GO-biopolymer biocompatible composite scaffolds for the repair and 
regeneration of skeletal muscle and other tissue types using human mesenchymal stem 
cells. These studies are challenging and demanding. Therefore, within the present 
scenario, the main objectives of the present thesis work are: 
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 To develop electrospun biopolymer based composite scaffolds 
 To characterize the developed scaffolds from the studies of morphological, 
physicochemical and mechanical properties  
 To assess in-vitro biocompatibility of the prepared scaffolds 
 To differentiate mesenchymal stem cells seeded on these scaffolds to skeletal 
myoblast cells  
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3. Materials and Methods 
This chapter deals with the preparation of graphene oxide nanoplatelets (GOnPs) from 
natural graphite and electrospun GO–biopolymer composite (GO-PCL and GO-PLGA) 
meshes. A brief description of the different experimental techniques used for the 
characterization of prepared scaffolds used for cell culture was also briefly elucidated. 
Other than morphological, structural characterizations, standard methods were also 
used for the study of some physical properties (viz. measurements of conductivity, 
dielectric constants and surface charge behaviour) of GO and GO-polymer composites. 
3.1 Materials  
(a) Scaffold materials 
Chemicals used for the prepration of GOnPs were analaytical grade graphite powder, 
H2O2, H2SO4, KMnO4 (each of purity better than 99.9%) from E Merck (India). PCL (Mol 
wt. 65,000 g/mol), PLGA (PLGA: 50/50, MW=70-110kDa), chloroform and N, N-
Dimethyleformamide (DMF) were purchased from Sigma-Aldrich , USA. 
(b) Cell culture media and reagents 
Dulbecco’s modified eagle medium (DMEM), Penicillin-Streptomycin solution, fetal 
bovine serum (FBS), Dulbecco’s phosphate buffered saline (DPBS), horse serum, 
antibiotic-antimycotic solution, phosphate buffer saline (PBS) solution, 0.25% Trypsin 
/ethylene diamine tetra acetic acid (EDTA) solution  were purchased from (GIBCO, USA); 
paraformaldehyde, dimethyl sulfoxide (DMSO) from Sigma Aldrich, USA, All CD-markers 
were procured from BD pharminogen (Becton Dickenson, San Jose, CA). Tissue culture 
plates (TCP) ware from BD falcon and MP Biomedical-USA. Skeletal muscle growth media 
and skeletal muscle differentiation media (Promocell, Germany); insulin like growth 
factor 1 (IGF-1) (Invitrogen, USA); Ficoll Histopaque, paraformaldehyde, dimethyl 
sulfoxide (DMSO), WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium, monosodium salt], collagen type-1 (rat tail) and FITC-
phalloidin (Sigma Aldrich, USA); all primary and secondary antibodies (Abcam, United 
Kingdom) were purchased and used as received. 
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3.2. Preparation of Graphene Oxide Nanoplatelets (GOnPs) 
High quality uniform shaped nanoflakes of GOnPs were prepared from pure (99.99%) 
natural graphite powder by the modified Hummers method [267,268] using NaNO3, 
H2SO4, and  KMnO4. The oxidation product was purified by rinsing with 10% HCl solution, 
repeatedly washing with copious amounts of Milli-Q water, and filtering through 
standard filter paper. The filtered material was dried under vacuum (80°C, 3 h) and 
finally peeled off from the filter paper in the form of a ~0.5-mm-thick film. For the 
preparation of GOnPs dispersions in different solvents, the said dried product was first 
grounded and then added to the solvent followed by sonication in an ultrasound bath 
cleaner (J. P. Selecta Ultrasonic system, 40kHz) for 1 hr. To allow direct comparison 
between the dispersing behavior of the different solvents, a certain amount of graphite 
oxide powder (~5 mg) was added to a given volume of solvent (~10mL) in such a way 
that the resulting nominal concentration was adjusted to 0.5 mg mL-1 for all of the 
solvents. Graphene oxide dispersions were tested in different organic solvents such as 
acetone, methanol, ethanol, 1-propanol, ethylene glycol, dimethyl sulfoxide (DMSO), N, 
N-dimethylformamide (DMF), N-methyl-2-pyrrolidone (NMP), pyridine, tetrahydrofuran 
(THF), dichloromethane, o-xylene, and n-hexane. The water content of the solvents was 
below 0.1%. Because the common solvent for the preparation of graphite oxide 
dispersion is water, aqueous dispersions of the as-prepared graphite oxide materials 
were also made under exactly the same conditions as those used in the case of the 
organic solvents. Such water dispersion served as a reference against which the organic 
solvent dispersions were compared. 
 
Figure 3.1. (a) Filtration of graphene oxide suspension, (b) graphene oxide suspension  after 
hydrothermal treatment. The dried GOnPs were used for the fabrication of  GO-polymer 
composites (GO-PCL or GO-PLGA).  
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A pictorial view of the preparation procedure of GOnPs suspension used for 
making GO sheet and GO-PCL composite meshes was presented in Figure (3.1) for 
demonstration. 
3.2.1. Fabrication of thin GO sheets and hybrid composite materials with 
biocompatible polymers (PCL and PLGA) 
The pure GO sheet was obtained from graphene oxide hydrosol prepared by ultrasonic 
peeling of GOnPs in aqueous suspension. The solution was dried in vacuum oven for 
making the GO sheet by spin coating. Graphene oxide solution in water was applied to a 
2cm/2cm clean glass slide or Teflon plate which was mounted on a spin coater (Scientific 
India) attached with local vacuum unit.  The sample was spun at 1500rpm for 20 seconds 
to fully cover the glass or Teflon slides with thin film of GO. The sample was then placed 
inside fume hood overnight before being placed in vacuum for complete evaporation of 
solvent and film formation [4,28]. To prepare GO-PCL or PLGA composites, the 
percolation threshold concentration of GO-PCL and GO-PLGA  composites were studied.  
For this purpose,  GO-polymer composite solutions were made in DMF (20v/v%) and 
chloroform (80v/v%) solutions with different GO concentration (0-1wt% GO) and were 
treated with ultrasound for 45 minutes to make a homogenous brown dispersion. PLGA 
(50:50) (or PCL) was dissolved at ~80oC and the solution was subsequently cooled to 
room temperature (RT).  The  GOnPs  were gradually added to the polymer solution (for 
instance DMF, for PLGA) with stirring and sonicated at RT for 45 minutes to obtain 
homogeneous GOnPs/polymer solutions. Finally, the above solutions were allowed to 
stand overnight to remove air bubbles, then poured into glass dishes and kept at ~40oC 
for film formation until its weight equilibrated [4,28]. Similarly GO-PCL composite films 
of different GO concentrations were prepared. The final disc-shaped composite films for 
different GOnPs concentrations were prepared each having ~10-20mm in diameter and 
~0.1mm in thickness. The concentrations of the GOnPs fillers were varied systematically 
to investigate the influence of GOnPs on the dielectric and electrical properties of the 
composite. 
 
50 
 
3.2.2. Preparation of electrospun GO-polymer (PCL and PLGA) composite 
meshes 
To prepare electrospun GO-PLGA  composite meshes, for cell culture, specific amount of 
GOnPs (20μg/ml) was dissolved in calculated amount of DMF 
(20v/v)/Chloroform(80v/v%) mixture under continuous stirring for three h. GOnPs were 
added at a concentration of 20μg/ml PLGA solution (to keep GO concentration within 
non-toxicity limits) and stirred again for another 1 h. making homogeneous solution. The 
final colloidal solution thus obtained was loaded into a 12ml plastic syringe with a 
stainless-steel needle (diameter ~0.60mm) and used for making fibrous meshes by using 
electrospinning machine (PICO ESPIN, India). The needle for electrospinning was 
connected to a high voltage supply  (~25kV) and the flow rate of the solution was 
adjusted to 1.5ml/h. The fibrous meshes were collected on aluminium foil placed at a 
distance of 12 cm from the needle tip. Electrospun collagen (0.10g/ml acetic acid) 
meshes were also prepared for control using similar technique and sterilized for one hr 
by UV (wavelength ~254nm and power 15W). GO-PCL electrospun fibrous meshes  were 
also similarly prepared from GO-PCL solution using PCL (1gm /100ml) and GO (20μg/ml). 
The final colloidal solution was used for making  scaffolds by electrospinning as 
mentioned above. 
3.3. Characterization of Scaffolds 
Graphene oxide and graphene oxide polymer composites have been characterised by 
using different techniques like XRD, SEM, FESEM, AFM, Raman, FTIR and UV-VIS. The 
porosity of the electrospun scaffolds was measured by Mercury intrusion  porosimeter. 
3.3.1. Phase analysis 
X-ray powder diffraction (XRPD) is a rapid analytical technique primarily used for phase 
identification of a crystalline or amorphous material and can provide information on the 
unit cell dimensions. The monochromatic collimated beam of X-ray from the source 
interact with the sample producing constructive interference (and a diffraction ray) 
when conditions satisfy Bragg’s Law:  
 
2dsinθ = nλ     (3.1) 
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Where d is the inter-planer spacing, θ  is the incident angle, n is the order of diffraction 
and λ is the wave length of the incident X-ray. Samples for XRD were taken in the form of 
powder in the holder and placed in the radiation chamber for obtaining the diffraction 
patterns indicating different phases of the samples. Conversion of the diffraction peaks 
to d-spacing allows identification of the material because each material has a different 
set of d-spacing. Typically, this is achieved by comparison with d-spacing of the standard 
pattern [269].  To ensure phase purity of the sample, XRD was  performed  for all GO and 
GO-polymer composite samples and materials at room temperature by a PHILIPS 
SHIFFERT 3710 diffractometer using Cu Kα radiation source (λ =1.5418 Å and  35kV, 
30mA) [269].  The samples were scanned from 20° (2θ) to 70° (2θ) at a scanning rate of 
3.0θ/min. Crystallinity was determined by integration using Kaleida Graph (Synergy 
Software). 
3.3.2. FTIR analysis 
Fourier-transform infrared (FTIR) spectroscopy is a measurement technique whereby the 
spectra are collected based on measurement of the coherence of a radioactive source, 
using time-domain or space domain measurements of the electromagnetic radiation or 
other type of radiation  [270,271]. The FTIR spectra were recorded using the Perkin–
Elmer spectrum 100 FTIR spectrometer with a 4 cm-1 resolution. FTIR spectrum (in the 
range of 500-4000cm-1  was  obtained for the prepared graphene oxide and GO-polymer 
composites. FTIR spectroscopic study of pure PCL, PLGA, GO and the composites were 
done using Shimadzu 800 spectrometer. 
3.3.3. UV-Visible spectral analysis 
Solutions of transition metal ions can be coloured (i.e. absorb visible light) because d 
electrons within the metal atoms  can be excited from one electronic state to another. 
Organic compounds, especially with a high degree of conjugation, also absorb light in the 
UV or visible region of the electromagnetic spectrum. For the UV-Vis measurements GO 
samples were taken in solution (water, chloroform and DMSO). The UV–visible  
spectrophotometric measurements of nanocomposite solution [272] were done within 
the wavelength range from 400-700nm by using a double beam spectrophotometer 
(Model No. EI2375). 
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3.3.4. Atomic force microscopy (AFM) studies 
The AFM measures the forces acting between a fine tip and a sample surface. The tip is 
attached to the free end of a cantilever and is brought very close to a surface [273,274]. 
Attractive or repulsive forces resulting from interactions between the tip and the surface 
will cause a positive or negative bending of the cantilever. Atomic force microscopy (di 
CP-II, Veeco) was used to characterize the samples. AFM imaging of the dispersions 
deposited onto silicon wafer was performed and the corresponding tapping mode AFM 
images of graphene oxide nanoplatelets were detected. The fractured surfaces were 
coated with gold before analysis. FM tapping mode image of graphene oxide 
nanoplatelets from aqueous dispersion(spin coated on mica substrate at 2000rpm) with 
superimposed cross section measurements was taken along blue and cyanine indicating 
~1567nm in radial diameter and  GO sheet thickness around 450nm. 
3.3.5. Scanning electron microscopic (SEM) analysis 
Scanning electron microscopic studies were made to observe the morphology of the 
developed GO sheet, GO-PCL and GO-PLGA meshes using  SEM model (SEM: JEOL JSM 
6480) following  standard procedure [269,272]. The traces of moisture present in the 
scaffolds were removed by drying in a vacuum drier for 2 h. at  40°C. Platinum coating 
was done prior to imaging. A minimum of 25 pores were considered for calculating the 
pore size of the developed scaffolds along with the estimation of fiber diameter by using 
Image J (USA) software.  
3.3.6. Field emission scanning electron microscopy (FESEM)  
Field emission scanning electron microscopy was used for better analysis of the 
nanostructure feature of the graphene oxide nanoplatelets (GOnPs) and GO embedded 
in PCL and PLGA polymer composite meshes using the FESEM (FEI Nova NanoSEM 230 
FESEM), following standard procedures [269,272]. Almost similar procedure was 
adopted for the SEM and FESEM studies. The fractured surfaces of the GOnPs/polymer 
composite films were also observed via field emission scanning electron microscopy (FEI 
Nova NanoSEM 230 FESEM). The samples were dried in vacuum dryer for two h. at 40oC 
and  platinum  (Pt)  sputter  coating  was done prior to imaging. 
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3.3.7. High resolution transmission electron microscopy (HRTEM) analysis 
High resolution transmission electron microscopic (HRTEM) analysis was made to study 
the presence and morphology of the GOnPs embedded in the GO-Polymer composite 
meshes. Small grains of GOnPs and composite samples were placed on copper grid using 
alcoholic solution and dried before use as usual. Selected area electron diffraction 
(SAED) confirmed the structure. The high resolution transmission electron microscope 
(Model: JEM-2010, JEOL) was used for the HRTEM analysis [275]. 
3.3.8. Raman spectroscopy 
This is a vibration spectroscopic technique suitable for characterizing carbon based 
materials like graphene and graphene based composites with their characteristic peaks 
[276]. The laser Raman spectroscopic study was carried out for characterizing the 
graphene oxide and graphene oxide–polymer composites providing information about 
the GO band present in GO-polymer composite.  Raman spectroscopy (HORIBA JOBIN 
Yuon: Exciting wavelength 514nm with Argon ion laser) was used.  Raman spectra were 
taken in water solution of GOnPs and in chloroform solution of GO-PCL and GO-PLGA  
meshes.  All measurements were made at ambient temperature. 
3.3.9. Electrical conductivity and dielectric constant measurement 
Frequency dependent electrical conductivity and dielectric measurements were carried 
out with the help of an impedance analyser (HP 4192A) [277].  To look for the origin of 
excellent cellular interaction of GO sheet and GO-polymer composite meshes, surface 
charge, current- voltage (I–V) and capacitance -voltage (C-V) characteristics were 
measured using standard methods [278]. Samples were cut in rectangular shape and 
both sides were coated with conducting paint which acted as electrodes. A two terminal 
capacitor configuration was employed for this measurement. 
3.3.10. Conductivity and dielectric constant stability of the composite 
samples 
The conductivity and dielectric constant stabilities related to degradation of the 
scaffolds [279] meshes were assessed by immersing in physiological solution (PBS) at 
~37oC for about one week. in vitro degradation of electrical conductivity and dielectric 
constant stabilities of the electrospun samples in PBS solution were determined from 
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the morphological changes and also by surface electrical conductivity and dielectric 
constant measurements. The dried electrospun fiber meshes with a thickness of 50-60 
µm were cut into small rectangular pieces (~20x20mm2) and the specimen were 
immersed in phosphate buffered saline (PBS) solution at pH ~7.4 in test beakers. These 
samples were incubated in a water bath at ~37oC.  After one week, each sample was 
retrieved from the beaker, rinsed several times with deionized water to remove adhered 
PBS solution and kept in a vacuum chamber before the measurements of resistivity, 
dielectric constant and the morphology study using SEM measurements. 
3.3.11. Mechanical property   
Mechanical tests were performed to define tensile strength (from load - elongation 
curves) of the scaffolds  by using a Universal Testing Machine (Model: Instron Electro 
Puls E1000) with a 1 kN load cell at room temperature (~30oC). Samples were prepared 
with an average length of ~15mm, width ~10mm and thickness of ~0.5mm. All tests 
were carried out at room temperature (RT) [4]. Mechanical characterization of the GO 
sheet was performed by uniaxial tensile testing. GO sheets were carefully cut into 
rectangular stripes (15×30mm) and loaded with an Instron 3369 tensile strength 
measuring system. A segment of electrospun meshes (10×25mm) was fixed at the cut 
ends for the axial testing (n=5). 
3.3.12. Water contact angle measurement  
Contact angle measurement of a water droplet on the scaffold surface can provide  
information about  hydrophobicity [280]. Water contact angle (CA) measurements 
against distilled water were performed using a sessile drop method (DAS100S: KRUSS 
GMbH, Germany). The advancing (wetting CAw) and receding (dewetting CAdw) contact 
angles were measured at room temperature at different locations for the GO sheets and 
GO-polymer meshes. The advancing CA of liquid on homogeneous surface is mostly 
dependent on the surface resistance to wetting-presence of hydrophobic domains in the 
case of water. Conversely, the receding contact angle is most strongly controlled by the 
strength of the interaction between the liquid and the surface, that is, the presence of 
hydrophilic domains.   
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3.3.13. Porosity measurement 
The porosity of the composite scaffolds was measured by Mercury intrusion porosimeter 
(Poremaster-33, Quanta chrome, USA). The bulk density of samples was calculated by 
equation,  BD = D/W-S,  where D =  dry weight,  S =  suspended Weight, W = soaked 
Weight [281]. The percentage porosity was calculated from intrusion data. For all types 
of scaffolds, experiments were carried out in triplicates. 
3.4. Swelling Behaviour and Biodegradation Study 
Each rectangular shaped sample film (initial weight Wo) was cut and immersed in 
deionized water for 12h. After retrieving from immersion, water from the scaffold 
surface was removed with water soaking paper and the sample was weighed in wet 
condition (W1)  [282].   Swelling ratio  Sr  (%)  was calculated from the following relation. 
Sr (%) = [(W1 –Wo)/Wo ] × 100 
Each such experiment was repeated three times. 
For biodegradation study, the fabricated scaffolds were cut into small pieces 
(6mm/8mm) with initial weight Mo and immersed in PBS at ~37
oC (pH ~7.4). The samples 
were soaked in PBS solution for different periods. Then the scaffold samples were taken 
out of the solution and  properly dried at 40oC in an oven for 24h and the  weights  of 
dried scaffolds were again measured as Mt. 
Whereas the biodegradation (B) was calculated as: 
B (%) = [(Mo – Mt)/Mt] × 100 
3.5. In-Vitro  Cell Study  
3.5.1. Human umbilical cord blood (UCB) collection 
UCB was collected from ISPAT General Hospital, Rourkela with prior patient’s consent. 
All procedures were approved by the Institutional (National Institute of Technology, 
Rourkela, India) Ethical Committee. In brief, UCB sample was collected in a blood bag 
containing ~15ml of Citrate Phosphate Dextrose Adenine (CPDA) anticoagulant agent to 
prevent blood clot and processed in laboratory.  
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3.5.2.  Isolation and culture of mononuclear cells (MNCs) 
Mononuclear cells (MNCs)  were isolated directly from UCB following standard Ficol 
Hypaque density gradient method [4,261,283]. In brief, first, 30ml of UCB (diluted with 
RPMI 1640 in the ratio of 4:1 (v/v)) and 25ml of Ficol was added in sterile tube. This 
solution was centrifuged at 430×g at 4oC for 30 min. Then the solution inside the tube 
was found separated into three various layers. Just above the Ficol layer (middle layer – 
buffy coat) a smoky white layer was produced where MNCs were present. This smoky 
layer was then carefully pipette out without hampering the other layers and kept in 
another sterile tube. Next, 25ml of D-PBS was added with this solution and again 
centrifuged for 15 min at 300×g. The supernatant was removed and bottom part (about 
~5ml) was collected where the density of the MNCs were the highest. This solution was 
then mixed with 45ml of DMEM media consisting of 10% FBS, 2mM glutamine and 1% 
100-x antibiotic-antimycotic solution in another sterile  50ml tube. The entire solution 
was mixed gently and poured in three sterile T75 culture flux and placed in a 
CO2  Incubator. After 24h, the cells were washed with D-PBS  to remove non adherent 
cells and fresh media was introduced.  These cells were cultured for up to 5th passaging. 
The media change was carried out twice a week. 
3.6. Characterization of Umbilical Cord Blood (UCB) Derived 
hMSCs 
3. 6.1. Morphological characterization 
Morphological characterization of  the  cultured hMSCs were observed from the culture 
flask under phase-contrast inverted microscope. Images were captured using a Carl Zeiss 
Axiovert 40 microscope without any kind of specific staining. 
3.6.2. Immunophenotypic characterization   
This is one of the major techniques used in modern research for the acknowledgement 
of specific cells type using cell surface markers. Specific surface antigens expressed by 
hMSCs were characterized by flow cytometry analysis. UCB derived cells were stained 
with human monoclonal antibodies against CD90-FITC, CD73-PE, CD105-APC, CD34-FITC, 
HLA DR-APC, and CD45-PE [4,261]. This experiment was carried out using a  flow 
cytometer (Becton Dickinson and Co, San Jose, CA, USA). 
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3.6.3. Proliferation of hMSCs (DNA quantification assay) 
Proliferation of hMSCs was assessed by DNA quantification assay. Cell scaffold 
constructs from each predetermined time period of culture (3, 7, 11 days) were 
collected and washed with serum free DMEM to remove the traces of serum 
components. The constructs were washed twice with PBS and the cells were lysed using 
0.4ml of Lysis buffer containing 10mM tris and 2% triton for about an hour. Quant-it 
PicoGreen reagent was used following the manufacturer’s protocol. In brief, 100µL of 
Quant-it PicoGreen reagent was added to 100µL of sonicated cell lysate and incubated at 
RT for 10 minutes. The fluorescence was measured with a spectrofluorometric plate 
reader (Model: LS 55 Perkin Elmer, USA) at excitation and emission wave lengths of 
528nm and 485nm, respectively.  
3.7. Differentiation Potential of Umbilical Cord Blood (UCB) 
derived hMSCs 
3.7.1. Cells seeding and culturing 
UCB derived hMSCs (5×103cells/well) were directly seeded (following static seeding 
method) onto the thin film like GO sheet (~30µm thick) and GO-polymer mesh (areas 
~45mm2) as well as on control in a 12 well plate. 
3.7.2. Cell attachment and morphology 
Cells adhesion on the different substrates was studied by SEM or FESEM analysis. After 
specific days of culture, the cells seeded on all the substrates were carefully washed 
twice with PBS, fixed with 2.5% glutaraldehyde for 4h. and then dehydrated through a 
gradient series of ethanol from 70% to 100%. All the said substrates were then carefully 
dried using a vacuum desiccator to make them moisture free prior to SEM or FESEM 
analysis.  
3.7.3. Cell viability and proliferation assay 
Cell viability and proliferation on GO-PCL composite meshes, thin GO sheet and controls 
were measured by water-soluble tetrazolium  salt  (WST-8)  assay after  3, 7 and  11  
days of cell seeding in 96 well culture plate.  10μl of cell proliferation reagent (WST-8) 
was added into each well containing sample with 100μl of culture medium and 
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incubated for 4h. at 37oC. Absorbance (OD) of the solution was then measured at 450nm 
by a microplate  reader (Varioskan Flash, Thermo Scientific). The cells seeded on tissue 
culture plate and/or collagen mesh were evaluated as controls.  
3.7.4. Myogenic differentiation 
hMSCs grown onto the scaffolds were cultured with skeletal muscle differentiation 
media (90 v/v%) supplemented with FBS (10 v/v%) and 100x antibiotic-antimycotic 
solution (1 v/v% approximately), and incubated at 37oC and 5% CO2  atmospheric 
condition. In addition, insulin like growth factor-1 (IGF-1) was added (5ng/ml) to 
enhance the myogenic differentiation process. After 12-15 days of culture, cell 
morphology was found to change towards bipolar skeletal myoblasts. Low serum (2% 
horse serum) media was introduced to enhance myoblast fusion and formation of 
myotubes  [4,261]. 
3.8. Characterization  of  Myoblast  Cells 
3.8.1. Immunohistochemical characterization of myoblasts 
Fluorescence (Zeiss  Axivert 40 CFL) and Confocal (Leica TCS SP2) microscopes were used 
for the detection of fluorescence spectra of the cells. The fluorescent images were 
analysed for the expression of muscle specific antigens such as Desmin, MyoD, 
Dystrophin and Myosin Heavy Chain (MHC) to assess the expression of myogenic cell 
specific antibodies. A computer monitor was attached with the microscope camera for 
the capture of images [4,261]. Immunohistochemical analysis was done directly on cells 
grown on scaffold samples along with tissue culture plate (TCP) taken as control. 
3.8.2. Immunophenotypic characterization of myoblasts 
Specific surface antigens expressed by skeletal myoblasts were characterized by 
Fluorescence-activated cell sorter (FACS) analysis. The skeletal myoblast cells adhered 
onto the GO sheet, GO-PCL meshes and control were trypsinized and flow cytometry 
analysis was performed to verify the expression of skeletal muscle differentiation 
markers like CD56 and desmin. For all antibodies, 5×105 cells were incubated in 100 ml 
of PBS containing 1% FBS and the dilution of primary antibodies was ranged from 1:15 to 
1:100. The cells after being incubated with primary antibody on ice for 30 min, were 
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washed with 1% FBS in PBS, re-suspended in 100 ml of FITC-labelled secondary antibody  
and diluted 1:100 in 1% FBS in PBS.  Finally, the cells were incubated again for 30 min on 
ice and washed with PBS containing 1% FBS prior to re-suspension in PBS with 1% FBS 
for FACS analysis. Isotype-matching immunoglobulin (IgG) and FITC-labelled secondary 
antibody were used to determine nonspecific signals. The flow cytometric analyses were 
performed using a flow cytometer  (BD LSR Fortessa, San Jose, CA, USA) equipped with 
an air cooled argon laser. FACS data were analysed by FCS Express software.  
3.9. Myogenic Protein Expression 
Western Blotting method was used for this experiment. To study the expression of 
myogenic specific proteins, the trypsinized cells from specific cell-seeded scaffolds were 
suspended in buffer containing 20mM TRIS, 2mM EDTA, 150mM NaCl, 0.5%Triton X-100 
and protease inhibitors (Sigma). The samples were then sonicated,  centrifuged and the 
pellets were discarded. Cells were assayed for protein concentration following standard 
Bradford- assay. Protein extracts of approximately 45-50μg/sample were separated onto 
the 10% SDS PAGE and transferred to nitrocellulose membrane followed by incubation 
with primary and secondary antibodies following the manufacturer’s protocol and 
visualized on film with the ECL substrate kit (Abcam Inc., Cambridge, MA, USA) [284]. 
3.9.1. Myogenic gene expression 
Myoblast cells grown on scaffolds were analyzed via the expression level of myogenic 
genes  such as Desmin, MyoD  and  MHC using Quantitative real-time RT-PCR. Synthesis 
of cDNA synthesis was performed from cells cultured on control,  GO-PCL and  GO-PLGA 
meshes separately using FastLane cDNA synthesis kit (Qiagen, Germany).   Real time RT-
PCR was carried out using Quantitect SYBR Green (Quigen, Germany) with BioRad CFX96 
Real Time detection system (Bio-Rad, USA). Thermocycling conditions followed were 
95oC for 15 min, 40 cycles of denaturation (15s, 94oC), annealing (30s, 55oC) and 
extension 30s, 72oC). The sense and antisense primers used were: MyoD, sense 5'-AAG 
CGC CAT CTC TTG AGG TA-3' and antisense 5'-GCG CCT TTA TTT TGA CC-3' (PCR product, 
500 bp); Desmin, sense5'-CCAGCTCTCAGTGGCCATGCAGA-3' and antisense 
5'ACCTCCAGCACTGTGAGCACCG-3' (PCR product, 400bp) and myosin heavy chain (MHC), 
sense 5'-TGT GAA TGC CAA ATG TGC TT-3' and antisense 5'- GTG GAG CTG GGT ATC CTT 
GA-3' (PCR product, 750 bp). Relative expression level of each gene compared with that 
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of beta-actin was calculated and normalized by the value for cells cultured on tissue 
culture plate taken as control [285-287]. 
3.9.2. Cell signalling pathway analysis 
Insulin-like growth factor 1 (IGF-1) pathway is one of the important cell signaling 
pathways to assess myogenesis that is related to skeletal muscle differentiation and 
maturation [285,287,288]. The main pathway proteins involved here are IRS-1, PI(3)K, p-
Akt and MyoD, sequentially. Expressions of these proteins were assessed by western 
blotting analysis. In addition, inhibition of Akt, present in this pathway, was done via 
chemical inhibition to assess the final expression of MyoD for confirmation of this 
pathway. 
3.10. Statistical Analysis  
All data were presented as mean ± standard deviation (SD). Single factor analysis of 
variance (ANOVA) was carried out to compare the mean of different data sets and a 
value of p ≤ 0.05  was considered significant. 
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4. Characterization of the Prepared Graphene Oxide 
Sheet  and  GO-PCL  Composite  Scaffolds. 
 
This chapter deals with the experimental characterization of the prepared  GO sheet 
(composed of grapheme oxide nanoplatelets, GOnPs) and electrospun GO-PCL 
composite meshes from the studies of  XRD, SEM, TEM, HRTEM, FTIR, Raman spectra, 
mechanical property, contact angle measurement, and electrical properties 
(conductivity and dielectric constant). These properties indicated GO and GO-PCL 
electrospun scaffold meshes as suitable candidates for skeletal muscle tissue 
engineering and other biomedical applications.  
Detailed discussion on the preparation of pure GO sheet and electrospun GO-PCL 
composite meshes has  already been made (chapter-3). These novel bioactive composite 
materials have drawn special attention because of their great potential in applications 
for the differentiation of human neural stem cells [31], drug delivery [227,229], TE 
[56,60,233] and also in cancer therapy [248]. More discussion on the importance GO and 
GO-polymer composites for skeletal muscle tissue engineering applications have already 
been discussed in chapters 1 and 2. The GO concentration in the prepared GO-PCL 
composite scaffold meshes used for the present investigation was kept within the 
percolation limit.  
4.1.1. Percolation threshold behaviour of GO-PCL composite 
The percolation behaviour of GO-PCL composite was investigated from the study of GO 
(or GOnPs) concentration dependent conductivity and dielectric constant measurements 
of the composite at room temperature.  The  GO-PCL composite scaffolds were prepared 
with different GO concentrations (0-1wt% ). Figure (4.1a) showed the well dispersed GO-
PCL solution, spin coated GO film on glass and as prepared thin GO sheet (composed of 
GOnPs).  
GO concentration (fGO) dependent dielectric permittivity (ε) and frequency 
dependent  conductivity (σ)  of the GO-PCL composites showed maximum values (figure 
4.1b and c, respectively) and a typical anomalous behaviour (phase transition) around 
fGO = fc ~0.79wt%. As GO concentration (fGO) in GO-PCL composite was increased to 
0.79wt%, dielectric constant and conductivity decreased to a lower conducting regime. 
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This anomalous transition occurred at the percolation threshold value (fc = 0.79wt% GO) 
which  is  associated with the  formation of semiconducting network [87,88]. 
 
Figure 4.1.  (a) Well dispersed GO-PCL  solution (1), a free standing bendable tin GO sheet 
composed of GOnPs prepared  by solution casting (2) which can be dispersed in water and spin 
coated GO sheet on cover glass (3) produced from GO solution.(b) Dependence of  effective 
dielectric constant  (ɛ) and (c) conductivity (σ) of the GO-PCL  composite on GO concentration 
fGO. Inset of (b) shows the  best fit dielectric constant  with Eq.1 (with fc~0.79). The inset  of (c) 
shows the best fit  conductivity  data  with Esq. 2 and 3 (with fc~0.79).  
 
The observed value of fc is comparable with that of GO-PVA (polyvinyl alcohol) 
composite [214, 289]. For nanomaterials like GO, the threshold concentration is 
generally low [289,290]. The percolation threshold, fc is a key parameter.  Below this 
concentration, GO-PCL will remain mechanically stable as well as maintain their 
flexibility suitable for tissue engineering application or electronic applications. In order 
to estimate fc, the experimental σ and ε data were fitted to the following equations [290-
292] to establish the percolation behaviour followed by the GO-polymer composites. 
 
ɛ ∝  (fc, - fGO)
-s  for  fGO<fc     (1) 
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σ ∝  (fc, - fGO)
-s’  for  fGO<fc     (2) 
σ ∝  (fGO – fc )
-t  for  fGO>fc     (3) 
 
Where t is the critical exponent in the semiconducting region and s′ is the critical 
exponent in the insulating region. A sharp increase in dielectric permittivity was found 
when GO content reaches the percolation threshold, ~0.79wt% which was ascribed to 
the formation of numerous micro-capacitors in the self-assembled polymer composite at 
fc. Linear regression fit of experimental data using Eq.1 yields a critical exponent of s 
~0.831 and fc   of ~0.78wt%  (shown in the insets of figure 4.1b)  which was consistent 
with the universal one (sun ≈0.8-1.0) and also observed in practical continuum systems 
[290]. The best linear fit of the conductivity data to the log-log plot of the power low 
with Eqs.  (2 and 3) gives fc = 0.79, t ~ 2.15 ± 0.15, s’= ~0.91 (inset of figure 4.1.c). The 
critical exponent (t) showed little higher value along with  (s’) which agreed  with the 
estimated values (t = 1.59-2  and  s’un= ~ 0.8-1). GOnPs  nanosheets provided percolated 
pathways for electron transfer, making the GO-PCL composites electrically more 
conductive than insulating PCL matrix. In the presence of oxygen (potential acceptor 
sites), there might be possible ionic channels of charge transfer form GO across the 
semi-conductive network with many cross-linked connections. Similar techniques can be 
achieved with other conductive carbon fillers such as carbon black [293], carbon 
nanofibers (CNF), and expanded graphite (EG).  Though GO-PCL  composites showed 
percolation threshold around ~0.79wt%  exhibiting maximum σ and ε  values, for human 
cell culture, the non-toxicity limit  was reported [210]  to be  (~20µg/ml solution). This 
concentration of GO, used for the preparation of GO-PCL electrospun meshes, was also 
within the percolation threshold concentration. For electronic applications, higher GO 
concentration around the  threshold  value might be important. However, electrospun 
GO-PCL composite scaffold meshes for myoblast differentiation were prepared within 
this non-toxicity and percolation limits,  as mentioned earlier. 
4.1.2.  Structural  analysis 
X-ray diffraction is used most frequently to investigate the structure of bio-composites 
with embedded nanostructure.  The XRD spectra of GO sheet showed (figure 4.2a) the 
characteristic GO peak appearing at 2θ =11.1o, corresponding to a lattice d-spacing of 
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0.78 nm. For the GO-PCL meshes, an XRD peak (figure 4.2b) appeared at 21.65o 
representing the crystalline phase of the polymer [294]. The XRD pattern of GO-PCL 
indicated only PCL diffraction peak with no peak for GO around 2θ=11.1o. The absence 
of GO peak was also reported earlier in case of GO-PVA composite [289,290]. These 
results demonstrated the disappearance of the regular and periodic structure of 
graphene oxide, the formation of fully exfoliated structures, and the homogeneous 
distribution of GOnPs in the polymer matrix [294,295]. As revealed from these data, 
well-dispersed GOnPs acted as nucleating agents and thus the crystallinity of the 
composites was also improved. 
 
Figure 4.2.  (a) The X-Ray diffraction patterns of GO and pristine graphite powder, (b)  GO-PCL 
and PCL , respectively. 
The peak around 22o  decreased in intensity after GO addition to PCL was due to the 
hydrogen bonding which are responsible for the change of structure and properties of 
the polymer-graphene nanocomposites [289]. At the same time Tg (glass transition 
temperature) was increased with decrease in the level of crystallization. This led to the 
decrease in intensity after GO is added to PCL.  Similar phenomenon was also observed 
in the case of GO-PVA (polyvinyl alcohol) composites reported earlier [289,291,294,295]. 
4.1.3.  SEM  and  TEM micrographs of GO sheet and GO-PCL meshes  
The SEM micrograph of the GO sheet surface shown in figure (4.3a) indicated uniformly 
rough surface morphology. Inset of figure (4.3a) also presented FESEM micrograph 
showing the surface morphology of thin GO sheet which indicated wrinkles stacked in 
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multiple GOnPs layers. It was reported [296] that such surface morphology might favour 
cell adhesion and growth.  Figure (4.3b)  represented the SEM micrograph of the 
electrospun fibrous meshes and the selected area electron diffraction (SAED) pattern 
(inset of figure 4.3b) indicating the presence of sharp diffraction spot of nanocrystalline 
GO in GO-PCL mesh (estimated average fiber diameter of 490+125nm) with porosity 
~80-85%. Figure (4.4c) presented the FESEM micrograph showing morphology of the 
broken edge of a GO sheet and inset of figure (4.3c) showed the HRTEM image of a 
single layer of the GOnPs film. 
 
Figure 4.3. (a) SEM micrograph showing surface morphology of thin GO  sheet (inset shows the 
FESEM micrographs of a particular point  on the surface). (b)  SEM micrograph of the GO-PCL 
electrospun meshes (inset shows the HRTEM image of GO present in GO-PCL along with the 
selected area  electron diffraction  (SAED) image).  (c)  FESEM  micrographs of a broken edge of 
thin GO sheet (inset shows the HRTEM image of a single layer GO film). 
4.1.4. AFM analysis of   graphene oxide nanoplatelets (GOnPs) 
Atomic force microscopy (AFM) was used to characterize the microstructural features of  
GO. To assess the  degree of exfoliation of the GO in water, AFM images of the 
dispersions deposited onto silicon wafer surface  was taken and the corresponding 
tapping mode AFM images of the GO nanoplatelets  was shown in figure (4.4a). As 
indicated in figure (4.4b), marked by blue line, the thickness of the sheet resides 
between 400-500nm, which is in agreement with the previously prepared single layered 
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GO sheets explained earlier [297,298]. Analysis of AFM images shows most GO had 
length ~165np, the part marked  by cyan line in  figure (4.4c). 
 
 
Figure 4.4. Atomic force microscopic (AFM) tapping mode image of the graphene oxide 
nanoplatelets sheets from an aqueous dispersion with superimposed cross section 
measurements taken along blue and cyan line indicating ~167 nm in  radial diameter (b) and (c) 
sheet thickness of approximately  450nm. 
4.1.5. Raman spectroscopic analysis of GO and GO-PCL composite meshes  
This is the vibrational spectroscopic technique used to characterize GO and identify the 
presence of GO in GO-PCL composite.  Raman spectra of GO sheet as shown in figure 
(4.5), indicated the characteristic feature of GO peaks at frequencies around 1345 and 
1597cm-1, respectively, for the G and D band usually assigned to the E2g phonon of Csp
2 
atoms and a phonon breathing mode of symmetry A1g. The presence of GO peaks was 
also observed from the GO-PCL Raman spectra (inset of figure 4.5). Characteristic 
frequencies corresponding to the well-studied G and D bands agreed with the literature 
values [296-299] and also indicated little lattice distortion of the GO nanostructure. The 
intensity ratio ID/IG of the two peaks was widely used as characterizing the defect 
quantity within the GO materials [298,299]. By controlling the amount of defect 
quantity, the electronic and mechanical properties of the GO sheets might also be tuned 
as per user’s requirement *300+. In single and/or multilayer graphene, Raman spectra 
showed 2D characteristic peak around 2700cm- 1 [301-304]. The observed D and G bands 
were comparable with those of previously reported values for graphene oxide [303,304].  
The D band was reported to be associated with the structural imperfections created by 
the attachment of hydroxyl and epoxide groups on the carbon basal plane [305]. The G 
band corresponds to the ordered sp2 bonded carbon. Graphene oxide conduction was 
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also reported to occur through sp2 regions via Klein tunnelling [306]. In figure 4.5a, the 
2D band corresponding to 2700cm-1 was hardly observed, which indicated  either  
absence or negligible presence of pure conducting   graphene in the GO sheet of present 
investigation. 
 
Figure 4.5. Raman spectra of GO (a) and GO-PCL (inset). The characteristic D (2Eg) and G (A1g) 
peaks of graphene are shown both in GO and in the GO-polymer composite. There is no 
detectable peak corresponding to 2D around ~2700cm -1  indicating that graphene is almost fully 
oxidised. 
4.1.6. FTIR analysis of GO sheet and GO-PCL meshes  
FTIR is one of the most common vibrational spectroscopic techniques used to obtain an 
infrared spectrum of absorption for the verification of GO and GO-PCL. Far infra-red 
(FTIR) spectra of GO and pristine graphite powder were shown in figure (4.6). The 
intense band at 3438cm-1 is attributed to the O-H band of CO-H.  The band at 1639cm-1 is 
associated with the stretching of the C-O bond of  carbonyl and carboxyl group.  
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Figure 4.6.  FTIR spectra of GO sheets and pristine graphite powder (inset) distinguishing the 
behaviour of graphene and graphite powder. In GO intense bond around 3438cm-1 
corresponding to O-H band of CO-H is observed. 
Deformation of the C-O band is observed at the band present at 1070 cm-1. FTIR 
spectra (figure 4.7) of GO-PCL showed absorption band at 1727cm-1 indicating carbonyl 
stretching. The bands appearing at 1295cm-1 and 1240cm1 represented the C-O and C-C 
stretching bonds [307]. The bands at 1239cm-1 and 1175cm-1 were comparable with the 
asymmetric C-O-C stretching bonds indicating characteristic absorption [307] of PCL.  
The band at 1639cm-1 was associated with stretching of the C-O bond of carbonyl 
groups. Deformation of the C-O band was observed at around 1017cm-1. From FTIR 
spectroscopy, evidence of different types of oxygen functionalities on GO were 
exhibited. 
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It is well known that both the O-H stretching and the –C-OH stretching bonds are 
sensitive to the hydrogen bonding. The decrease of the intensity of the peak at  1727cm-
1  was due to the dissociation of the hydrogen bonding among the  hydroxyl groups in 
the polymer [1,2]. This result also indicates strong bonding between the polymer and 
graphene to the detriment of hydrogen bonding among polymer chains  and  diminishing  
the  crystallinity of  the  polymer [305-307]. 
4.1.7. UV-visible analysis 
UV spectroscopic studies are important for the molecular structural analysis (chemical 
bonding etc.) of the scaffold materials [303]. The UV spectrum of GO exhibited 
maximum at 371nm [289,290] which is characteristic feature of the π-π transition of 
aromatic C-C bonds. The corresponding peak in GO-PCL in chloroform solution was 
observed around 450nm (figure4.8). The π-π stacking force created by the sp2 bonding 
and hydrophobic interaction between molecules allow graphene to be conducting [306-
308] which provides important cues for the biocompatibility of GO  added  polymer 
composites.  
 
 
Figure 4.8.  UV-visible spectra of GO-PCL composite.  The GO peak exhibits maximum around 371 
nm,   the characteristic feature of the π-π transition of aromatic  C-C bonds.  
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The corresponding peak of the composite (dissolved in chloroform solution)  was 
observed at around 450nm. The ionic bonds, the π-π stacking forces formed by the sp2 
bonding and hydrophobic interaction among molecules allowed graphene to be 
conducting and also adsorb proteins and low molecular weight chemicals which 
provided important  cues  for  biocompatibility  of  GO and GO based  composites. 
 
4.1.8.  In-vitro  biodegradability   
The degradation behaviour of scaffold plays an important role in the formation of new 
tissue at the site of an implant. The in-vitro degradation pattern of PCL and GO-PCL 
composite scaffolds shown in the figure (4.9) indicated electrospun GO-PCL composite 
meshes  degraded upto ~16%  whereas electrospun PCL mesh degrade ~9% after 30 days 
of time interval.  Slower rate of pure PCL is due to its lesser degradability and rigidity 
that hamper its use in pure form. But, On the other hand,   GO-PCL composite mesh 
showed optimised degradability rate that is suitable for cellular growth. Optimized 
degradation of scaffolds eases the longevity of the scaffold implants at the site of the 
implant [309]. GO-PCL composite scaffold can thus provide support to the growing tissue 
for a long period of time in an optimised way which may be useful for in-vivo 
applications. 
 
4.1.9. Contact angle measurement 
Contact angle (CA) measurements provides important information about the surface 
roughness and hydrophilicity [90]. CA also indicates a measure of solid-liquid interaction. 
Wetting (CAw) and dewetting (CAdw) contact angles (discussed in chapter-3) of thin GO 
sheet and GO-PCL mesh were shown in figure (4.9 inset).  
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Figure 4.9. In-vitro degradation pattern of electrospun PCL and GO-PCL composite  scaffolds in 
SBF (simulated body fluid) for 30 days.  Inset shows contact angle analysis (in degrees) 
representing both advancing (wetting) and receding (dewetting) water sessile drop on GO 
sheets, GO-PCL and PCL meshes. Error bars present standard deviation. 
 
In case of thin GO sheets, CAw  was found to be around ~58.7
o with hysteresis 
(CAw-CAdw) of  ~4
o  which might be a measure of the solid-liquid interaction [310]. For the 
GO-PCL meshes, the contact angle (CA) was ~78o. Due to the presence of GO with 
abundant hydroxyl group, CA of GO-PCL significantly (p<0.05) decreased compared to 
PCL, (CA ~119o). It is suggested that GO-PCL composite fibrous meshes could enhance 
cell adhesion as they are more hydrophilic due to the presence of  GOnPs . 
 
4.1.10. Mechanical property 
The mechanical stability of the polymer scaffolds is important for cell adhesion and 
proliferation. Studies of mechanical properties of GO sheet and GO-PCL meshes were 
carried out indicating suitable mechanical strength of the scaffolds. The stress-strain 
curves of GO sheets and GO-PCL meshes were shown in figure 4.10. The tensile strength 
of PCL (~1.88 ± 0.25MPa) was found to increase significantly with addition of GO (~4.8± 
0.25MPa). Mechanical property of the tensile strength is also known to increase with 
increasing GO concentration [64]. Favourable mechanical  property supported GO sheet  
and GO-PCL meshes for tissue engineering applications. 
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Figure 4.10.  The stress-strain curve of the GO sheet and GO-PCL meshes carried out at room 
temperature with GO concentration within the non-toxic limit (~20µg/ml). 
 
 
4.1.11. Conductivity (σ), dielectric constant (ε) of thin GO sheet and GO-
PCL meshes  
 
Figures  4.11 and 4.12 demonstrated room temperature (RT) σ  value of GO sheet (~10-7 
S/m). Quite high value of ε (~900) was also reported [15] for GO sheet  which might be 
attributed to its high charge trap density [311,312] (~1.2×1018 cm-3/eV) that influenced 
its σ, ε and even the  piezoelectric (PE) behaviour [313] of GO that influenced improved 
cellular interaction. GO conductivity arises through the sp2 regions via Klein Tunnelling  
mechanism  [306]. 
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Figure 4.11. Room temperature (RT~300C)  conductivity (σ) data of a GO sheet as a function of 
frequency (a) and corresponding conductivity data of the same sheet (measured at 1000 kHz) 
after immersion in PBS solution for up to 7 days (b) . (c) RT dielectric constant (ε) data of the GO 
sheet as a function of frequency. (d) Corresponding ε data of the sheet (measured at 1 kHz) after 
immersion in PBS solution. (e) FESEM micrograph showing morphology of the GO sheet surface 
after immersion in PBS upto 7 days.  (f) RT variation of electrical conductivity and (g) dielectric 
constant of PCL fibrous meshes as a function of frequency. In (b) and (d), 0 days indicate, 
respectively, RT σ and ε data of GO before immersion in PBS (shown for comparison). 
 
From the study of room temperature conductivity and dielectric constant data as 
shown in figures 4.11 (a-d), GO added PCL (GO-PCL composite) exhibited appreciably 
large increase of both  ε  (~300 for GO-PCL and only ~25 for PCL) and  σ  (more than two 
orders of magnitude higher in GO-PCL compared to GO sheet). Similar enhancement of σ 
and ε was also observed in GO-polyvinyl alcohol (PVA) and other GO-polymer 
composites [289,290,313]. Similar conductivity increment in GO-PMMA (poly-methyl 
methacrylate) was suggested to be due to deformed graphene nanosheets (considered 
to be the effect of agglomeration of GOnPs in polymer matrix) [313-315]. Enhancement 
of σ and ε in GO-PCL and other GO-polymer composites might , therefore, be associated 
with the formation of conducting pathways between the more conducting deformed 
GOnPs sheets (enhancing σ) and micro-capacitors with insulating polymer (PCL) as 
insulating dielectric films (enhancing effective ε) similar to those reported in case of 
other polymer composites [313-317].   
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Figure 4.12. (a) Room temperature (RT) dielectric constant (ε) and (b) conductivity (σ) data of 
GO-PCL meshes before (0 days) and after immersion in PBS solution for up to 7 days. RT ε (c) and 
σ (d) data of PCL meshes before (indicated by the O days) and after immersion in PBS solution 
(all measurements were performed 1 kHz). 
In pure GO there is a mixture of both positive and negative charges which lead to 
a decrease of  σ  but increases polarizability and hence  ε  value of GO  [289,290,318]. It 
is further noticed from figures 4.12  that both   and  ε values of GO and GO-PCL mesh 
decreased  only  a  little with increase of immersion time in PBS solution  (up to one 
week in our present study)  indicating in-vitro stability of the GO and the GO-PCL 
composite mesh. Moreover, no significant morphological change of the thin GO sheet 
was observed as revealed from the unchanged FESEM micrograph of the sheet after 
immersion in PBS solution (figure 4.11e).  The room temperature (RT) variation of electrical 
conductivity and (figure 4.11f) dielectric constant (Figure 4.11g) of PCL fibrous meshes 
considered as a function of frequency. The addition of GO also reduced the degradation 
rate of GO-PCL (compared to PCL) in PBS solution (Figure 12a and b) which is indicated 
by the lesser decreasing rates of σ and ε compared to those of pure PCL (Figure 12 c and 
d). Thus, along with enhancement of  and ε, the stability of GO-PCL mesh was also 
improved by the GO filler. The little decrease of both ε and σ of GO-PCL after immersion 
might be associated with a small amount of material  leaching  from the scaffolds as in 
the case of polyaniline  doped  PCL [272]. 
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4.2. Conclusion 
Addition of GO in PCL enhanced the mechanical property, contact angle and 
hydrophilicity of the GO-PCL composites. Structural characterization indicated well-
dispersed GOnPs acted as nucleating agents and thus the crystallinity of the composites 
was also improved. FTIR study showed stretching of the C-O bond of carbonyl groups. 
Deformation of the C-O band was observed at around 1017cm-1. From FTIR 
spectroscopy, evidence of different types of oxygen functionalities on GO were exhibited 
necessary  for better cell scaffold interaction.  UV-visible spectra indicated the π-π 
stacking forces formed by the sp2 bonding and hydrophobic interaction among 
molecules allowed graphene to be conducting and also adsorb proteins and low 
molecular weight chemicals which provided important cues for biocompatibility of GO 
and GO based composites. Both conductivity and  dielectric constant (associated with 
GO surface charge) increase in the GO-PCL composites. Enhancement of conductivity is 
important for the enhancement of biocompatibility [84].  The composite showed 
percolation threshold behaviour with GO concentration around 0.79wt% which was 
quite low. Below this concentration GO-PCL composite retains its mechanical stability. 
This study confirmed that both GOnPs and GO-PCL meshes retained their σ and ε values 
almost unaltered after immersion in PBS solution for about a week and, therefore, the 
cellular interaction associated with the biocompatibility of such composites appeared to 
remain almost unaltered even after immersion in PBS solution over one week.  
Controllable enzymatic degradation of graphene/PCL materials was studied by Murry 
and his collaborators [71] and these substrates were proved to be promising 
biodegradable electro-responsive type scaffolds for TE applications  as discussed in the 
next chapter. Even the degradation products of the composite materials were reported 
[71] to exhibit less inhibition to cell metabolism and proliferation than the degradation 
product of pure PCL. Controllable non-toxic degradation and unique physical properties 
confirmed that covalently-linked PCL-graphene oxide based composites are ideal 
materials for the development of scaffold for skeletal muscle TE applications.  
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5. Myoblast Differentiation of Cord Blood Derived hMSCs 
on GO Sheet and Electrospun GO-PCL Composite Meshes 
 
In the previous chapter (4) characterization of the GO films and GO-PCL electrospun 
meshes have been described.  This chapter describes myoblast differentiation of cord 
blood-derived mesenchymal stem cells on the well characterized graphene oxide 
nanoplatelets sheets and GO–polycaprolactone (PCL) electrospun meshes.  The 
expression of myogenic proteins and IGF-1 cell  signalling  pathway analysis has also 
been presented.  
 
5.1. In-vitro Cell Culture Study 
Differentiation of human umbilical cord blood (UCB) derived multipotent mesenchymal 
stem cells to myoblasts and formation of myotubes on the GO added electroconducting 
polymer scaffolds described in this thesis are new and challenging one. Excellent 
myoblast differentiation of hMSCs on GO sheet and GO-PCL meshes have been reported, 
for the first, to elucidate their potentiality for skeletal muscle tissue regeneration.   
 
5.1.1. Isolation and culture of mononuclear cells (MNCs) from UCB 
The mononuclear stem cells (MNCs) were isolated from UCB (figure 5.1a) and cultured in 
DMEM media (90v/v%) containing FBS (10v/v%)  supplemented with 100x antibiotic-
antimycotic  solution (~1v/v%) for cell culture study and myoblast differentiation. The 
morphology of MNCs was initially round shaped (after 48 h of culture) as observed 
under phase contrast microscope (Figure 5.1b). These MNCs were cultured upto the 
formation of mesenchymal stem cells (hMSCs) up to 5th passage. 
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Figure 5.1. (a) Mononuclear cells (MNCs) layer (middle) and red blood cells (RBC) precipitated at 
the bottom in a 50ml culture tube. (b) Isolation of MNCs being cultured in a cell culture plate. 
5.1.2. Morphological characterization of  hMSCs 
The cultured hMSCs isolated from UCB were used for the cell culture study to examine 
the cell supportive property of the developed composite scaffolds. The morphological 
variation in the cultured cells was studied by phase contrast microscopic images as 
shown in Figure 5.2. After initial culture, the hMSCs were observed to be round/ 
spherical  shaped  during the initial days of culture and turned gradually towards 
elongated fibroblast shape like morphology after 5th passage (Figure 5.2.a-d).  These cells 
were used for further characterization as well as for myogenic differentiation. 
 
Figure 5.2.  Gradual morphological changes of umbilical cord blood derived mesenchymal stem 
cells (hMSCs). After 5thpassage  fibroblast like morphology (d) of the cultured cells were 
observed under phase contrast microscope. 
 
The morphology of cells was also analyzed using cytoskeleton staining of actin 
filaments (Figure 5.3). Cells (stained with FITC-phalloidin) were observed under a Zeiss 
Axivert 40 CFL fluorescence microscope. 
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Figure 5.3. Morphology of hMSCs was analysed using phase contrast microscope (a) and  
cytoskeleton  staining of  actin  filaments (b) along with Nuclei counterstained  with DAPI. 
5.1.3.  Immunophenotypic characterization of  hMSCs 
Besides morphology, Immunophenotypic characterizations of hMSCs were assessed by 
performing flow cytometry analysis. The immunophenotypic characterizations shown in 
figure (5.4)  were found to be positive for CD90 (99.2%), CD73 (98.5%), CD105 (98%) and 
negligible for hematopoietic markers like CD45 (1.5%), CD45 (0.5%) and HLA-DR (1.0%) 
indicating mesenchymal stem cells phenotype. The stem cells thus isolated from human 
umbilical cord blood were used for  in-vitro  skeletal myoblast cells differentiation on GO 
sheet  and  GO-polymer  composite  scaffolds.  
 
Figure 5.4. The immunophenotypic analysis was found to be positive for CD90 (99.2%), CD73 
(98.5%), CD105 (98%) and negative for CD45 (1.5%), CD34 (0.5%)  and HLA-DR (1.0%)  indicating 
mesenchymal stem cells phenotype.  
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5.1.4. hMSCs seeding, attachment and spreading 
After seeding of hMSCs (by static seeding method with ~2×104 cells/ml), attachment and 
spreading of these cells onto the scaffold surface were evaluated by scanning electron  
microscope (SEM) on various time intervals. SEM micrographs revealed excellent cell 
adherence as well as proliferation of hMSCs on the developed scaffolds after three, five 
and seven days of culture as shown in figure (5.5). Cellular attachment and spreading  
also indicat  their compatibility to the scaffold environment.  
 
Figure  5.5.  Attachment and Spreading of hMSCs on GO-PCL composite scaffolds on Day 3(fig. a), 
5(fig. b) and 7(fig. c) days of culture. The cells  are well visualized from the micrographs. 
5.1.5. Cell metabolic activity 
The cellular viability in terms of metabolic activity of the cultured hMSCs on the 
prepared GO based scaffold was further evaluated quantitatively by WST-8 assay as 
shown in figure (5.6). Difference in the increase of O.D (optical density) values with 
culture period have been observed for hMSCs grown on different substrates (GO sheet, 
GO-PCL composite mesh and tissue culture plate   as control). The higher O.D value 
representing higher metabolic activity is obtained with GO based substrates. The 
increase in metabolic activity achieved with GO-PCL composite mesh can be attributed 
to the addition of GOnPs that provided essential physicochemical properties suitable for 
better cellular interaction. The amount of formazan dye generated (by the activities of 
dehydrogenases) was directly proportional to the number of living cells. Thus, GO based 
substrates  proved their superior biocompatibility. 
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Figure 5.6.  WST-8 assay of hMSCs grown on GO sheet, GO-PCL and control (tissue culture plate)  
substrates after 3, 7 and 11 days of culture. Superior cellular metabolic activity has been 
observed on GO-PCL based composite meshes. Results presented as the means ± SD. * indicates 
significant difference (n=5; p<0.05). Metabolic activity was increased with time with the scaffolds 
showing the trend GO-PCL>GO>control substrate. 
5.1.6. Cell proliferation assay (via DNA quantification) 
The proliferation of hMSCs on the prepared scaffolds was evaluated by DNA 
quantification assay. Figure (5.7) shows an increasing rate  in DNA content of hMSCs 
with time as observed in different GO based substrates prepared for investigation.  
 
Figure 5.7. Cell proliferation represented in terms of DNA quantification on GO sheet, GO-PCL 
mesh and control (tissue culture plate) substrates. An increased trend in DNA content is 
observed on all the GO based matrixes. Results represented as mean ± SD, * indicates significant 
difference (n=5; p < 0.05). Proliferation of hMSCs were increased with time with the scaffolds 
showing the trend GO-PCL>GO>control  substrate. 
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The corresponding DNA contents of hMSCs cultured on tissue culture plate (TCP) 
taken as control, GO sheet and GO-PCL composite meshes on 3 to 11 days of culture are 
~50ng/ml to ~285ng/ml, ~58ng/ml to ~375ng/ml and ~65 to ~430ng/ml, respectively. 
GO based substrates have shown significantly higher amount of DNA content 
representing the higher proliferation rate of hMSCs on these novel substrates indicating 
their  superior cell supportive property. Proliferation of hMSCs was increased with time 
with the scaffolds showing the trend GO-PCL>GO>control. 
5.2. Differentiation Potential of hMSCs on GO-PCL Composite 
Scaffolds 
 
5.2.1.  Myoblast differentiation potential 
After confirming viability and proliferation of cord blood derived hMSCs onto the novel 
GO-PCL composite scaffolds, hMSCs were further allowed for myoblast differentiation 
on these substrates.  Along with differentiation of hMSCs, elongated bipolar morphology 
of myoblasts have been observed as depicted in FESEM micrographs (Figure 5.8. (ab)).  
 
Figure 5.8. Morphology of hMSCs (a) changes towards bipolar structure (b), same as myoblasts, 
on GO-PCL electrospun composite scaffold that indicates differentiation of hMSCs  to myoblast 
cells (morphology  wise). 
 
These myoblasts were further used for various characterizations as described 
below.  Myoblasts morphology on GO-PCL scaffold indicates myogenic differentiation 
potential of the scaffold.  
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5.2.2. Myoblast viability and proliferation  
Figure 5.9. shows viability and proliferation of myoblast cells on GO sheets, GO-PCL 
mesh and controls. Cell viability (from WST-8 assay analysis) was found to increase 
significantly for GO sheets and GO-PCL meshes compared to the control surfaces 
(*:p<0.05).This was ascribed to be due to the better myogenic differential potential 
contributed by the favourable physicochemical properties of graphene oxide. This result 
implied that GO sheets and GO-PCL meshes were cytocompatible and supported cell 
viability that increased the biocompatibility of GO-PCL composite scaffolds.  
 
Figure 5.9.  Viability and proliferation of myoblasts observed by  tetrazolium salt (WST-8) assay.  
Superior viability of cells has been found on GO-PCL composite meshes compare to GO sheet 
and other controls (collagen and tissue culture plate)  indicating better myogenic  potential and 
hence biocompatibility. Results presented as the means ± standard deviation). * indicates 
significant difference (n=5; p<0.05). 
5.2.3.  Immunophenotypic  characterization of myoblast  cells 
Flow cytometric analysis of cells adhered on thin GO sheets and GO-PCL meshes was 
performed to confirm the positive expression of myogenic markers CD56 and desmin 
indicating skeletal myoblast cells phenotype (Figure 5.10). Myogenic markers expressed 
better on GO-PCL meshes than that on the GO sheets indicating GO-PCL composite mesh 
as a better candidate for skeletal muscle tissue regeneration. Electrospun GO-PCL 
composite mesh provided increased  interconnectivity  along with electroconductivity 
and biocompatibility of PCL compare to plane GO sheet resulting better cell-scaffold 
interaction.  
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Figure 5.10.  Flow cytometric analysis of hSkMCs obtained from GO–PCL mesh and GO sheet (by 
trypsinization method) after 7 days of culture. Cells highly expressed for skeletal muscle markers 
CD56 and desmin that confirmed myoblast cell phenotype. 
5.2.4. Aspect ratio analysis 
Aspect ratio of myoblast is important to obtain the elongated structure of the cells that 
further differentiate to myotubes through cells fusion. After 3 days of culture, the aspect 
ratios measured on GO-PCL meshes, GO sheets and controls were found to be ~6.6, ~5.4 
and (~4.7 for collagen mesh and ~4.3 for tissue culture plate (TCP)), respectively, (Figure 
5.11). Compared to GO sheets and controls, a more elongated bipolar morphology of 
skeletal myoblasts was observed on GO-PCL electrospun meshes due to its better 
physicochemical and biological properties indicating its improved myogenic potential. 
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Figure 5.11.  Analysis of cytoskeleton development of hSkMCs grown on (a) control (tissue 
culture plate (TCP)), (b) collagen mesh, (c) GO sheets, (d) GO-PCL meshes. (e) Cell aspect ratio 
quantification from (a-d) after 3 days of culture. Increased aspect ratio indicates better 
elongation of these cells on GO based substrates. 
5.2.5. Formation of myotubes 
The myoblast cells were bipolar at the initial stage (Figure 5.12 a-b) and they were fused 
together on extended time interval (day 11) under proper condition and formed 
myotubes that were further clarified by FESEM micrograph (Figure 5.12 c) as well as 
immunostaining assay (Figure 5.12 d-l). These figures showed improved myoblasts cell 
proliferation, differentiation and formation of myotubes onto GO-PCL meshes compare 
to GO-sheet and control, which might be attributed to the  interconnectivity of fibrous 
meshes and enhanced σ and ɛ of the composite induced by the addition of GO. Thus the 
presence of GO in the polymer composites played an important role for guiding cellular 
interaction, resulting in a higher proliferation and myotubes formation. 
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Figure 5.12.  FESEM micrographs of GO-PCL electrospun scaffolds representing cells attachment 
as well as spreading at increasing time interval (Day3(a)-Day7(b)) and also formation of 
myotubes at extended time of differentiation (Day11(c)). For better comparison, 
Immunostaining (with Desmin-FITC and MHC-FITC conjugated) images of the corresponding 
FESEM images have also been shown alongside (d-l) with GO sheet and control (tissue culture 
plate (TCP)) substrate. 
5.2.6. Immunohistochemical characterization 
This process has widely been used for the detection of cells specific antigens (proteins 
e.g., Desmin, MyoD, Myosin Heavy Chain, Dystrophin etc.) to verify the presence of 
specific cells/tissues. Immunohistochemical analysis (Figure 5.13 a-l), along with FESEM 
analysis of the corresponding samples (Figure 5.13 m-p), confirmed differentiation of 
hMSCs to myoblasts via early expression of myogenin-positive nuclei on controls (tissue 
culture plate and collagen mesh), GO sheet and GO-PCL mesh (Figures 5.13 a-d). 
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Figure 5.13. Expression of the early myogenic differentiation marker Myogenin-positive nuclei 
(green) on controls (a,b), GO sheets (c) and  GO-PCL meshes (d). Immunostaining of MHC 
(green), respectively, on controls (collagen and tissue culture plate) (e-f), GO sheets (g) and GO-
PCL meshes (h) and Dystrophin (red) similarly on controls (I,j),  GO sheets (k) and GO-PCL meshes 
(l). Nuclei were counterstained with DAPI. FESEM micrographs (m-p) of the corresponding 
samples were also shown  for better demonstration. 
Moreover, muscle specific antigens like myosin heavy chain (MHC) shown in 
figures 5.13 e-h and dystrophin  (Figures 5.13 i-l)  were expressed more intensely on GO-
PCL meshes compared to those on thin GO sheets or control substrates. Myotubes 
formed on GO sheets and GO-PCL meshes were found to be more aligned compared to 
those on the control substrates. Quantitative analysis of the percentage of myogenin-
positive nuclei showed in (Figure 5.14) that myogenin expression increased more on thin 
GO sheets and GO-PCL  meshes compared to that on control substrates (collagen mesh 
and tissue culture plate), which also indicated a better differentiation potential of the 
GO-based substrates. Importantly, GO-PCL meshes showed the highest percentage of 
myogenin positive nuclei (~19%) (Figure 5.14). Significantly higher expression of early 
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myogenic marker (myogenin) indicated  superior  myogenic differentiation potential of 
GO-PCL electrospun meshes compared to GO sheets and controls. 
 
Figure 5.14. Quantitative analysis of percentage myogenin-positive nuclei (cells cultured in 
differentiation medium for 5 days before staining). * represents significant difference (p<0.05) 
compare to collagen mesh and tissue culture plate (TCP) taken as controls. 
As discussed above graphene oxide nanoplatelets impregnated GO-PCL 
composite meshes showed excellent cell scaffold interaction as such they are potential 
candidates for electro-responsive skeletal muscle tissue (SMT) regeneration.  This is 
because of the extraordinary physicochemical properties, nanostructural feature and 
surface charge of GOnPs which contributed to the enhancement of conductivity of the 
meshes and hence the biocompatibility as a whole.  Enhanced  biocompatibility of GO-
polymer composites was  also revealed from the expression of  myogenic protein, gene 
and IGF-1 cell signalling pathway analysis as discussed in the subsequent section. 
5.3. Expression of Myogenic Protein and IGF-1 Cell Signaling  
Pathway Analysis 
The ability of cells to correctly respond to their microenvironment is the basis of tissue 
repair and development [285,287]. Here, myogenic protein expression on GO sheet and 
electrospun GO-PCL scaffolds and cell signaling pathway (Insulin-like Growth Factor-1 
(IGF-1)) analysis have been investigated. Better myogenic protein expression was 
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observed on GO based polymer composites representing their superior myogenic 
differential potential. It was also observed that late myogenic protein, myosin heavy 
chain (MHC) related to the formation of myotubes, expressed more on GO-PCL 
composite scaffolds compare to GO sheet and control (tissue culture plate). Myogenic 
gene (Desmin, MyoD and MHC) expression was also found to be better on GO based 
polymer composite substrate. In addition, IGF-1 pathway, important for skeletal 
myoblast cells growth and maturation [319,320], was also studied with various 
intermediate proteins (IRS-1/PI(3)K/Akt/MyoD) expression. Inhibition of Akt was 
investigated to examine the variation of the expression of myogenic protein MyoD, 
involved in skeletal muscle differentiation [319,320]. The expression of MyoD was 
observed to reduce along with the inhibition of Akt that indicated the effectiveness of 
IGF-1 pathway for skeletal myoblast  cells differentiation and maturation. 
5.3.1. Expression of Desmin, MyoD and MHC proteins on scaffolds 
Expressions of myogenic proteins such as Desmin, MyoD and MHC were assessed on GO-
PCL meshes, GO sheet and control (tissue culture plate) using Western Blot analysis. 
Figure (5.15) showed expressions of Desmin and MyoD on these substrates after 5 days 
of culture. Both of these proteins expressed well on GO based substrates. The 
electroconducting GO-PCL composite mesh showed the highest expression due to better 
interconnectivity that enhanced cellular growth and hence their protein expressions. 
 
Figure  5.15.  Expression of myogenic protein Desmin and MyoD (left) and expression of fold 
change on GO-PCL mesh, GO sheet and control (tissue culture plate) (right) for the 
corresponding proteins. * indicates significant difference compare to control (p< 0.05). 
From the present observation (Figure 5.15), the expression levels of Desmin and 
MyoD  proteins were found to be enhanced on graphene based scaffolds, compared to 
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that of control as follows: 2.4-fold on GO, 4-fold on GO-PCL for Desmin and 1.8-fold on 
GO, 3.1-fold for GO-PCL for MyoD. Data reported as fold change from control (means ± 
SE). *indicates significant differences (n=5; p<0.05).  
After 11 days of culture on the same substrates, expression of MHC (a late 
myogenic marker) was assessed using Western Blot analysis (Figure 5.16). Expression of 
MHC, related to formation of myotubes was found to be better on GO and GO-PCL 
meshes compared to control substrate.  
 
Figure 5.16. Expression of  myogenic protein (MHC) (left) and expression of fold change on 
control, GO and GO-PCL substrates (right). * indicates significant difference from control (p< 
0.05).   
Here, better expression of this protein in GO-PCL mesh also indicates better 
myotube formation on this substrate. Similar result was also observed from previous 
studies (flow cytometry analysis, cell viability assay etc.) described earlier in this chapter. 
The expression levels of MHC protein were found to enhance on GO-PCL composite and 
GO sheet compared to that observed with control: 1.6-fold on GO and 2.5-fold on GO-
PCL mesh. Data were reported as fold change from control (means ± SE). * indicates 
significant difference (n=5; p<0.05). 
5.3.2. Myogenic gene expression  
Real-time RT-PCR was used to analyze the expression level of MyoD, Desmin and MHC 
on GO sheet, GO-PCL scaffolds and control. It was found, similar to protein expression, 
these myogenic genes expressed better on GO-PCL composite and GO sheet.  
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Figure 5.17.  Expression of myogenic genes (Desmin, MyoD and MHC) in myoblasts grown on 
electrospun GO-PCL mesh, GO sheet and control (tissue culture plate)  substrates. * indicates 
significant difference from control (p < 0.05). 
Highest expression was found on myoblast cells grown on GO-PCL meshes. 
Quantitative RT-PCR analysis was performed  after differentiation for 5 days for Desmin 
and MyoD and 11 days for MHC (as MHC express late). As shown in figure (5.17), the 
expression level of all of the tested genes were enhanced on graphene derivative  and  
GO-polymer composites, compared with that of the control as 1.60-fold on GO and 1.98-
fold on GO-PCL for Desmin; 1.48-fold on GO and 1.88-fold on GO-PCL for MyoD; 1.86-
fold on GO and 2.33-fold on GO-PCL for  MHC. * denotes a significant difference 
compared to control substrate.  
 Significant up-regulation of myogenic gene expression indicated that  the  GO 
based substrates  enhanced both early and late stages of myogenic differentiation, 
subsequently stimulating the formation of myotubes. In addition, higher  expression  of 
myogenic proteins and genes on GO-PCL substrates again confirmed its superiority 
perhaps due to its higher conductivity and dielectric constant associated with GO surface 
charge. 
 
 
94 
 
5.4. Cell Signaling Pathway Analysis 
5.4.1. Insulin-like growth factor 1 (IGF-1) pathway study 
IGF-1 is one of the most important pathways that have been studied extensively in the 
field of muscle growth [285,319,320].  Researchers studied IGF-1/IRS-1/PI(3)K/Akt/MyoD 
pathway and concluded its importance for skeletal muscle differentiation and 
maturation [285,319,320]. In the present study it was attempted to verify this pathway 
using the novel graphene based composite scaffolds (Figure 5.18). IGF-1 is one of the 
primary mediators of the effects of growth hormone (GH) in body that stimulates 
growth via growth promoting effects on almost every cell, especially muscle cells 
present in the body. IGF-1 is also capable of regulating cellular growth and development. 
In addition, IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy, very much 
important for proper development of muscle tissue [4]. So, skeletal muscle healing is 
associated with IGF-1.   
 
Figure  5.18. A Schematic representation of IGF-1 cell signaling pathway  that involves in skeletal 
muscle differentiation and maturation.  
5.4.2. Protein expression for IGF pathway 
To study IGF pathway, expression of IRS-1/PI(3)K/Akt/MyoD proteins is important.  
Initially, the expression of IRS-1/PI(3)K/Akt/MyoD proteins on GO, GO-PCL and control 
(tissue culture plate) substrates (Figure 5.19) was analysed. All of these proteins 
expressed better on GO and GO-PCL, while the expression was highest for GO-PCL. This 
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indicates that the GO-PCL substrate is the most suitable candidate for myoblast 
differentiation of hMSCs. 
 
Figure 5.19. Expression of PI(3)k, Akt, pAkt, IRS-1 (a) and expression of fold change for these 
corresponding signaling proteins (b) on control (tissue culture plate), GO sheet and GO-PCL 
meshes. * indicates significant difference (p< 0.05).  
To evaluate IGF-1 pathway, Akt is the most important protein that regulates 
skeletal muscle differentiation and hypertrophy. It was also reported that IGF-1 
dependent Akt-phosphoralization increased along with a higher rate of myogenic 
differentiation. Properties of MyoD, responsible for skeletal muscle differentiation, are 
controlled by Akt and blockage of Akt that prevents formation of skeletal muscle 
transcript some [285,319,320]. The present investigation demonstrates that the 
investigated pathway proteins expressed better on GO-PCL composite meshes than 
those on GO sheet or control (tissue culture plate). Up-regulation of such pathway 
proteins on GO-PCL further emphasizes the IGF-1 pathway which is related to skeletal 
muscle development. Thus, it reveals the importance of GO-PCL composite meshes for 
skeletal muscle tissue engineering applications. 
5.4.3. Effect  of  Akt  inhibition on MyoD expression 
As mentioned above, Akt is a major component that regulates IGF-1 pathway. Inhibition 
of Akt deters IGF-I stimulated nuclear translocation of Akt and also suppresses the 
growth of various cells. Akt is a vital component of the cell survival pathway as it 
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functions by resisting apoptosis via improving communication between cells that are 
damaged [320-322]. Inhibition of Akt results in much higher rate of apoptosis and a 
decrease in IGF-1 cell signaling. Inhibition of Akt was done using 10-DEBC hydrochloride, 
a selective and precise cell permeable Akt phosphorylation inhibitor that shows no 
activity at PDK1, SGK1 or PI 3-kinase [323,324]. In the present experiment, the 
expression of MyoD, a vital myogenic protein that helps in myogenic differentiation has 
been studied by pre and post Akt inhibition. The results showed (Figure 5.20) that after 
inhibition of Akt, the expression of MyoD intensity decreased rapidly. Akt inhibitor 
inhibits IGF-I-stimulated nuclear translocation of Akt that results in much reduction of 
MyoD protein assessed by Western Blotting. This finding indicates the importance of 
IGF-1/IRS-1/PI(3)K/Akt/MyoD cell signaling pathway for the system of present 
investigation.  
 
Figure 5.20. Expression of MyoD (a) and the corresponding relative intensity (b) indicating pre 
and post inhibition of Akt. * indicates significant difference from post Akt inhibition (p< 0.05).  
The expressions of myogenic proteins on graphene oxide based substrates (GO 
sheet and GO-PCL scaffold) have been assessed. It has been demonstrated that 
myogenic proteins expressed better on the GO-PCL composite meshes than GO sheet 
and the control (tissue culture plate). This highlighted the superiority of graphene based 
substrates for myoblast differentiation. Favourable physicochemical and biological 
properties established these scaffolds as potential platforms for myogenic 
differentiation and maturation for tissue engineering and other biomedical applications. 
In addition, we have also shown preliminary study of IGF-1 pathway that is important for 
skeletal muscle differentiation and maturation as well. This pathway proteins (IRS-
1/PI(3)K/Akt/MyoD) also expressed better on graphene based substrates, particularly on 
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GO-PCL scaffolds. Moreover, selective inhibition of Akt has reduced the expression level 
of MyoD, a myogenic protein important for skeletal muscle differentiation.  
Hence, it was noticed that lower expression of MyoD along with Akt inhibition 
indicated the importance of the IGF-1 cell signaling pathway observed from this 
preliminary investigation. Further elaborate study seems to be more interesting. 
5.5. Conclusion 
In conclusion, the present study clearly demonstrated that pure GO sheet and GO added 
GO-PCL fibrous scaffolds are suitable for myoblast differentiation. Electrospun GO-PCL 
scaffolds are excellent biocompatible substrates for human skeletal myoblast cells 
differentiation of cord blood derived mesenchymal stem cells. GO-PCL composite with 
increased conductivity and dielectric constant (compared to PCL) showed enhanced 
myoblast differentiation and oriented multinucleated myotubes formation, like natural 
orientation, which is highly desirable for the in-vivo regeneration of electro-responsive 
skeletal muscle tissue. Myogenic proteins also expressed better on GO-PCL composite 
meshes. Preliminary investigation of IGF-1 cell signalling pathway examined on the 
prepared substrates further confirms the superiority of GO-PCL composite scaffolds for 
myoblast differentiation. Thus the present result also supports that GO-PCL electrospun 
scaffold is a potential  candidate for skeletal muscle tissue regeneration. Therefore, in 
demand of cell specific substrates  GO based polymer composite meshes might be 
considered as one of the most favourable scaffolds for electro-responsive skeletal 
muscle tissue engineering applications.  
Moreover, it would be worthwhile to mention that the easily available cord 
blood derived multipotent hMSCs used for the myoblast differentiation might also be 
similarly employed on these GO based biocompatible substrates for the regeneration of 
other lineages for future biomedical applications in a cost effective way. 
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CHAPTER-6 
 
Characterization of the Fabricated  Electrospun GO-PLGA 
Composite Meshes 
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6. Characterizations of the Electrospun GO-PLGA 
Composite Scaffold 
This chapter deals with the experimental characterization of the samples from the studies of 
XRD, SEM, FTIR, Raman spectra, mechanical property, contact angle, electrical and dielectric 
properties. GO added GO-PLGA electrospun scaffold meshes was also demonstrated as a 
potential substrate for skeletal muscle tissue regeneration. 
6.1. Characterization of GO- PLGA Scaffold Materials 
6.1.1. Morphology of the GO film and GO-PLGA electrospun scaffold 
meshes  
Preparation of GO-PLGA composite and electrospun meshes have already been discussed 
in chapter 3. Figure (6.1) represents GO solution (figure 6.1a) used for making GO films 
(figure 6.1b) composed of GO and typical SEM micrograph of electrospun GO-PLGA 
composite meshes shown in figure 1.6c. The average fiber diameter estimated (using the 
method discussed in chapter 3) 540 ±130nm and the corresponding porosity lied within 
80±10%. However, porosity of the meshes depends on the fiber diabetes. The GO 
concentration dependent percolation behavior of conductivity and dielectric constant of 
the composite films was also studied in the present case at room temperature. 
 
Figure  6.1.  (a) GO solution, (b) GO film composed of GO and (c) scanning electron micrograph 
of a typical; electrospun GO-PLGA  meshes. 
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6.1.2. Percolation threshold behaviour exhibited by GO-PLGA composite 
To make electroconducting electrospun GO-PLGA composite scaffolds (like GO-PCL 
composite),  GOnPs concentration within non-toxicity limit (20µg/ml solution) was taken 
within the percolation threshold  concentration (fc~ 0.75wt% observed in case of PLGA) 
shown in figure (6.2). Percolation threshold fc was determined, as usual, from the 
measurements of GO concentration dependent conductivity and dialectic constant 
measurements. GO concentration dependent dielectric constant (ε) and conductivity () 
showed maximum values near the percolation threshold.  
 
Figure 6.2.  GO concentration (fGO) dependent dielectric permittivity (ε) and conductivity () 
showing maximum  ε  and   around 0.75wt%. 
 
PLGA and GOnPs also found to form homogeneous composite showing very low 
GO concentration. GO-PLGA composite exhibited maximum ε and  values around fc.  
The fc  value(~ 0.75wt%) of GO-PLGA  was found to be slightly lower than that of the GO-
PCL composite (~0.79wt%) (shown in chapter-4) but it is comparable to the 
corresponding value of GO-PVA (~0.76wt%) composite [289]. The percolation behavior 
of the GO-PLGA composites (figure 6.2) also follow the theoretical formulae [290] as 
discussed in chapter-4. As mentioned above, for myoblast differentiation, GO-PLGA 
polymer composite scaffold was also prepared with GO concentration (~20µg/ml) within  
nontoxicity and the percolation threshold limits.  
6.1.3. Phase behaviour of GO-PLGA fibrous meshes  
Figures (6.3a and b) showed X-Ray diffraction patterns of PLGA and GO-PLGA  meshes. 
As reported earlier (chapter-4), the X-Ray diffraction patterns of GO indicated the 
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characteristic GO peak appearing at 2θ =11.1o with d-spacing of ~0.78 nm. The 
corresponding XRD patterns of PLGA shown in figure (6.3a) indicated amorphous 
character with a hum around 2θ~19.2o while the XRD patterns of GO-PLGA composite 
exhibited diffraction peak (Figure 6.3b) at 21.65o indicating crystalline phase of the 
polymer. For the GO-PLGA  composite, XRD data only showed the sharper diffraction 
peak with no peak for GO similar to the case observed earlier in GO-PCL [4] and GO-PVA 
[214] composites which was attributed [4] to the disappearance of the regular and 
periodic structure of graphite oxide and formation of fully exfoliated structures and the 
homogeneous distribution of GOnPs in the polymer matrix. The well-dispersed low 
concentration GOnPs acted as nucleating agents and thus the crystallinity of the 
composites was improved which enhanced conductivity hereby improving 
biocompatibility of the composite [4]. 
 
 
Figure 6.3. XRD pattern of PLGA (a) and GO-PLGA (b) composite meshes indicating sharp 
crystalline peaks. Insets  of (a) and (b) show the SEM micrographs of electrospun meshes of 
PLGA and GO-PLGA  composite, respectively. 
 
6.1.4. Raman spectroscopy  
Raman spectra of GOnPs sheet shown in figure (6.4a) indicated the characteristic feature 
of GO peaks at frequencies around 1338 and 1600cm-1, respectively, for the G and D 
band usually assigned to the E2g phonon of Csp
2 atoms and a phonon breathing mode of 
symmetry A1g [325,326]. 
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Figure 6.4.  Raman spectra of GO (a) and GO-PLGA  composite showing the presence of E2g (D) and A1g 
(G) peak corresponding to the graphene oxide GO and GO-PLGA composite meshes.  
The presence of GO peak  corresponding to 2D graphene band around 2700cm-1 was 
hardly observed in the present system  as also mentioned in chapter 4 in case of GO-PCL 
system.  This indicated  the  absence or traces amount  of  pure conducting graphene in the 
synthesized GOnPs and GO-PLGA composites also observed from the GO-PLGA Raman 
spectra (figure 6.4b). The characteristic frequency corresponding to the well-studied G and D 
bands are in good agreement with the literature values of graphene oxide [321] and also 
indicate little lattice distortion of the GO nanostructure. The intensity ratio ID/IG of the two 
peaks was widely used as characterizing the defect quantity within the GO materials [294]. By 
controlling the amount of defect quantity, the electronic and mechanical properties of the 
GO sheets might also be tuned  [295]. The D band was reported to be associated with the 
structural imperfections created by attachment of hydroxyl and epoxide groups on the 
carbon basal plane [301]. The G band corresponds to the ordered sp2  bonded carbon GO 
conduction was also reported to occur through sp2 regions via Klein tunnelling [301].  Figure 
(6.4a) indicated GO Raman  spectra  shown for the  comparison  as in the case  of GO-PCL 
system. 
6.1.5. FTIR spectra  
The Fourier transform infrared (FTIR) spectra of pure PLGA and GO-PLGA  composites  
are shown in figures (6.5 a and b), respectively, for comparison. The absorption bands 
observed in the GO-PLGA  at 1727 cm-1 (Figure 6.5b) indicates carbonyl stretching. The 
bands appeared at 1295 cm-1 and 1240 cm-1 represent the C-O and C-C stretching bonds. 
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The bands at 1239 cm-1 and 1175 cm-1 were the asymmetric C-O-C stretching bonds 
indicating characteristic absorption [303] of PLGA. 
 
Figure 6.5.  FTIR spectra of PLGA (a) and GO-PLGA  (b). The corresponding spectra of GO have 
been shown in chapter-5. The intense band at 3438cm-1 was attributed to stretching of the O-H 
band of CO-H. The band at 1639cm-1 was associated with stretching of the C=O bond of carbonyl 
groups. 
 
The FTIR spectrum of GO-PLGA (Figure 6.5b) indicated an intense band at 
3438cm-1 which was attributed to stretching of the O-H bond of CO-H. The band at 
1639cm-1 was associated with stretching of the C-O bond of carbonyl groups. 
Deformation of the C-O bond was observed at the band appeared at 1017cm-1. From 
FTIR spectroscopy, evidences of different types of oxygen functionalities on GO were 
exhibited. The ultra violet (UV) spectrum of water solution GO exhibited a peak at 
371nm, characteristic feature of the π-π* transition of aromatic C-C bonds [4]. Similar 
peaks were also observed in GO-PCL as well as in GO-PLGA around 460nm. The ionic 
bonds, the π-π stacking forces created by the sp2 bonding and hydrophobic interaction 
between molecules allowed graphene to adsorb proteins and low molecular weight 
chemicals which are important for biocompatibility [246,308] of GO.  Chen and Eda and 
his co-worker suggested that the fluorescence of prepared GO may originate from the 
optical transitions from structural disorder-induced states in the π-π* gap of sp2 sites 
[327,328]. 
6.1.6. Mechanical property of GO-PLGA composite scaffold 
Figure (6.6) showed the stress-strain curves of GO-PLGA composite mesh. From the 
stress-strain curves of GO-PLGA mesh, tensile stress is estimated to be ~2.87± 0.05 
(MPa) which is comparatively higher to that of the GO-PCL mesh as discussed earlier in 
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chapter 5. This value is also comparable to that of the GO-PCL electrospun fibers [67]. In 
GO-PCL composite, the tensile strength was also reported to increase with increasing GO 
concentrations [67]. This indicates that mechanical property of the composite depends 
on the GO concentration. The changes of conductivity and other properties (discussed in 
chapter 5) also indicate that physical and mechanical properties of the composites 
depend on GO concentration. 
 
Figure 6.6. Showed the stress strain curve of a typical GO-PLGA scaffold mesh. The 
corresponding curve for the GO has been shown in part-1 of this chapter.  
6.1.7. In-vitro  biodegradability  study 
As already mentioned (chapter-2), degradation behaviour of scaffold plays an important 
role in the formation of new tissue at the site of an implant. The in-vitro degradation 
pattern of PLGA and GO-PLGA composite scaffolds as shown in the figure (6.7) indicates 
electrospun PLGA meshes  degrade upto ~28% where as electrospun GO-PLGA mesh 
degrade ~17% after 30 days of time interval.  Therefore, degradation rate of electrospun 
GO-PLGA mesh is more optimized and suitable for cellular growth compares to quicker 
degradation rate of PLGA mesh. Optimized degradation of scaffolds eases the longevity 
of the scaffold implants at the site of the implant [309]. GO-PLGA composite scaffold can 
thus provide support to the growing tissue for long period of time in an optimized way 
which may be beneficial for in-vivo applications as well.  
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6.1.8. Contact angle (CA) measurement 
The wetting (CAw) and dewetting (CAdw) contact angles of sessile water drops on spin 
coated thin GO sheet, PLGA and GO-PLGA scaffold meshes were shown in Figure (6.7 
inset) for comparison. In the case of thin GO sheets, CAw =58.7o and hysteresis (CAw-
CAdw) was estimated as ~5.5
o  which is a measure of the solid–liquid surface interaction 
and  chemical  heterogeneity [310]. 
 
Figure 6.7.  In-vitro degradation pattern of electrospun PLGA and GO-PLGA composite  scaffolds 
in SBF (simulated body fluid) for 30 days. Inset shows contact angle (CA) of GO, PLGA and GO-
PLGA  meshes. The wetting and dewetting difference is a measure of the molecular interaction 
of the liquid and the scaffold.  
Both CAw and CAdw values of GO-PLGA  meshes (130 and 126
o, respectively) were 
reduced compared to that of PLGA meshes (~143o). Small CA hysteresis for the 
composite meshes was due to few micron level surface inhomogeneity, which is 
favourable for cell adhesion and proliferation [329]. Such moderately wettable 
composite surface like GO-PLGA  meshes are favourable for cell growth and proliferation 
[330,331].  GO-PLGA-Collagen hybrid fiber also showed [4] decrease of CA from 147 to 
127o. Due to the presence of GO with abundant hydroxyl group, CA of GO-PLGA   
significantly (p<0.05) decreased while its hydrophilicity of the GO-PLGA  meshes 
increased. It is suggested that in GO-PLGA  composite fiber meshes cell adhesion might 
be enhanced as they are more hydrophilic and have higher surface energy in presence of 
GO than pure PLGA fiber. Observed contact angles of GO is less than that of conducting 
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GOnPs-PLGA meshes indicating better biocompatibility of GO-PLGA due to enhanced 
hydrophilicity. 
6.1.9. Swelling behavior 
Figure (6.8) shows the swelling ratio of the PLGA and GO-PLGA scaffolds. Compared to 
PLGA mesh, the swelling ratio of the GO-PLGA scaffolds increased from 223 to 305%, 
indicating that the addition of GOnPs improves the hydrophilicity of the scaffold.  
 
Figure 6.8. Swelling ratio of PLGA and GO-PLGA  meshes. The ratio increases with  addition  of 
GO in PLGA. Figure shows that GO addition in PLGA in DMF solution (20 µg/ml and 40 µg/ml of 
PLGA solution) enhance hydrophilicity of the scaffolds.  
This attributed to the GO-PLGA bonding. Additionally, according to the report of 
Li and co-workers [332,333], the capillary effect might also lead to better water 
adsorption. Therefore, it can be seen from figure (6.8) that the GO addition contributes 
to a higher swelling ratio in GO-PLGA meshes.  Both swelling and hydrophilicity are 
important properties of the tissue engineering scaffolds, their enhanced values with the 
addition of GO in the polymers would enhance the cells viability and proliferation 
[332,333]. 
6.1.10. Stability of conductivity and dielectric constant of GO-PLGA 
meshes  
Stability of conductivity and biodegradation of PLGA and GO-PLGA meshes were 
assessed by immersing them in PBS solution for up to one week. Upon immersion in PBS 
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solution, both effective   and  ε  values of PLGA and GO-PLGA were found to decrease 
with increase of immersion (Figure 6.9) in the PBS solution (discussed in experimental 
chapters-3 and 4). However, the   and ε values in case of  GO-PLGA  composite meshes 
decreased at a slower rate with respect to those of pure PLGA meshes (Figure 6.9) 
indicating that GO-PLGA  meshes are more stable than PLGA meshes. 
 
 
Figure 6.9. (a) Room temperature (RT) effective dielectric constant (ε) and (b) effective 
conductivity () data of GO-PLGA composite meshes before (indicated by 0 days) and after 
immersion in PBS solution for upto 7 days. Similar ε (c) and  (d) data from PLGA meshes before 
(0 days) and after immersion (maximum 7 days) in PBS solution discussed in chapter 3 (all 
measurements were performed at  1kHz).   
 
These results  specifying that the addition of GO increased  ,  ε  and stability of 
GO-PLGA which also indicate better biocompatibility of GO- PLGA (compared to PLGA 
with much lower ε and   values). Similar results were also reported earlier in case of 
GOnPs-PCL composites meshes [4] where GOnPs addition to PCL significantly increased 
both conductivity and dielectric permittivity. At percolation threshold, the conductivity 
of GO-PLGA  reached more than two orders of magnitude higher value than that of 
PLGA.  A slight decrease in ε and  of GO-PLGA  (Figure 6.9) after immersion up to one 
week might be associated with small amounts of material leaching from GO-PLGA  
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scaffolds as in the case of PANi added PCL scaffolds as reported earlier [84]. By varying 
the GO concentration in PLGA or similar biopolymers, conductivity and degradation rate 
could also be varied.  It was also shown earlier that after immersion for one week, no 
significant morphological change of the GO film was observed as shown in chapter-5. 
Due to the presence of GOnPs, mechanical stability and bioactivity of  GO-PLGA  
composite remained quite stable even after immersion in PBS solution, which was 
important for belter cell scaffold interaction similar to the case of GO-PCL composite 
meshes studied earlier [4]  as discussed in the following sections. 
6.2. Conclusion 
Electrospun GO-PLGA biocompatible nanocomposite also showed low percolation 
threshold (~0.75wt%) similar to that of GO-PCL and enhanced conductivity compared to 
pure PLGA. The electrospun GO-PLGA scaffolds prepared with GOnPs concentration 
within the non-toxicity limits were characterized from the study of structural, 
mechanical properties, contact angle, SEM and vibration spectroscopy properties. GO-
PLGA also showed similar favourable characteristic properties suitable for skeletal 
muscle tissue regeneration. Due to the addition of GO mechanical property and contact 
angle increased while the biodegradability decrease to a little extent. This study also 
confirmed that both σ and ε did not change appreciably after immersion in PBS solution 
for about a week as observed in case of the GO-PCL meshes. This indicated that the 
cellular interaction associated with the biocompatibility of such composites appears to 
remain almost unaltered even after immersion in PBS solution over one week. The 
mechanical property, hydrophilicity, controllable non-toxic degradation and unique 
physical properties also pointed out that covalently-linked GO-polymer based 
composites [71]  are suitable for skeletal muscle tissue engineering and other biomedical 
applications.  
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7. Myoblast Differentiation on Electrospun GO-PLGA 
Meshes 
This Part deals with the study of myoblast differentiation of hMSCs on the developed 
electrospun GOnPs-PLGA (or GO-PLGA) composite scaffold meshes. Like GO-PCL, GO-
PLGA meshes also showed excellent myogenic differentiation and cell viability. These 
results further demonstrated the high potential of electroconducting GO-PLGA 
composite meshes for skeletal muscle tissue regeneration using hMSCs similarly to the 
case of GO-PCL composite meshes with immense potentiality. 
7.1. In-Vitro  Cell  Study 
7.1.1. hMSCs isolation, culture and characterization  
Isolation of human umbilical cord blood derived hMSCs have already been  described in 
chapter 5 . 
7.1.2. hMSCs seeding, attachment and spreading 
After seeding of hMSCs (by static seeding method with ~2×104 cells/ml), attachment and 
spreading of these cells were evaluated by scanning electron microscopic (SEM) 
micrographs on increasing time interval. SEM micrographs revealed excellent cell 
adherence as well as proliferation on the developed scaffolds after three, five and seven 
days of culture as shown in figure (7.1). Cellular attachment and well spreading of the 
cells also  indicate  their  compatibility  to the scaffold environment.  
 
Figure 7.1.  Attachment and spreading of  hMSCs on GO-PLGA  composite  scaffolds examined on 
3rd(fig. a), 5th(fig. b), and 7th(fig. c) days of culture. Proliferation of cells has been found with 
increasing time interval indicating cells are compatible with scaffold environment. 
7.1.3. Cell metabolic activity 
The metabolic activity of the cultured cord blood derived hMSCs seeded on the prepared 
GO-PLGA scaffold was further evaluated quantitatively by WST-8 assay as shown in 
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figure (7.2). Difference in the increase of O.D (optical density) values with culture period 
were observed for hMSCs grown on different substrates (GO-PLGA  meshes and  tissue 
culture plate (TCP) as control).  
 
 
Figure 7.2. WST-8 assay of hMSCs grown on GO-PLGA  composite scaffolds  after 3, 7 and 11 
days of culture. Superior cellular metabolic activity has been observed on GO-PLGA  composite 
meshes. Results presented as the means ±SD. * indicates significant difference (n=5; p<0.05). 
Metabolic activity was increased with time with the scaffolds showing the trend PLGA>control 
substrate. 
 
However, the higher O.D value representing higher metabolic activity was 
obtained with GO-PLGA  composite scaffolds than the control. The increase in metabolic 
activity achieved with GO-PLGA  composite mesh could be attributed to the addition of 
GOnPs that provided essential physicochemical properties suitable for better cellular 
interaction. The amount of formazan dye generated (by the activities of 
dehydrogenases) was directly proportional to the number of living cells.  Thus, GO-PLGA  
scaffolds proved superior biocompatibility compared to GO sheet and the control. 
7.1.4.  Cells proliferation assay (via DNA quantification) 
The proliferation of hMSCs on the prepared scaffolds was evaluated by DNA 
quantification assay. Figure (7.3.) showed an increasing rate  in DNA content of hMSCs 
with time as observed in different GO based substrates prepared for investigation. The 
corresponding DNA contents of hMSCs cultured on tissue culture plate (taken as control) 
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and GO-PLGA  composite meshes on 3 to 11 days of culture were ~50ng/ml to 
~275ng/ml,  and  ~62 to ~350ng/ml,  respectively.  
 
 
Figure 7.3.  Cell proliferation represented in terms of DNA quantification on GO-PLGA  mesh and 
control substrates (tissue culture plate). An increased trend in DNA content is observed on GO-
PLGA composite matrixes. Results represented as mean ± SD, * indicates significant difference 
(n=5; p < 0.05).  Proliferation of hMSCs was increased with time with the scaffolds showing the 
trend GO-PLGA >control substrate. 
 
Electrospun GO-PLGA meshes have shown significantly higher amount of DNA 
content representing highest proliferation rate of hMSCs. Proliferation of these cells  
was increased with time with the scaffolds showing the trend of GO-PLGA>control 
(tissue culture plate)  substrate. 
7.2. Differential Potential of hMSCs on GO-PLGA Composite 
Meshes 
 
7.2.1. Myoblast differentiation and spreading 
After confirming excellent viability and proliferation of hMSCs onto the novel GO-PLGA  
composite scaffolds, these cells were further allowed for myoblast differentiation. Along 
with differentiation of hMSCs, elongated bipolar morphology of myoblasts was observed 
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on GO-PLGA composite scaffolds which were further confirmed by 
Immunohistochemical (Desmin, MyoD, MHC, Dystrophin) as well as FESEM analysis. 
7.2.2. Myoblast viability 
The viability of Myoblast cells on GO-PLGA  composite scaffolds were analysed by WST-8 
assay. Figure (7.4) showed myoblast viability on GO-PLGA mesh along with control 
(tissue culture plate) and GO sheet (for comparison). Cell viability   was found to increase 
significantly on GO sheets and GO-PLGA meshes compared to that on the control 
surfaces (*:p<0.05). This result implies that GO-PLGA mesh is cytocompatible and 
supported myoblast  proliferation as in the case of GO-PCL composite meshes studied 
earlier [4,28]. It was thus seen that electrospun GO-polymer meshes with low GO 
concentration (not toxic to human cells) provided favourable circumstance for the 
growth and proliferation of  myoblast  cells.  
 
Figure 7.4. Myoblast cells viability and proliferation observed by tetrazolium salt (WST-8) assay. 
Results presented as mean ± standard deviation. * indicates significant difference (n=5, p<0.05). 
Viability was found to increase with time on the samples showing the trend of GO-
PLGA>GO>control  substrate  (tissue culture plate). 
7.2.3.  Immunophenotypic  characterizations 
The flow cytometry analysis of the myoblasts grown  onto the GO-PLGA  mesh confirmed 
the positive expressions of myogenic markers CD56 and Desmin indicating the 
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differentiation of hMSCs to myoblast cells. Expression of these myogenic markers 
indicates  myoblast cells phenotype (Figure 7.5). 
 
 
 
Figure 7.5. Flow cytometric analysis of myoblasts grown onto the GO-PLGA composite scaffold. 
Positive expression of myogenic markers CD56 and Desmin represents myoblast cells  
phenotype. 
7.2.4. Formation of myotubes 
The formation of Myotubes on GO-PLGA  meshes was examined by FESEM as well as 
immunostaining as represented in figure (7.6). The myotubes are observed to be the 
highest and more aligned on the GO-PLGA scaffold meshes compared to that on control 
substrate indicating better compatibility of myotubes formation. A better 
interconnectivity of the  GO-PLGA  fibrous meshes along with  enhanced conductivity 
and dielectric constant, due to the presence of GO, might play a combined role at the 
cell anchoring sites for better myoblast proliferation and myotubes orientation on GO-
PLGA  meshes as discussed as in the case of GO-PCL. 
7.2.5. Immunohistochemical analysis 
Similar to the GO-PCL composite meshes studied in the previous chapter, 
Immunohistochemical study has also been performed with myoblasts grown on 
electrospun GO-PLGA scaffold meshes. The experimental results confirmed the 
differentiation of hMSCs into skeletal myoblasts by the expressions of Desmin and 
MyoD, and formation of myotubes by the expression of MHC on GO-PLGA composite 
meshes and controls (pure PLGA mesh and tissue culture plate, TCP) as evidenced from 
Figure (7.6). Immunostaining of Desmin and MyoD after 3-7 days of culture expressed 
almost similarly on both control and  GO-PLGA  substrates. But, the formation of MHC 
on GO-PLGA mesh was much better compare to pure PLGA and TCP control substrates. 
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Figure 7.6. Immunostaining of Desmin, MyoD and MHC (myosin heavy chain) on controls (a-f) 
and GO-PLGA electrospun composite mesh (g-l). Corresponding FESEM micrographs (m-o) of 
these samples were shown for better demonstration. It is revealed that GO-PLGA showed better 
myoblast differentiation compared to that on control groups (pure PLGA mesh and TCP).  
The formations of myotubes on this composite scaffold were also more aligned, 
similar to natural tissue orientation. This indicates better myotubes formation hence 
better myogenic maturation potential of GO-PLGA mesh. But, GO-PCL composite meshes 
showed even superior myoblast proliferation as well as differentiation potential 
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compared to GO-PLGA meshes. This might be due to the fact that PLGA released acidic 
by-products upon its degradation that hamper cellular interaction. Moreover, 
conductivity, a highly desirable material property  for skeletal muscle regeneration, of 
GO-PCL was higher than GO-PLGA  mesh that also makes GO-PCL more suitable for 
electro-responsive skeletal muscle tissue regeneration.  
7.2.6. Myogenic protein and gene expression 
For myogenic gene expressions, such as Desmin, MyoD and MHC quantitative real-time 
RT-PCR was used after differentiation for five days for Desmin and MyoD and seven days 
for MHC. The expression levels for all the tested myogenic genes were enhanced on GO-
PLGA  meshes as compared with control substrate (tissue culture plate). Significant up-
regulation of these myogenic gene expressions (Figure 7.7) indicated that GO based 
substrates improved myogenic differentiation compared to the control substrate and 
subsequently stimulated the formation of myotubes. 
 
 
Figure 7.7.  Expression  of  myogenic  proteins Desmin, MyoD and MHC (a) and expression of fold 
change on control and GO-PLGA substrates (b-d) for the corresponding proteins. Expressions of 
myogenic genes (analysed by quantitative real-time RT-PCR) in myoblasts grown on GO-PLGA 
mesh and control substrates (e). * indicates significant difference compared with control (p< 
0.05). Up regulation  of  myogenic proteins and genes indicates the better myogenic differential 
potential of the scaffolds.  
 
Similar  enhanced myoblast differentiation potential was also observed  in the 
case of GO-PCL composite meshes (chapter-5) where increased in conductivity and 
dielectric constant were reported to be little higher than those of  GO-PLGA which might  
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be due to the fact that PLGA is less conducting  with lower dielectric constant 
than those of PCL. Therefore, the excellent biocompatibility and myoblast differentiation 
potentiality of GO added GO-PLGA meshes might also be associated with the surface 
charge increasing conductivity of the GO based polymer composites.  
7.3. Conclusion 
Fabricated electrospun PLGA-GO electrospun fibrous meshes with GO concentration 
within low percolation threshold and toxicity limits exhibited excellent biocompatibility. 
Well dispersed GOnPs with adhered surface charge enhanced both conductivity and 
dielectric constant of the composites due to quantum tunnelling between the graphene 
oxide nano-flakes. The increased  hydrophilicity of the GO added PLGA meshes provided 
favourable environment for cell attachment and proliferation. Initial enhancement of 
myoblast attachment, proliferation and differentiation were  stimulated by the presence 
of GOnPs in the PLGA-GO scaffolds. Such spontaneous myogenic differentiation was due 
to the presence of GO in the polymer matrix which gave rise to better cell scaffold 
interaction (arising due to GO surface charge and other inherent physicochemical 
properties) favourable for cells growth and proliferation. Thus the enhancement of 
mechanical property, hydrophilicity, conductivity and excellent biocompatibility make 
the GO-polymer composite an ideal scaffold material. Moreover, one important 
characteristic of graphene is that it adsorbs protein and low molecular weight chemicals 
which are important for enhanced cell-scaffold interaction. For growth or cellular 
communication, cells secrete different substances that are adsorbed onto GO surface 
and affect cell proliferation and differentiation [127,306]. The present results 
demonstrated enhanced biocompatibility of PLGA-GO fibrous meshes showing excellent 
myoblast differentiation and self-aligned myotubes formation with cord blood derived 
mesenchymal stem cells. Increased biocompatibility of GO-polymer composites was 
attributed to the surface charge and nano-flake structure of GO as in the case of GO-PCL 
meshes. Therefore, in demand of cell specific substrates, the use of GO-based polymer 
composites (both GO-PCL and GO-PLGA) scaffold meshes might be considered as one of 
the most potential substrates for the next generation tissue engineering and other 
biomedical applications. 
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8. On the Origin of Excellent Biocompatibility of GO Based 
Polymer Composites 
 
In the previous chapters (5 and 7), it was showed that GO sheet, GO-PCL and GO-PLGA 
electrospun meshes are promoted for myoblast differentiation of cord blood derived 
mesenchymal stem cells and thus suitable for tissue engineering and other biomedical 
applications. The origin of such excellent biocompatibility of GO based composite 
polymers had not been elucidated. Study of GO surface charge, current (I)- voltage (V) 
and capacitance (C)- voltage characteristics indicated the presence of GO surface charge 
which actually provided excellent cues for excellent biocompatibility of such GO based 
polymer composites for electro-responsive skeletal muscle tissue engineering 
applications. 
It was observed from the results of myoblast differentiation of hMSCs on GO-
PLGA and GO-PCL (chapter-5) meshes that conductivity enhancement of the GO-polymer 
scaffold materials (compared to PLGA or PCL) favoured biocompatibility. Conductivity of 
insulating polymers was increased by the addition of GO. Electroconducting scaffolds 
were also reported to stimulate bone [334], cardiac [335] and skeletal muscle [4] tissue. 
On the contrary, although GO is a low-conducting and high dielectric nanomaterial with 
surface charge [4,312], it provides excellent necessary supporting cues towards 
biocompatibility of the composites.  
Therefore, the conductivity of GO (~10-7 S/m at RT) might not be responsible for 
the excellent potentiality of the GO-polymer composite for myoblast differentiation of 
stem cells. This is also in contrast to the behaviour displayed by PCL-PANi where 
increased conductivity, by blending PCL with conducting polyaniline (PANi), enhances 
the biocompatibility and cell proliferation of electrospun PCL-PANi composite fibers [84]. 
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Figure 8.1.  The variations of surface charge (Q) and current (I) with applied voltage (Vpp) 
measured at two different fixed frequencies. Inset shows capacitance (C) – voltage (V) 
characteristic curve of thin GO sheet at 100 kHz  (all measurements at room temperature). 
 
 
However, addition of GO in insulating polymers like PCL or PLGA  was observed 
to largely increase both ε and  values (figure 4.13 in chapter 4 and figure 6.2 in chapter 
6) similar to that of GO-PCL composite reported earlier *4,312+. The ε value of GO-PLGA  
used for myoblast differentiation reached to a high value of ~200 at 1 kHz which was 
much higher than the corresponding measured value of PLGA (~8-10). The dielectric 
constant of GO-PLGA, at percolation with 0.75wt% GO, is more than 600  which was 
around 900 in case of GO-PVA composite [307] and around 800 in case of GO-PCL 
composite.  The    value of GO-PLGA composite also increased by about two orders of 
magnitude compared to pure  PLGA. This increase in conductivity and dielectric constant 
led to the enhancement of biocompatibility of GO-PLGA as in the case of GO-PCL 
meshes.  
Therefore, the origin of such conductivity enhancement is needed to be explored. 
Within the non-toxicity limits, conductivity enhancement in case of GO-PCL [4,312] was 
little higher than that observed in case of GO-PLGA. Interestingly, both dielectric 
constant and conductivity of PLGA are little less than those of pure PCL which might be 
responsible for GO-PCL meshes showing slightly better myoblast differentiation 
potential  compared to GO-PLGA meshes on their surface. However, polymer structure 
and GOnPs-polymer interaction might also have some contribution to the 
biocompatibility of the composite other than conductivity. 
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It is worthy to note that GOnPs possess high charge trap density (~1.2×1018 cm-3/eV) 
[311] and high charge mobility [312]. Moreover, GO was also reported to be 
piezoelectric (PE) that stimulates cells growth [4, 302].  Surface charge and dielectric 
constant are related to the PE behavior (PE coefficient d33 is related to dielectric 
constant [336]) of the materials [337-341]. PE properties are the unique universal 
properties of living tissues, and play a significant role in several physiological 
phenomena [342-346]. The biocompatibility of GO added GO-polymer composites 
might, therefore, be attributed to the presence of GO surface charge. The presence of 
significant GO surface charge was visualized from the measurements of the surface 
charge related C-V (capacitance –voltage), I-V (current-voltage) and I-Q (current –charge) 
characteristics of GO sheet at ambient temperature as shown in figure (8.1). 
These curves showed the presence of appreciable surface charge and surface 
current associated with the high mobility of the charges which increased with frequency 
and applied external voltage. Almost similar trend of variations of I-V and Q-V curves 
(Figure 8.2) with frequency and applied voltage indicated that same surface charge was 
responsible for the development of surface current. The C-V characteristic curve (inset 
of Figure 8.2) also indicated the presence of surface charge on GO sheet. If the charges 
on the GO nanoplatelets are denoted by +q and −q , respectively, and V gives the voltage 
between the two nanoplatelets, then the capacitance, C, is given by (C = q/V) which 
gives the voltage/ current relationship (I= C [dV(t)/dt]). Static surface charge of GO sheet 
was also visualized from the repelling character of the GO flakes kept in a plastic 
container. 
8.1. Surface Charge Related Properties of GO and GO-Polymer 
Composites 
The GO added to a polymer like PLGA matrix also retained the GO surface charge and 
formed conducting pathways that stimulated cell growth (myoblast differentiation, 
proliferation and myotubes formation in GO-PLGA, GO-PCL meshes). Recognizing the 
fact that GOnPs are coated with thin layers of PLGA or PCL, the tunnelling conduction 
(like proton tunnelling) between nanoplatelets prevailed above the percolation 
concentration (tunnelling is a quantum mechanical phenomenon where a particle tunnel 
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through barrier classically does not surmount [342,346]. This  mechanism of 
enhancement of conductivity in GO is quite different from the mechanism of 
enhancement of PANi added conductivity in PCL or PVA [347-349] where conductivity 
increment arose from the electrode polarisation rather than the interfacial polarization 
within the material like GO. 
 
In the GO-polymer electrospun meshes substantial electronic disorder occurred 
because of the distortion of graphene oxide nanoplatelets (as also revealed from the 
analysis of the Raman spectra) which might give rise to the variable sp2 and sp3 carbon 
ratio in GO and increase conductivity (since conductivity depends on the sp3/sp2 ratio 
[207]. 
 
Figure  8.2. Thermal variations of resistivity of thin GO sheet and GO-PLGA composite indicating 
a metal insulator like transition around room temperature. Inset indicates the room temperature 
current (I) - dc voltage (V) characteristics of GO-PLGA composites with increasing GO 
concentrations (maximum  with  fc=0.75wt%). 
Chien and Eda  [327,328] also pointed out that the disorder-induced states and the 
newly formed graphitic domain of sp2 clusters during reduction were responsible for GO 
photoluminescence (PL).  Interesting metal insulator like transitions were observed in 
the GO sheet and GO-PLGA composite around room temperature (275 and 305K, 
respectively)as shown in figure (4.51). Similar transition was also observed in GO around 
275K [328]. A drastic change of the sp2 /sp3 ratio around 300K might be associated with 
conducting pathways between the GO flakes around this temperature, which gave rise 
to such anomalous large increase of conductivity of GOnPs around room temperature in 
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the composite  leading to the enhancement of biocompatibility. Table 8.1  showed some 
of the physical and mechanical properties of the GO-PCL and GO-PLGA composite 
meshes. Figure (8.2) was also reflected in the resistivity versus temperature curve of GO-
PLGA. Resistivity (inverse of conductivity) of GO-PLGA  decreased with decreasing GOnPs 
concentrations, which was attributed to the percolation in DC conductivity as shown in 
figure (8.2) as well as the progressive destruction of its layered structure. The current-
voltage (I-V) characteristics for the GO-PLGA  composite film samples measured at RT 
exhibited non-linear  behavior (figure 8.2 inset) which decreased with increase of GO 
concentrations. No saturation of the current was indicated. This feature resembled the 
width – normalized current (I/W) as a function of source drain bias voltage (V) from a 
single reduced GOnPs flake [326] The C-V, V-Q, and I-V characteristics related to the 
applications involving device or biosensors and biocompatibility of the GO based 
polymer composites are, therefore, mainly controlled by the GO surface charge, Q, and 
the nano-flake structure of GOnPs. This means, Q related electro-responsive parameters 
(conductivity, PE and dielectric constant) provided the supporting cues for the 
biocompatibility of GO-polymer composite materials for different biomedical and TE 
applications.  
Table 8.1. Summary of some important physical parameters of prepared GO-Polymer 
composite  scaffolds prepared with GOnPs concentration with the percolation  and 
non-toxicity limits* 
SL. 
No 
GO-
polymer 
composite  
scaffolds 
Conductivit
y (ơ) 
(T=300K, 
f=1kHz) 
(S/m) 
Dielectric  
Constant(
ɛ) 
(T=300K, 
f=1kHz) 
Contact angle 
(degree) 
Tensile 
strength 
(MPa) 
Hydrophilicity 
(%) 
Decrease of ơ and 
ɛ after immersion 
in PBS solution for 
seven days  is less 
than  2 %  
indicating stability 
of these composite 
meshes [84]. 
Wetting Dewetting 
1 GO-PCL 2.7 x 10
-6
 300 78±5 75±5 3.99±0.5 34 
2 GO-PLGA 2.8 x 10
-7
 198 130±5 126±5 2.95±0.5 30 
* Remark: Both conductivity and dielectric constant  of GO-PCL is Higher than those of GO-PLGA meshes 
indicating better biocompatibility of GO-PCL for electro-responsive skeletal muscle TE applications. 
 
This new observation of GO oxide and GO-Polymer composite might be utilized 
for the controlled and directional differentiation and proliferation of skeletal myoblast 
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or similar cell types (by controlling the GO surface charge orientation along the 
particular direction which could be done electromagnetically). Along with surface 
charge, physiochemical aspects of GO sheet,  GO-PCL and GO-PLGA meshes also play 
important role for the admirable myoblasts differentiation and proliferation. Well-
dispersed GOnPs with surface charge acted as nucleating agents for cells proliferation 
and aligned myotubes formation on the GO-PLGA or GO-PCL meshes. From FTIR 
spectroscopy, the evidence of different types of oxygen functionalities on GO were 
exhibited. The ultra violet (UV) spectrum [214]  of GO exhibited characteristic feature of 
the π-π transition of aromatic C-C bonds. The ionic bonds, the π-π* stacking forces 
created by the sp2 bonding and hydrophobic interaction between molecules allow 
graphene to adsorb proteins and low molecular weight chemicals (during cell growth, 
cells secrete various substances that are adsorbed by GO surface affecting cell growth 
and proliferation [308] which provided important supporting cues for the 
biocompatibility of GO and GO-Polymer meshes. Therefore, molecular interaction 
between GO and the living cells mediated by the GO surface charge carriers might be 
associated with the hidden mechanism of biocompatibility of GO based scaffolds, while 
electronic charge transfer process among the embedded GOnPs makes the same system 
also suitable for applications in electronic devices in a unified way. 
8.2. Conclusion 
The addition of GO has been shown to enhance the conductivity and dielectric constant 
of the composites due to quantum tunnelling between the graphene oxide nano-flakes. 
Enhanced biocompatibility of GO based polymer composites might be attributed to the 
surface charge and nano-flake structure of graphene oxide. Though GO-PCL and GO-
PLGA (with the same concentration of GOnPs) exhibited excellent myoblast 
differentiation of cord blood stem cells, superior myoblast alignment and myotubes 
formation were observed in case of GO-PCL meshes with higher conductivity and 
dielectric constant (associated with GO surface charge) compared to those of the GO-
PLGA meshes. Further study of conductivity variation of influencing cell-scaffold 
interaction might be interesting. 
 
125 
 
 
 
 
 
S U M M A R Y    
A N D   
CONCLUSION 
 
 
 
 
 
 
 
 
 
126 
 
 
 
 
 
 
CHAPTER-9 
 
Overall Summary and Conclusion  
 
 
 
 
 
 
 
 
 
127 
 
9. Summary and Conclusion 
Skeletal muscle is one of the most important tissue types that are responsible for the 
movement of various body parts. Due to various causes like diseases, trauma, burns, 
accidents etc. skeletal muscle tissues are damaged which requires repair and 
regeneration. In such a  case, Tissue Engineering (TE) can help in the regeneration of 
new muscle tissue maintaining its original structure as well as functionality.  One of the 
most important requirements of successful skeletal muscle tissue engineering is to 
develop suitable biocompatible scaffolds which provide the favourable environment for 
the proliferation and differentiation of myoblast cells for new muscle tissue 
regeneration. These scaffolds should provide guiding cues for skeletal muscle tissue 
regeneration within desired time frame. So far, a number of  biocompatible polymer  
composites have been developed for such applications. But various problems related to 
biodegradability, mechanical stability, cell scaffold interaction, hydrophilicity and 
conductivity of the scaffold materials hindered wide application of such polymer 
scaffolds for typical electro-responsive skeletal muscle tissue regeneration. No single 
polymer based scaffold has, however, been  found to provide most of the desirable 
properties to successfully regenerate skeletal muscle tissues. Therefore, development of 
suitable scaffold material that would be more appropriate for such application is a 
continuous process and seems to be highly appealing and various attempts are being 
made worldwide. 
The present thesis dealt with fabrication of a novel graphene oxide (GO) based 
electro  conductive biopolymer nanocomposite scaffold with improved mechanical, 
electrical and biological properties that provided suitable cues for the in-vitro electro-
responsive skeletal muscle tissue regeneration. The most interesting and encouraging 
results obtained from the present research work is described here. 
In the first phase, GO sheet (composed of GOnPs) and GO-PCL nanofibrous 
scaffolds were fabricated by electrospinning method (chapter-3) and characterized 
(chapter-4) from the studies of SEM, TEM, structural, vibration spectroscopy (FTIR and  
Raman), mechanical and surface (contact angle, hydrophilicity and swelling behavior), 
properties and measurements of fiber diameter and pore size (discussed in chapter-4). It 
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has been shown that the addition of GOnPs in bioactive polymer PCL, enhances its  
conductivity (σ) and dielectric constant (ε) which in turn enriches biocompatibility of the 
GO-PCL composite scaffolds (with ~34% hydrophilicity, ~80% porosity and tensile 
strength ~3.99MPa) are suitable for skeletal muscle tissue regeneration. The GO-PCL 
composite showed maximum values of room temperature conductivity (σ) and dielectric 
permittivity (ε) at low (~0.79wt% GO) percolation threshold, which made this composite 
suitable for skeletal muscle TE applications . 
In the second phase (chapter-5), possibility of using abundantly available cord 
blood derived mesenchymal stem cells for myoblast differentiation was explored. Cord 
blood derived stem cells were successfully proliferated and differentiated into skeletal 
myoblast cells (hSkMCs) on the electrospun fibrous mesh of GO-PCL composite and also 
on spin coated thin GO sheets. Compared to GO sheet as the control, GO-PCL 
electrospun scaffolds were found to exhibit enhanced myoblast differentiation and also 
promoted myotube formations similar to natural orientations. The addition of GO to PCL 
provided the necessary physicochemical and biological cues required for electro-
responsive skeletal muscle tissue regeneration. Observing admirable biocompatibility of 
GO-PCL mesh for the future skeletal muscle tissue engineering applications, IGF-1 cell 
signalling pathway, which is related to myoblast differentiation and hypertrophy, was 
also studied with GO-PCL meshes. Up regulation of IGF-1 pathway molecules indicated 
better myogenic differential potential. Therefore, it was demonstrated that GO added 
electrospun GO-PCL composite meshes are highly prospective scaffolds for hMSCs  
proliferation  and differentiation for skeletal muscle tissue regeneration. 
In the third phase (chapter-6) efforts have been given to prepare and characterize 
GO-PLGA electrospun fibrous meshes similarly to the case of GO-PCL meshes.  
Morphological, structural and other characterizations of the GO-PLGA scaffolds have 
been made from the studies of XRD, SEM, FESEM, Raman, FTIR, mechanical property 
(tensile strength ~2.95MPa), contact angle (~130), biodegradation and hydrophilicity 
(~30%) behaviour.  Moreover, electrical conductivity  and dielectric constant (associated 
with surface charge) of the scaffolds were measured and percolation behaviour of the 
GO-PLGA composite meshes was investigated. Similar to the case of GO-PCL, GO-PLGA 
meshes were also found to be suitable for myoblast differentiation of cord blood derived 
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mesenchymal stem cells (chapter-7). Myoblast viability, proliferation and formation of 
myotubes were also verified by various biological characterizations. The analysis of 
aligned myotubes formation and expression of muscle specific proteins and genes were 
also observed elucidating the potentiality of this composite scaffold for TE applications. 
These results confirmed that GO-PLGA meshes are also  found to be potential candidates 
for skeletal muscle tissue regeneration using cost effective and easily available hMSCs.  
Interestingly,  from the results of present investigations (discussed in chapters 5-
7), it was  revealed, for the first time, that though the novel GO-PCL and GO-PLGA 
composite meshes exhibited excellent myoblast proliferation potential, GO-PCL 
electrospun meshes showed better myogenic potential compared to those of GO-PLGA 
meshes. This might be due to the different chemical composition of the two different 
polymers and their interaction with the GO. Moreover, GO-PCL composite was found to 
be more conducting (2.7x10-6S/m2) (which is in favour of skeletal muscle regeneration) 
than the corresponding GO-PLGA (2.8x10-7S/m2) composite. The dielectric constant of 
the GO-PCL (ɛ ~300) composite (associated with surface charge of the composite, 
discussed in chapter 8) was also found to be higher than that of GO-PLGA (ɛ ~198)  
meshes indicating GO-PCL more appealing candidate (compared to GO-PLGA) for electro-
responsive skeletal muscle TE application using hMSCs. In addition, unlike PLGA, the 
degradation of PCL does not release any toxic by-product (i.e. lactic acid and glycolic 
acid) thereby favouring enhanced biocompatibility of GO-PCL. 
In the final phase (chapter-8), an attempt has also been made to explore the 
origin of biocompatibility of GO and GO polymer composites from the studies of some 
physical properties (i.e. electrical conductivity and dielectric constant related to GO 
surface charge) of GO and GO-polymer composites. Though PCL and PLGA are insulators 
(very low conductivity ~2-5x10-9S/m2), GO-polymer composites are much higher 
conducting  compared to those of either pure polymer or GO itself. This was attributed 
to the contribution of GO surface charge and percolation behaviour exhibited by the GO-
polymer composites, with the formation of nanoclusters that actually led to the 
enhancement of conductivity and better cellular interaction leading to boost the 
biocompatibility of GO-polymer composites. This conclusion was drawn from the study 
(chapter 8) of surface charge–voltage and current–voltage characteristics of GO sheet 
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and GO-polymer composite indicating the importance of GO surface charge (Q) for the 
enhancement of conductivity and dielectric constant of the composites. It was further 
concluded  that the ionic bonds, the π-π* stacking forces created by the sp2 bonding and 
hydrophobic interaction between molecules allowed graphene to adsorb proteins and 
low molecular weight chemicals that are adsorbed by GO surface affecting  cells growth 
and proliferation which might also provide important supporting cues for the 
biocompatibility of GO and GO-Polymer meshes. 
Overall, in this dissertation, it has been demonstrated that graphene oxide-
polymer composites are excellent biocompatible scaffold materials suitable for the 
skeletal muscle tissue regeneration. Graphene oxide enhances the cellular behaviour, 
including attachment, proliferation, and even myoblast differentiation. The 
extraordinary properties, nanostructural features and surface charge jointly provide the 
necessary guiding environment for the admirable myoblast differentiation and oriented 
myotubes formation on the developed electrospun  composite scaffolds. Among the 
derived scaffolds, GO-PCL was found to be the best showing superior scaffold properties 
and myoblast differential potential making it most favourable candidate which can be 
used as a template for the skeletal muscle tissue regeneration. Moreover, it was 
established that, as an alternative to bone marrow derived stem cells, the use of 
abundantly available human umbilical cord blood (commonly considered as a biological 
waste) derived mesenchymal stem cells would also be beneficial to develop tissue 
constructs in an economical and  more efficient way. 
It is finally concluded that development of such novel graphene oxide based 
composite scaffolds, GO-PCL in particular, might pave the way for their application for 
the next generation skeletal muscle regeneration by developing tissue grafts for clinical 
applications. 
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9.1.  Future Scope of Research  
In the present dissertation, we have confirmed excellent in-vitro biocompatibility and 
myogenic differentiation potential of GOnPs sheet, GO-PCL and GO-PLGA 
nanocomposite electrospun meshes using human cord blood derived mesenchymal 
stem cells.  
The suggested future research study can be summarized as follows: 
 In-vivo biocompatibility study using animal model. 
 Biocompatible reduced graphene oxide (rGO), another derivative of graphene, 
might also form important rGO-polymer composite suitable for myoblast 
differentiation.  
 Generation of skeletal muscle tissue constructs using bioreactor and its 
optimizations. 
 Scale up of the fabrication of electrospun GO-PCL composite scaffold. 
 Developing appropriate preservation strategies (such as cryopreservation) for 
long term storage of the developed constructs for future use.  
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